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Abstract 
Yi Su 
Modification of Polysialic Acid towards Scaffolds for Tissue Engineering and Synthesis 
of Sialic Acid Derivatives 
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Tissue engineering is a powerful tool in the field of regenerative medicine. It provides the 
opportunity to generate artificial organs and tissues. More and more attention is drawing to 
this topic due to the lack of organ donors. A challenging technology in this field is the synthe-
sis of suitable scaffold materials which mimic the extracellular matrix of the required tissue. 
An ideal scaffold should provide an optimal environment for cell adhesion, proliferation, and 
growth.  
Three dimensional scaffolds based on natural occurring polysaccharides fulfill these require-
ments. In the past, various scaffolds based on polysaccharides such as chitosan, alginate, and 
hyaluronate were used for tissue engineering. The aim of this study was to synthesise novel 
3D-scaffolds based on α-2,8-polysialic acid (polySia) for applications in nerve regeneration. 
PolySia is a promising candidate for tissue engineering due to its poor immunogenicity, non-
cytotoxicity, and selective enzymatic degradability. To form three dimensional water insolu-
ble networks, polySia was decorated with different functional groups. PolySia hydrogels were 
successfully prepared using three crosslinking strategies including Cu-catalyzed and metal-
free “click” chemistry (A), photopolymerization (B), or hydrazone crosslinking (C). The syn-
thesized polySia hydrogels were investigated regarding their biocompatibility and biodegrad-
ability. Hydrogels were degradable by endosialidase endoNF, when the degree of derivatiza-
tion was adjusted under 50%. In order to improve the cell-scaffold interactions, the polySia 
scaffolds were successfully immobilized with cyclic RGD peptides.  
Besides the derivatization of polysaccharides, their monomeric unit, neuraminic acid was also 
modified with various functionalities such as azido-, alkyno-, methacryl-, and pentenyl-
groups. To get functional polymers, the modified monosaccharides should be enzymatically 
polymerized in further investigations.  
 
Zusammenfassung 
Yi Su 
Modifikation von Polysialinsäure zur Synthese neuer Gerüstmaterialien für das Tissue 
Engineering und Synthese Sialinsäure Derivate 
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Tissue Engineering ist ein zunehmend bedeutsames Feld im Bereich der regenerativen Medi-
zin, da es die Herstellung künstlicher Organe und Gewebe ermöglicht. Aufgrund einer gerin-
gen Verfügbarkeit von Spenderorganen, gewinnt das Tissue Engineering mehr und mehr 
Aufmerksamkeit. Eine anspruchsvolle Aufgabe in diesem Bereich ist die Synthese von geeig-
neten Gerüstmaterialien, die die extrazelluläre Matrix des entsprechenden Gewebes imitieren. 
Ein ideales Gerüstmaterial bietet eine geeignete Umgebung für Zell-adhäsion, -Proliferation 
und -Wachstum.  
Dreidimensionale Gerüstmaterialien basierend auf natürlich vorkommenden Polysacchariden 
erfüllen diese Anforderungen. In der Vergangenheit, werden verschiedene Gerüstmaterialien, 
die auf den Polysacchariden wie Chitosan, Alginat und Hyaluronat basieren, für das Tissue 
Engineering eingesetzt. Ziel der vorliegenden Arbeit war die Synthese von neuartigen 3D-
Gerüsten basierend auf α-2,8-Polysialsäure (PolySia) für die Anwendungen in der Nervenre-
generation. PolySia ist ein besonders viel versprechendes Polymers aufgrund seiner begüns-
tigten Immunogenität, Nicht-Zytotoxizität und enzymatischen Abbaubarkeit. Um dreidimen-
sionale, wasserunlösliche Netzwerke herzustellen, wurde das Polysaccharid mit verschiede-
nen funktionellen Gruppen modifiziert. Die polySia Hydrogele wurden unter Verwendungen 
von drei Vernetzensstrategien erfolgreich hergestellt: Cu-katalysierte und Metall-freie "click“ 
Chemie (A), Photopolymerisation (B), oder Hydrazon-basierte Quervernetzung (C). Die syn-
thetisierten PolySia Hydrogele wurden hinsichtlich ihrer biologischen Abbaubarkeit unter-
sucht. Wenn die PolySia in Derivatisierungsgraden unter 50% funktionalisiert wurden, die 
PolySia Hydrogele waren enzymatisch abbaubar gegenüber der Endosialidase EndoNF Um 
die Adhäsion von Zellen auf PolySia Hydrogels zu erhöhen, wurden die Hydrogels auch mit 
zyklischen RGD Peptide erfolgreich funktionalisiert. 
Neben der Derivatisierung der Polysaccharide wurde auch dessen Monomer Neuraminäure 
mit verschiedenen Funktionalitäten wie Azid-, Alkin-, Methacryl-, und Pentenyl-Gruppen 
modifiziert. Um die funktionalisierten Polymere zu erhalten, sollten die modifizierten Mono-
saccharide in folgende Experimenten enzymatisch polymerisiert.  
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1 Introduction Background  
1.1 General aspects of tissue engineering  
The term “Tissue Engineering” was initially defined at the first National Science Foundation 
(NSF) sponsored meeting in 1988 as “application of the principles and methods of engineer-
ing and life sciences towards fundamental understanding of structure-function relationship in 
normal and pathological mammalian tissues and the development of biological substitutes for 
the repair or regeneration of tissue or organ function.”1 The commonly applied definition of 
tissue engineering was given by Langer and Vacanti as “an interdisciplinary field that applies 
the principles of engineering and life sciences towards the development of biological substi-
tutes that restore, maintain, or improve tissue".2 Tissue engineering has also been defined by 
Macarthur and Oreffo as "understanding the principles of tissue growth and applying this to 
produce functional replacement tissue for clinical use." 3 
Tissue engineering in the nervous system facilitates the controlled application and organiza-
tion of neural cells to perform appropriate diagnostic and therapeutic tasks in the nervous sys-
tem.4 This is a novel strategy for the therapy of human neurodegenerative diseases such as 
Parkinson´s disease. Over the last decades the investigations of tissue engineering in the nerv-
ous system focussed on the following three areas: 5(i) “The functional replacement of missing 
neuroactive components; (ii) The rescue or regeneration of degenerated neural tissue; (iii) The 
building of intelligent neural cell-based biosensors and simple in vitro neural circuits.”  
Tissue engineering is a combination of cells, biomaterials, and signalling molecules such as 
growth factor. Cells are harvested and dissociated from the donor tissue including nerve, liver, 
pancreas, cartilage, and bone. Embryonic or adult stem or precursor cells are used as well. 
Biomaterials are scaffold substrates in which cells are attached, cultured, and followed by 
implantation at the desired site of the functional tissue. Growth factors were naturally occur-
ring proteins capable of stimulating cellular proliferation and cellular differentiation. They are 
important for the regulation a variety of cellular processes. 
The basic principles of tissue engineering are illustrated in Figure 1. At first, different cells 
(osteoblasten, chondrozyten, hepatozyten, enterozyten, and urotheliale cells) are isolated from 
                                                 
1
 R. Skalak, C. F. Fox, Tissue engineering. Granlibakken, Lake Tahoe: Proc workshop, New York Liss, 1988, 
26–29. 
2
 R. Langer, J. P. Vacanti, Science 1993, 260, 920-926. 
3
 B. D. Macarthur, R. O. C. Oreffo, Nature 2005, 433, 19. 
4
 R. Bellamkonda, P. Aebischer, The Biomedical Engineering Handbook, Second Edition. CRC Press LLC, 
2000. 
5
 R. Bellamkonda, P. Aebischer, Biotechnol. Bioeng. 1994, 43, 543-554. 
Introduction and Background                                                                                                    2 
the patient’s body and expanded in a Petri dish in vitro. Once enough cells are available, they 
can be seeded on a polymeric scaffold material and cultured in vitro in a bioreactor or incuba-
tor under appropriate conditions. When the construct is matured enough it can be implanted in 
the area of defect in the patient’s body.  
 
Figure 1. Schematic illustration of the basic principles of tissue engineering.6  
1.2 Biodegradable scaffold matrices for tissue engineering  
Scaffolds used in tissue engineering should have biological and physical properties which are 
compatible with the physiological conditions in vitro and in vivo. The major function of the 
scaffolds is to provide a temporary support to tissue structures. The scaffolds are commonly 
made from biodegradable polymers. In this context, biodegradability means that the polymer 
can be digested into less complex intermediates by enzymes and the end products can be eas-
ily removed by solubilisation or simple hydrolysis from the implantion site. 7 The degradation 
rate of the biopolymers depends on crystallinity, molecular weight, hydrophobicity, and loca-
tion in the body. Additionally, the process conditions for the formation of the scaffolds also 
play a critical role for the biodegradability. 
Ideally the scaffolds should regulate cell adhesion, proliferation, expression of a specific phe-
notype and extracellular matrix deposition in a predictable and controlled fashion. An ideal 
biodegradable polymer for a particular application should be configured possessing the fol-
lowing properties:  
 The scaffold should have an appropriate mechanical strength to mimic in vivo condi-
tions. 
 The polymer does not invoke an inflammatory or toxic response. 
                                                 
6
 Image from http://web.iitd.ac.in/~textile/highlights/fol8/01.htm 
7
 Y. Tabata, J. R. Soc. Interface 2009, 6, 311-324. 
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 The polymer is metabolised in the body after fulfilling its purpose, leaving no trace 
(bioabsorbable). 
 The polymer is easily processable into the final 3D form. It should be either porous or 
compatible with a range of extremely additives (starch, salt) to create porosity. 
 The polymer demonstrates acceptable shelf life and is easily sterilized.  
Biodegradable polymers can be basically classified into four types.8  They are (i) natural 
polymers, (ii) synthetic polymers, (iii) composites, and (iv) hydrogels. Natural polymers used 
for tissue engineering applications include collagen, alginate, agarose, chitosan, fibrin, and 
hyaluronic acid. Synthetic polymers compared to natural polymers offer many advantages. 
They are more flexible, more predictable, and processable into different size and shapes. Fur-
thermore, the physical and chemical properties of synthetic polymers can be modified and 
their mechanical and degradation characteristics can be altered by changing the chemical 
composition of the macromolecular precursor. Composites are polymers prepared from two or 
more materials to produce a better scaffold taking the advantages from each of the materials 
independently. Hydrogels are three-dimensional highly hydrated polymeric networks, which 
swell in water without dissolving. Most of the naturally occurring polymers can be syntheti-
cally modified to form hydrogels such as collagen, alginate, agarose9 Due to the natural origin 
these hydrogels have macromolecular properties similar to the natural extracellular matrix 
(ECM). Hydrogels made of nature polymers often have high tissue compatibility and are suit-
able for many tissue engineering applications.10 Hydrogels are usually made of hydrophilic 
polymers, which are crosslinked by various interactions including chemical bonds, hydrogen 
bonding, ionic interactions, and hydrophobic interactions. Crosslinking can be achieved either 
through physical (UV irradiation, freeze drying and heating) and chemical means such as 
ionic crosslinking in the presence of divalent ions or by chemical crosslinkers such as 
diepoxyoctane and glutaraldehyde. Besides the standard chemical crosslinking methods some 
novel approaches like hydrazone crosslinking and “click” chemistry11 have been used to con-
struct 3D hydrogels for tissue engineering.   
1.3 Scaffold materials based on polysaccharides 
The selection of the scaffold material plays a key role in the design and development of a par-
ticular tissue engineering product. In addition, the process conditions and additives can also 
                                                 
8
 H. Y. Cheung, K. T. Lau, T. P. Lu, D. Hui, Composites. Part B 2007, 38, 291-300.  
9
 N. A. Peppas, P. Bures, W. Leobandung, H. Ichikawa, Eur. J. Pharm. Biopharm. 2000, 50, 27-46. 
10
 A. Montembault, C. Viton, A. Domard, Biomaterials 2005, 14, 1633-1643. 
11
 S. A. Krovi, D. D. Smith, S. B. T. Nguyen, Chem. Commun. 2010, 46, 5277-5279. 
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affect the mechanical performance of biodegradable polymers. Polysaccharides, the widest 
distributed naturally occurring biopolymer, possess excellent properties including non-toxicity 
and good water solubility.12 Furthermore, polysaccharides have a broad variety of chemical 
structures such as linear chains or various degrees of branching. Besides hydroxyl groups they 
often contain functional groups such as amino and carboxyl groups. These groups can be eas-
ily modified or functionalized with other groups. The naturally occurring polymers are often 
biodegradable and biocompatible. Therefore, polysaccharides are suitable macromolecular 
precursors for the synthesis of 3D-scaffolds in tissue engineering.  
1.3.1 Scaffold materials from Alginate and Hyaluronate 
Alginic acid 1 (also called algin or alginate) is one of the most versatile natural materials 
known to form 3D-hydrogels. Alginate is a linear unbranched anionic polysaccharide which is 
widely distributed in the cell walls of brown algae. Alginate consists of 1,4-linked ß-D-
manuronic acid (M) and α-L-guluronic acid (G) with a molecular mass ranging from 10,000 
up to 600.000 Da (Figure 2).  
 
Figure 2. Structural date for alginates: A) The monomers of alginate; B) The alginate chain. 
The hydrogel based on alginate has reversible gelling properties in aqueous solutions due to 
the ionic interactions of the carboxylic acid moieties on the sugar residues with divalent 
cations like calcium, barium, and magnesium.13 Due to limitation in the control of mechani-
cally properties, swelling ratios, and degradation profiles the ionic crosslinked alginate hy-
drogels are limited to the applications in tissue engineering. The investigation of photo-
crosslinked alginate hydrogels has gained increased attention.   
                                                 
12
 M. A. Barbosa, P. L. Granja, C. C. Barrias, I. F. Amaral, ITBM-RBM 2005, 26, 212-217. 
13
 T. Covillo, P. Matricardi, C. Marianecci, F. Alhaique, J. Controlled Release 2007, 119, 5-24. 
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Hyaluronic acid 2 (also called hyaluronan, or hyaluronate) is also a naturally occurring linear 
polysaccharide comprised of ß-1,4-linked D-glucuronic acid (ß-1,3) N-acetyl-D-glucosamine 
disaccharide units (Figure 3). This polyanionic polymer can consist of 25,000 disaccharide 
units in length and has a range of naturally occurring molecular sizes from 1000,000 to 
10.000.000 Da. It can be found in connective, epithelial, and neural tissues of all higher ani-
mals. 
 
Figure 3. Structure of hyaluronate 2 composing of D-glucuronic acid and N-acetyl-D-glucosamine. 
Hyaluronate is enzymatically degraded by hyaluronidase and is completely resorbable 
through multiple metabolic pathways.14 Therefore, hyaluronate is an ideal candidate for tissue 
engineering and for modulation of wound healing.15  
1.3.2 PolySia as a biomaterial for neural tissue engineering  
Polysialic acid 3 (polySia) is a homopolymer of 8-200 sialic acid units. The most common 
structure of polySia is the negatively charged homopolymer of α-2,8-linked neuraminic acid 
residues (Figure 4).  
O
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Figure 4. Structure of α-2,8-linked polSia 3 (polySia (sodium salt)).  
The structure of polySia was analyzed by Sato and co-workers using different methods in-
cluding methylation analysis, NMR, and mild acid hydrolysis-TLC. They described the con-
formation of polySia as a helical structure in which the N-acetyl residue of the C-5 position 
faces the outer spacer of the helix.16  
                                                 
14
 P. A. Band, Portland Press Ltd 1998, 33-42. 
15
 J. B. Leach, K. A. Bivens, C. W. Patrick Jr, C. E. Schmidt, Biotechnol. Bioeng. 2003, 82, 579-589.  
16
 C. Sato, K. Kitajima, Experimental Glycoscience 2008, Part 1, Section II, 77-81. 
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PolySia 3 was first identified in the glycocalyx of neuroinvasive bacteria. PolySia conjugates 
in vertebrates are for example the polysialoglycoprotein (PSGP) in fish egg, in the neural cell 
adhesion molecule (NCAM) in brain, a voltage-gated sodium channel in eel and rat brain, 
CD36 in human milk, and neuropilin-2 in human lymphocytes. 17 In humans polySia is ex-
pressed in embryonic brains during neural differentiation and mostly disappears in adult 
brains.  
PolySia on NCAM possesses antiadhesive effects on the cell-cell/extracellular matrix interac-
tion due to its bulky polyanionic nature.18 It is also involved in tumor progression and differ-
entiation.19,20 In nervous system, polySia plays an important part in cell migration, axonal 
guidance, synapse formation, and functional plasticity via not only homophilic binding of 
NCAM but also heterophilic binding of other cell adhesion molecule (CAMs) in a tissue- and 
stage-specific manner.21  
For neural tissue engineering, polySia 3 was used for the synthesis of 3D-scaffold 4 which 
was completely degradable and presented good biological properties like perfect cytocom-
patibility and no cytotoxicity by viability assay on cultured Schwann cells.22 In a previous 
investigation, a biocompatible scaffold material on the basis of polySia has been developed 
for nerve regeneration. For the synthesis of the scaffold material diepoxyoctane was used as a 
hydrophobic cross-linking agent to increase the molecular weight of the polymer and decrease 
its hydrophilicity resulting in a flexible network structure (Scheme 1).  
 
Scheme 1. A 3D-scaffold based on the polySia use of diepoxyoctane as crosslinker. 
                                                 
17
 Y. Kanato, K. Kitajima, C. Sato, Glycobiology 2008, 18, 1044-1053. 
18
 L. Bonfanti, Prog. Neurobiol. 2006, 80, 129-164. 
19
 J. L. Bruse´s, U. Rutishauser, Biochimie 2001, 83, 635-643. 
20
 U. Rutishauser, Nat. Rev. Neurosic. 2008, 9, 26-35. 
21
 J. L. Bruses, U. Rutishauser, Glycobiology 2000, 116-128. 
22
 Y. Haile, S. Berski, G. Dräger, A, Nobre, K. Stummeyer, R. Gerardy-Schahn, C. Grothe, Biomaterials 2008, 
29, 1880-1891. 
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The analysis of neural and glial cell viability on the scaffold material and the degradability of 
the hydrogel by phage born endosialidase demonstrated that the novel biomaterial is well suit-
able for neural tissue engineering.23 
1.4 Strategies for 3D-scaffold formation 
Since 3D-scaffolds were introduced as novel materials possibly suitable for a variety of appli-
cations in the field of tissue engineering, they have become a fast-developing and exciting 
research field. In last decade, various crosslinking strategies were based on chemical reaction 
or physical interactions exploited for the design of polymeric networks. The often applied 
chemical crosslinking approaches included photopolymerization, hydrazone crosslinking, 
“click” chemistry, and other chemical reactions. 
1.4.1 Hydrogel formation via photocrosslinking 
Photopolymerization is used to convert a liquid monomer or macromer to a hydrogel by free 
radical polymerization at room temperature or under physiological conditions. As an exciting 
new technique, photopolymerization has obtained considerable attention in the area of tissue 
engineering in recent years. Up to date, photopolymerization techniques are applied in many 
different research areas. For example, photopolymerized hydrogels have been investigated for 
a number of biomaterial applications including prevention of thrombosis, post-operative adhe-
sion formation, drug delivery, coatings for biosensors, and for cell transplantation.24 Further-
more, photopolymerization was used in the fabrication of electronic and printing materials as 
well as for coating and surface modifications.25 
Many photopolymerizable macromolecular hydrogel precursors like PEG acrylate deriva-
tives,26 PEG methacrylate derivatives,27 polyvinyl alcohol (PVA) derivatives,28 and dextran 
methacrylate29 were developed. The common principle is illustrated in Scheme 2. The mac-
romolecular precursor is initially functionalized with methacrylate group. The modified mac-
romolecular precursor is dissolved in a solution containing a suitable photoinitiator, which is a 
light-sensitive compound used to create free radicals. The solution is then irradiated by UV-
                                                 
23
 S. Berski, J. V. Bergeijk, D. Schwarzer, Y. Stark, C. Kasper, T. Scheper, C. Grothe, R. Gerardy-Schahn, 
A. Kirschning, G. Dräger, Biomacromolecules 2008, 9, 2353-2359.  
24
 K. T. Nguyen, J. L. West, Biomaterials 2002, 23, 4307-4314. 
25
 A. B. Scranton, C. N. Bowman, ACS Publishers, New Orleans 1996. 
26
 A. S. Sawhney, C. P. Pathak, J. A. Hubbell, Macromolecules 1993, 26, 581-587. 
27
 J. Elisseeff, W. Mclntosh, J. K. Anseth, S. Riley, P. Ragan, R. Langer, J. Biomed. Mater. Res. 2000, 51, 
164-171. 
28
 P. Martens, K. S. Anseth, Polymer 2000, 41, 7715-7722. 
29
 S. H. Kim, C. C. Chu, J. Biomed. Mater. Res. 2000, 49, 517-527. 
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light at a wave length of 245 nm to form the crosslinked hydrogel. The mechanical properties 
of the hydrogel such as swelling, compression and creep compliance can be easily controlled 
by changing the degree of methacrylate modification.30 
 
Scheme 2. Schematic illustration of 3D-hydrogel formation from methacrylate modified macromolecular precur-
sor using photopolymerization.  
For the photoinitiator, many factors should be considered such as its biocompatibility, solubil-
ity in water and cytotoxicity. Photopolymerized hydrogels were often used in in vivo system. 
Therefore, the photoinitiator should be nontoxic and very efficient in low concentration. Ac-
cording to the mechanism involved in photolysis, photoinitiators are classified in two types 
include cationic and radical photoinitiators. Cationic photoinitiators are problematic for tissue 
engineering application since they generate protonic acids. Most photoinitiators used for tis-
sue engineering applications are radical photoinitiators. As one example, Irgacure 2959 is 
commonly used as photoinitiator to form hydrogels for tissue engineering due to its high 
solubility in water and its minimal toxicity compared to other photoinitiators. Upon UV-
irradiation Irgacure 2959 undergoes a homolytic cleavage resulting in two radicals 
(Scheme 3).31  
 
Scheme 3. The chemical structure of Irgacure 2959 (A) and creating of radical by photocleavage (B).  
                                                 
30
 A. I. V. D. Bulcke, B. Bogdanov, N. D. Rooze, E. H. Schacht, M. Cornelissen, H. Berghmans, 
Biomacromolecules 2000, 1, 31-38. 
31
 B. D. Fairbanks, M. P. Schwartz, C. N. Bowman, K. S. Anseth, Biomaterials 2009, 30, 6702-6707. 
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A novel photocrosslinked alginate hydrogel was developed by Jeon and co-workers.32 They 
also characterized the procedure of the polymerization using 1H-NMR analysis. Sodium algi-
nate 1 has been functionalized with methacrylate groups by reacting low molecular weight 
alginate with 2-amionethyl methacrylate 5 in presence of N-hydroxy succinimide (NHS) and 
EDC to give methacrylated alginate 6. The 3D alginate hydrogel 7 was obtained by irradiation 
using UV-light with 0.05% (w/v) photoinitiator (Scheme 4).  
 
Scheme 4. Synthesis of alginate hydrogel based on methacrylated alginate using photopolymerization.  
The photocrosslinked alginate hydrogels showed low cytotoxicity and excellent 
cytocompatibility. The hydrogels have broad biomedical applications, including use in cell 
transplantation and drug delivery. This gelling methodology can also be used for the synthesis 
of biodegradable 3D-scaffold materials for tissue engineering based on many other naturally 
occurring polymers and synthetic polymers.33 For example, Smeds and co-workers have re-
ported on a viscoelastic gels from two methacrylate modified polysaccharides alginate and 
hyaluronate using photopolymerization.34 
                                                 
32
 O. Jeon, K. H. Bouhadir, J. M. Mansour, E. Alsberg,  Biomaterials 2009, 30, 2724-2734. 
33
 Q. P. Hou, P. A. D. Bank, K. M. Shakesheff, J. Mater. Chem. 2004, 14, 1915-1923. 
34
 K. A. Smeds, M. W. Grindstaff, J. Biomed. Mater. Res. 2001, 54, 115-121.  
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1.4.2 Hydrogel formation via hydrazone crosslinking 
Hydrazone crosslinking provides also a powerful method for the chemical hydrogel formation 
as well as site-specific crosslinking of biomolecules. Carbonyl-groups (aldehydes and ke-
tones) react with hydrazides and amines at slightly acidic aqueous conditions (pH = 5-7) to 
form hydrazones and water as by-product. This method can be used for in situ gelling scaffold 
materials including hyaluronate, alginate, and dextran hydrogels.35 Aldehydo- and hydrazido- 
functional groups were introduced to the macromolecular precursors, and then simply mixed 
in aqueous solution to create 3D-hydrogel network (Scheme 5).  
 
Scheme 5. Schematic illustration of 3D-hydrogel formation from aldehydo- and hydrazido-modified macromo-
lecular precursor using hydrazone crosslinking. 
Ossipov and co-workers described the development of an injectable hydrogel based on hy-
drazido- and aldehyde-modified polyvinyl alcohol (PVA) precursors. The hydrogel was 
formed in situ after injection. They demonstrated that the hydrazone crosslinking chemistry is 
a biocompatible method thus it can potentially be used for cells and tissues.36 Luo and co-
workers developed crosslinked hyaluronate hydrogel films for drug delivery using a macro-
molecular crosslinker poly(ethylene glycol)-propiondialdehyde 8 (PEG-diald) under neutral 
aqueous conditions.37 For their applications, the hyaluronate 2 was functionalized with hy-
drazide groups. Under aqueous acidic conditions, the carboxylic acid group of the glucuronic 
acid reacted with the adipic dihydrazide 9 (ADH) in the presence of coupling reagent EDC 
resulting to desired hydrazide-modified product 10. The 3D hyaluronate hydrogel 11 was 
formed by simply mixing the modified hyaluronate and PEG-dialdehyde in water (Scheme 6). 
The resulted hydrogel film has significant potential to act as a delivery vehicle for sustained 
release of drugs at wound sites.  
                                                 
35
 Y. Luo, J. B. Kobler, J. T. Heaton, X. Q. Jia, S. M. Zeitels, R. langer, J. Biomed. Mater. Res. B 2010, 93, 
386-393. 
36
 D. A. Ossipov, K. Brännvall, K. Forsberg-Nilsson, J. Hilborn, J. Appl. Polym. Sci. 2007, 106, 60-70. 
37
 Y. Luo, K. R. Kirker, G. D. Prestwich. J. Controlled Release 2000, 69, 169-184.  
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Scheme 6. Synthesis of hyaluronate hydrogel based on hydrazide modified alginate using hydrazone crosslink-
ing. 
1.4.3 Application of “click” chemistry in the field of polymer science 
The [2+3] dipolar cycloaddition between an azide and an acyclic alkyne was developed by 
Huisgen.38 The reaction requires heat to overcome the activation barrier to deform the alkyne 
bond angle and form the triazole. It often produces mixtures of two regioisomers when using 
asymmetric alkynes.39 In 2001, Sharpless developed a Cu-catalyzed version of this reaction 
using terminal alkynes as substrates allowing the selective synthesis of 1,4-disubstituted re-
gioisomers and introduced the name “click” reaction.40 By definition “click” reactions are 
hemoselective high yielding with little or no by-products, and can be carried out under various 
reaction conditions.41 
The mechanism of the Cu-catalyzed azide-alkyne cycloaddition (CuAAC) reaction was dis-
cussed by Fokin (Scheme 7). 42 
                                                 
38
 R. Huisgen, Angew. Chem. Int. Ed. Engl. 1963, 2, 565-598. 
39
 J. C. Jewett, C. R. Bertozzi, Chem. Soc. Rev. 2010, 39, 1272-1279. 
40
 V. V. Rostovtsev, L. G. Green, V. V. Fokin, K. B. Sharpless, Angew. Chem. Int. Ed. 2002, 41, 2596-2599. 
41
 M. G. Finn, V. V. Fokin, Chem. Soc. Rev. 2010, 39, 1231-1232. 
42
 P. Wu, V. V. Folkin. Aldrichimica ACTA 2007, 40, 7-17. 
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Scheme 7. The proposed mechanism of the1,3-dipolar cycloaddition of azides and alkynes.42 
In the first step, Cu(I) coordinates to the alkyne forming the copper acetylide II. In water, this 
step has been calculated to be exothermic by 11.7 kcal/mol. Then the azide group binds to 
copper giving intermediate III which is converted to the unusual 6-membered copper metalla-
cycle IV. The reaction is endothermic by 12.6 kcal/mol with a calculated barrier of 18.7 
kcal/mol. Compound IV is not stable therefore it leads to the triazolyl-copper derivative V. 
Protonolysis of V releases the final triazole and closes the catalytic cycle.43,44 
The active Cu(I) catalyst can be generated from Cu(I) salts like CuBr and CuI. In cases where 
the Cu(I) species are not stable enough the Cu(I) catalyst can be generated from Cu(II) salts 
using sodium ascorbate as the reducing reagent. Besides the Cu-catalyst, Ruthenium can be 
used as catalyst for “click” reaction termed as RuAAC as well. In contrast to the CuAAC the 
RuAAC leads to 1,5-disubstituted 1,2,3-triazoles and can be used with internal alkynes to 
provide fully substituted 1,2,3-triazoles.45 Besides the two species Ni(II), Pt(II) and Pd(II) can 
also be used in azide-alkyne 1,3-dipolar cycloaddition.  
The metal catalyzed azide/alkyne “click” reaction has experienced wide application in poly-
mer, material, and surface science.46 In the area of tissue engineering the “click” reaction was 
used for the formation of 3D-hydrogel which was used as material for cell growth. The poly-
mers were modified with azide and alkyne residues, respectively. When the two solutions 
                                                 
43
 A. Ulman, Chem. Rev. 1996, 96, 1533-1554. 
44
 R. K. Smith, S. M. Reed, P. A. Lewis, J. D. Monnell, R. S. Clegg, K. F. Kelly, L. A. Bumm, J. E. Hutchison, 
P. S. Weiss, J. Phys. Chem. B 2001, 105, 1119-1122. 
45
 B. C. Boren, S. Narayan, L.K. Rasmussen, L. Zhang, H. Zhao, Z. Lin, G. Jia, V. V. Fokin, J. Am. Chem. Soc. 
2008, 130, 8923-8930. 
46
 W. H. Binder, R. Sachsenhofer, Macromol. Rapid Commun. 2007, 28, 15-54. 
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were mixed together a 3D-hydrogel was obtained through the formation of the triazole con-
nection in the presence of a Cu-catalyst (Scheme 8).   
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Scheme 8. Schematic illustration of 3D-hydrogel formation from azido- and alkyno-modified macromolecular 
precursor using Cu-catalyzed “click” cycloaddition. 
However, the CuAAC has its limitations in living systems due to the potential toxicity of the 
copper catalyst.47 For example, the copper catalyst may induce oligonucleotide48 and polysac-
charide49 degradation. In order to overcome this drawback, Bertozzi and co-workers devel-
oped an alternative approach without metal-catalyst which was a strain-promoted [3+2] 
cycloaddition between azides and different strained cyclooctyne derivatives (12-15, Fig-
ure 5).50 They named this metal-free “click” reaction a strain-promoted alkyne-azide cycload-
dition (SPAAC).51 This method was widely used in the field of ligation processes like bioor-
thogonal labelling in living system. 
 
Figure 5. Strain-promoted alkyne-azide cycloaddition (SPAAC) and structures of the most commonly employed 
clickable cyclooctynes.  
                                                 
47
 C. W. Tornøe, C. Christensen, M. Meldal, J. Org. Chem. 2002, 67, 3057-3064. 
48
 J. Gierlich, G. A. Burley, P. M. E. Gramlich, D. M. Hammond, T. Carell, Org. Lett. 2006, 8, 3639-3642. 
49
 E. Lallana, E. Fernandez-Megia, R. Riguera, J. Am. Chem. Soc. 2009, 131, 5748-5750. 
50
 a) N. J. Agard, J. M. Maskin, J. A. Prescher, A. Lo, C. R. Bertozzi, ACS Chem. Biol. 2006, 1, 644-648;  
b) J. C. Jewett, C. R. Bertozzi, Chem. Soc. Rev. 2010, 39, 1272-1279.  
51
 N. J. Agard, J. A. Prescher, C. R. Bertozzi, J. Am. Chem. Soc. 2004, 126, 15046-15047. 
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The metal-free “click” chemistry is hampered by the limited commercial availability and 
lengthy synthetic routes to prepare the most common cyclooctynes. Most of reaction strate-
gies require more than eight synthetic steps while the yields are usually very low.52 As alkyne 
surrogate an activated oxanorbornadiene was developed by Rutjes and co-workers.53 The ox-
abridged bicyclic system 18 can be prepared by a Diels-Alder reaction from substituted propi-
onate 16 and furan in high yield. Firstly, the oxanorbornadiene reacts with an azide in a [3+2] 
cycloaddition to give an intermediate which gives a stable 1,2,3-triazole linkage (Scheme 9). 
This method was a combination of ring strain and electron deficiency. The strong electron 
withdrawing effect of the trifluoromethyl substituent results in an activation of the adjacent 
double bond which is more reactive than a common triple bond.  
 
Scheme 9. Synthesis of oxanorbornadiene and the metal-free “click” reaction of oxanorbornadiene with azido to 
form a triazole linkage. 
This method was used as an important tool for bioconjugation like labelling of peptide and 
proteins in living systems. For example, the cycloaddition of an azide functionalized cyclic 
RGD-containing peptide (see chapter 1.5) and diethylenetriaminepentaacetic acid (DTPA)-
functionalized oxanorbornadiene resulted in the formation of the desired RGD-CF3-triazole-
DTPA conjugate which showed high affinity for integrin receptor avß3 and favourable phar-
macokinetics.54 Up to date there is no report in which the method is used in the area of poly-
mer chemistry. In this dissertation the oxanorbornadienyl-linker will be used to achieve 3D-
scaffold material formation. The azido- and oxanorbornadienyl-system modified macromo-
lecular precursors are crosslinked each other via the CF3-triazole linkage to give a network 
structure (Scheme 10).  
                                                 
52
 J. Dommerholt, S. Schmidt, R. Temming, L. J. A. Hendriks, F. P. J. T. Rutjes, J. C. M. van Hest, D. J. Lefeber, 
P. Friedl, F. L. van Delft, Angew. Chem. Int. Ed. 2010, 49, 9422-9425. 
53
 S. S. van Berkel, A. J. Dirks, M. F. Debets, F. L. van Delft, J. J. L. M. Cornelissen, F. P. J. T. Rutjes, 
ChemBioChem 2007, 8, 1504-1508.  
54
 S. S. van Berkel, A. J. Dirks, S. A. Meeuwissen, D. L. L. Pingen, O. C. Boerman, P. Laverman, F. L. van Delft, 
J. J. L. M. Cornelissen, F. P. J. T. Rutjes, Chembiochem 2008, 9, 1805-1815.  
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Scheme 10. Schematic illustration of 3D-hydrogel formation from azido- and oxanorbornadienyl-modified mac-
romolecular precursors using metal-free “click” cycloaddition. 
1.5 Significance of RGD peptides for tissue engineering  
The interactions of cells and extracellular matrix are vital for tissue engineering. This interac-
tion can be facilitated by the adhesion of integrin receptors and ECM which is called recep-
tor–mediated cell binding (Figure 6, A). Integrins are a class of cell surface receptors that 
mediate the interconnection between a cell and the surrounding tissues such as other cells or 
ECM. A few known integrins recognize and bind to a trimer RGD peptide sequence which is 
also present in ECM compound and can mediate adhesion of many cell types including neu-
rons.55,54 The RGD peptide sequence was first discovered in fibronectin by Pierschbacher & 
Ruoslahti.56  This tripeptide motif can also be found in other ECM proteins such as fibrino-
gen, prothrombin, tenascin, thrombospondin, vitronectin, von Willebrand factor, Adenovirus 
penton base protein, bone sialoprotein, collagen, decorsin and disintegrins.57 Many cyclic 
RGD peptides and peptide templates have a greater stability and selectivity over linear pep-
tides and were designed and synthesized for many different purposes. Cyclo (Arg-Gly-Asp-D-
Phe-Lys) is one of the various cyclic RGD peptides raised our interest and is an integral part 
of this thesis. According to the structure-activity relationship (SAR) investigations by Kessler 
58
 the Arg(R)-Gly(G)-Asp(D) sequence plays a crucial role for the adhesion process of cells 
and ECM as a common receptor recognition motif. The hydrophobic aromatic amino acid 
with D-conformation (D-Phe) in position 4 also increases the activity for some integrins like 
the αvβ3 receptor. The amino acid in position 5 (Lys) does not significantly influence the ac-
tivity and selectivity of the RGD-sequence. The lysine residue can act as spacer or anchors for 
                                                 
55
 U. Hersel, C. Dahmen, H. Kessler, Biomaterials 2003, 24, 4385-4415.  
56
 M. D. Pierschbacher, E. Ruoslahti, Nature 1984, 309, 30-33. 
57
 a) P. C. Brooks, Eur. J. Cancer, 32a 1996, 2423-2429; 
b) E. F. Plow,  T. A. Haas, L. Zhang, J. Loftus, J. W. Smith, J. Biol. Chem. 2000, 275, 21785-21788.   
58
 R. Haubner, R. Gratias, B. Diefenbach, S.L. Goodman, A. Jonczyk, H. Kessler, J. Am. Chem. Soc. 1996, 118, 
7461-7472. 
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diverse surfaces.59 The ε–amino group of the lysine residue can react with carboxyl or alde-
hyde groups. The amino group is frequently modified into an azide moiety for conjugation 
with other groups like alkynyl group via “click” reaction (Figure 6, B).60 
Many scaffolds immobilized with RGD peptides were developed in purpose to enhance the 
interaction of cells and scaffold. For example, Lee and co-workers synthesized a type of RGD 
peptide immobilized hyaluronate hydrogel and used this material for brain tissue engineering. 
The RGD peptide modified hydrogel can promote neurite extension.61 Cohen and co-workers 
designed a RGD peptide immobilized alginate scaffold for cardiac tissue engineering. The 
modified scaffold contributed to the formation of functional cardiac muscle tissue and to a 
better preservation of the regenerated tissue in culture.62   
 
Figure 6. The effect of RGD peptidefor tissue engineering. A) Receptor-mediated cell and ECM interaction; B) 
cyclo-RGD peptide.  
1.6 Sialic acids and their analogues 
Sialic acid, the monomeric unit of polySia, is an essential component of sialoglyco-
sphingolipids, which are widespread in living systems, and as part of oligosaccharide chains 
of numerous glycoproteins and glycolipids. They can be found in some microorganisms too. 
Most of them were located in cellular secretions and on the outer surface of cells.63 Since the 
first discovery of sialic acids in vertebrates by Blix and Klenk in 1941, an extensive effort has 
been focused on the identification of their structure and biological roles.64 More than 50 natu-
ral derivatives have been identified, the most common are O-acylated derivatives of 
                                                 
59
 S. Petersen, J. M. Alonso, A. Specht, P. Duodu, Maurice, M. Goeldner, A. del Campo, Angew. Chem. Int. Ed. 
2008, 47, 3192-3195.  
60
 J. Paleček, G. Dräger, A. Kirsching, Synthesis 2011, 653-661. 
61
 F. Z. Cui, W. M. Tai, S. P. Hou, Q. Y. Xu, I. S. Lee, J. Mater. Sci. Mater Med. 2006, 17, 1393-1401. 
62
 M. Shachar, O. Tsur-Gang, T. Dvir, J. Leor, S. Cohen, Acta Biomaterialia. 2011, 7, 152-162.  
63
 J. P. Kamerling, G. J. Boons, Y. C. Lee, A. Suzuki, N. Taniguchi, A. G. J. Voragen (Eds): Comprehensive 
Glycoscience-From Chemistry to Systems Biology 2007, Vol. 1-4, Oxford, Elsevier. 
64
 R. Schauer, Sialic Acids: Chemistry, Metabolism and Function 1982, Vol. 10, Springer-Verlag, New York 
City. 
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5-acetamido-3,5-dideoxy-D-glycero-D-galacto-2-nonulosonic acid called N-acetylneuraminic 
acid 19 (or named neuraminic acid).65 The 9-carbon monosaccharide contains an anomeric 
carboxylate, a deoxygenated methylene C-3 ring carbon, and an oligohydroxalated side chain 
at C-6. Other structurally similar sialic acids are N-glycolylneuraminic acid 20 66 and ketode-
oxy-nonulosonic acid 21, which is a potential oncofetal antigen (Figure 7).67  
 
Figure 7. The most common sialic acids: N-acetylneuraminic acid (19), N-glycolylneuraminic acid (20), and 
ketodeoxy-nonulosonic acid (21).   
The biological activities of sialic acids are widely discussed in the literature. The main roles 
of sialic acid in vivo are classified by Maru 68 as follows: (i) “endowment of negative charge 
on cellular membranes as glycoconjugates, (ii) determination of the macromolecular struc-
tures of certain glycoproteins, (iii) information transfer between cells and (iv) recognition of 
specified glycoconjugates and cells based on specific bio-activities.” Most recently, sialic 
acids regulators of molecular and cellular interactions was described by Schauer.67 
Due to their unique biological role, their densely functionalization, and the stereochemistry-
rich frameworks sialic acids have elicited increasing attention in different fields. Sialic acids 
and their analogues have been widely used as probes or inhibitors in biological and medical 
research, some of the sialic acid analogues have achieved commercial success. Examples for 
commercially successful sialic acid analogues are Relenza and Tamiflu which are used for the 
treatment of influenza.69 During the last decade, many neuraminic acids based novel pharma-
ceutical agents and diagnostic reagents for influenza viruses were investigated in medical 
fields.  
N-acetylneuraminic acid is the most ubiquitous sialic acid and is the biosynthetic precursor for 
all other sialic acids. The limited natural sources of sialic acids make them unsuitable for 
                                                 
65
 M. J. Kiefel, Von M. Itzstein, Chem. Rev. 2002, 102, 471-490. 
66
 R. Schauer, Current Opinion in Structural Biology 2009, 19, 1-8. 
67
 E. A. Voight, C. Rein, S. D. Burke, J. Org. Chem. 2002, 67, 8489-8499. 
68
 I. Maru, J. Ohnishi, Y, Ohta, Y. Tsukada, J. BioSci. Bioeng. 2002, 93, 258-265. 
69
 a) M. von Itzstein, W. Y. Wu, G. B. Kok, M. S. Pegg, J. C. Dyason, B. Jin, P. T. Van, M. L. Smythe, H. F. 
White, S. W. Oliver, Nature 1993, 363, 418-423;  
b) C. U. Kim, W. Lew, M. A. Williams, H. Liu, L. Zhang, S. Swaminathan, N. Bischofberger, M. S. Chen, D. B. 
Mendel, C. Y. Tai, W. G. Laver, R. C. Stevens, J. Am. Chem. Soc. 1997, 119, 681-690.  
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large–scale applications. Recently, several biological and chemical methods for the synthesis 
of sialic acids have been developed, allowing a large scale synthesis of sialic acid. 
1.6.1 Biosynthesis of neuraminic acids and analogues 
In the past two decades the biosynthetic pathway of sialic acids in mammalian cells has been 
intensively investigated for metabolic glycoengineering by glycobiologists. Most recently a 
detailed description of the sialic acid biosynthetic pathway was given by Yarema which is 
briefly illustrated in Scheme 11.70 The pathway begins with glucosamine which is phosphory-
lated into active glucosamine-6-phosphate and converted into the nucleotide sugar UDP-N-
acetyl-glucosamine through the hexosamine pathway. Subsequently, the UDP-N-acetyl-
glucosamine is converted into N-acetyl-D-mannosamine. 71  This process is catalyzed by 
N-acylglucosamine 2-epimerase. N-acetyl-mannosamine is the dedicated metabolic precursor 
for the sialic acid biosynthetic pathway. Then N-acetylmannosamine reacts with pyruvate to 
form N-acetylneuraminic acid catalyzed by D-sialic acid aldolase. In some bacterial cells the 
N-acetylneuraminic acid can be converted into the sialic acid analogue N-glycolylneuraminic 
acid.  
 
Scheme 11. Metabolic pathway of N-acetylneuraminic acid and N-glycolylneuraminic acid. 
                                                 
70
 J. Du, M. A. Meledeo, Z. Y. Wang, H. S. Khanna, V. D. P. Paruchuri, K. Yarema, Glycobiology 2009, 19, 
1382-1401.  
71
 J. A. Hanover, FASEB J. 2001, 15, 1865-1876. 
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Before the above-mentioned pathway of mammalian sialic acid metabolism was established 
various approaches for the enzymatic synthesis of neuraminic acid were reported.55 For ex-
ample, neuraminic acid was synthesized from N-acetylmannosamine and pyruvate catalyzed 
by N-acetylneuraminiate lyase [EC 4.1.3.3].72 Due to the use of expensive starting materials, 
this method is of limited use. After the discovery of the epimerization of N-acetylglucose and 
N-acetylmannose catalyzed by N-acylglucosamine 2-epimerase [EC 5.1.3.1] inexpensive 
N-acetylglucose was established as starting material in the synthesis of neuraminic acid 
through the coupling of the two enzymes in a membrane reactor.73   
1.6.2 Chemical synthesis of neuraminic acid 
Numerous chemical approaches were developed to produce neuraminic acid. However, most 
of these procedures can not deliver satisfactory amount of sialic acids from an economically 
point of view. Shiba and co-workers developed a novel approach to generate neuraminic acid 
with the correct stereochemistry using inexpensive D-glucose as starting material.74 The syn-
thetic route is shown in Scheme 12.  
 
Scheme 12. Synthesis of sialic acid through aldol condensation of glucose with oxalacetic acid. Conditions: a) 
Oxalacetic acid, sodium borate buffer (pH = 11.0), RT, 72 h; b) HCl, MeOH; c) H2O, Ba(OH)2; d) DCC, pyri-
dine; e) Ph-NCO, pyridine, 35.1% over 3 steps; f) HCl, MeOH, 57.8%; g) (CF3SO3)2O, pyridine, CH2Cl2, 92.8%; 
h) (CH3(CH2)3)4NN3, 92.3%; i) H2/Pd-C; j) (CH3CO)2O, DMAP, 35% over 2 steps; k) NaOH; l) Amberlyst 15 
(H form), 62.3% over 2 steps.   
 
                                                 
72
 M. J. Kim, W. J. Hennen, H. M. Sweers, C. H. Wong, J. Am. Chem. Soc. 1988, 110, 6481-6484. 
73
 U. Kragl, D. Gygax, O. Ghisalba, C. Wandrey, Angew. Chem. Int. Ed. Engl. 1991, 30, 827-828.  
74
 T. Yamamoto, T. Teshima, K. Inami, T. Shiba. Tetrahedron Lett. 1992, 33, 325-328. 
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The synthesis starts with the coupling of D-glucose and oxalacetic acid in alkaline solution 
and decarboxylated under acidic conditions, followed the treatment with acid to give desired 
pyranose compound 22. After liberation of the carboxyl group, δ-hydroxy ester 22 was lac-
tonized selectively with the axial C5-hydroxyl group. Simultaneous protection of hydroxyl 
groups was achieved with phenyl isocyanate. Through the one-pot reaction, the key interme-
diate lactone 23 was provided. Lactone 23 was treated with acid to convert to 5-hydroxy 
methyl ester 24. The hydroxyl group at C-5 was sulfonylated to give methyl ester 25. Subse-
quently, an azide group was introduced to C5 to afford 26. Afterward, the azide group was 
reduced to amine group and acetylated resulting in protected neuraminic acid 27. After depro-
tection, the desired N-acetylneuraminic acid 19 was obtained.   
1.6.3 Syntheses of N-acetylneuraminic acid derivatives 
Many procedures were optimized for the chemical synthesis of sialic acids and its derivatives. 
Some of these were not cost effective due to the long synthetic routes and low overall yields. 
A novel and interesting route was successfully developed by Wong and co-workers for the 
synthesis of L-N-acetylneuraminic acid.75 The fairly straightforward synthetic route is de-
picted in scheme 13 with L-arabinose as starting material. A Petasis reaction served to form 
the imine, which was treated with the dibutyl vinyl boronic acid ester 29 to subsequently af-
ford the acetamide intermediate 30. Then, the vinyl group of 30 reacted with N-tert-butyl ni-
trone 31 by means of a 1,3-dipolar cycloaddition to afford the nine–carbon sugar 32 contain-
ing a five-membered ring as a 10:1 mixture of diastereomers, the desired 4R-isomer being the 
major product. After deprotonation and ring-opening in one step, the desired product L-N-
acetylneuraminic acid 33 was obtained. This route has also been used for the synthesis of D-
N-acetylneuraminic acid using D-arabinose as chiral starting material, as well as other sialic 
acid derivatives using various aldoses or their substituted derivatives. This methodology is 
advantageous compared to other methods due to the simple procedure, good stereoselectivity 
and the avoidance of protection groups. 
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Introduction and Background                                                                                                    21 
 
Scheme 13. Three-step synthesis of L-N-acetylneuraminic acid. Conditions: a) EtOH/H2O (4:1), 50 °C, 3 d; b) 
TFA, 50 °C; c) Ac2O, MeOH, 55% over 3 steps, > 99% de; d) dioxane, 30°C, 90%; e) NaOMe in MeOH fol-
lowed by H2O, 60%. 
Another approach to sialic acid derivatives uses N-acetylmannose which can be modified to 
yield various analogues. These derivatives reacted with pyruvate to give desired neuraminic 
acid derivatives via a chemoenzymatic approach. Additionally, neuraminic acid itself can be 
used as starting material for the synthesis of many derivatives. In theory every position on the 
nine-carbon backbone of neuraminic acid can be derivatized for such purpose. A recent re-
view by Bennet described synthetic strategies developed for the synthesis of sialic acid and its 
derivatives at each position on the carbon skeleton.76  
The carboxylate moiety at C-1 is responsible for binding to numerous sialic acid specific pro-
teins and is partially responsible for many of the biological functions of sialosides. An evalua-
tion of the construction of the C-1 carboxyl group to enzyme binding and receptor interaction 
can be conducted by different functional groups. One example is the replacement by a phos-
phonate group in order to investigate the effects of another negatively charged functional 
group.77 Usually, C-2 and C-3 were decorated by various functionalities in order to investigate 
the actual structural information of the neuraminic acid or impact on binding to various en-
zymes.78 The synthesis of C4-modified sialic acid analogues has been of interest as influenza 
sialidase inhibitors like Tamiflu and Relenza.70 Tamiflu is a sialic acid analogue, in which 
among other variations at the C-4 position the hydroxyl group was substituted with an amino 
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 I. Hemeon, A. J. Bennet, Synthesis 2007, 13, 1899-1926. 
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 A. Vasella, R. Wyler, Helv. Chim. Acta 1991, 74, 451-463. 
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 R. Gantt, S. Millner, S. B. Binkley, Biochemistry. 1964, 3, 1952-1960. 
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group. Relenza is a sialic acid analogue with a guanidinyl group in place of a hydroxyl group 
at C4-position.  
For various purposes, the acetamido group at C-5 was substituted by different functional 
groups. The acetamido group can be hydrolysed to an amino group under acidic or basic con-
ditions. Thereafter new substituents can be introduced to give a variety of N-alkyl amides.79 
Using this method Guo and co-workers synthesized numerous N-derivatives of neuraminic 
acid including N-propionyl, N-butanoyl, N-isobutanoyl, N-phenylacetyl, N-benzoyl, and 
N-trifluoropropanoyl derivatives to investigate the properties of the important N-acetyl-D-
neuraminic acid aldolase.80 Elofsson and co-workers also designed and synthesized a series of 
N-acyl-modified sialic acids which were used as inhibitors in place of multivalent sialic acid 
for adenoviruses which cause epidemic Keratoconjunctivitis. 81  They synthesized various 
N-acyl functionalized sialic acids from pre-treated neuraminic acid and different acyl groups. 
However, the isolation of completely deprotected products after hydrolysis of the methyl ester 
appeared to be problematic. This can be explained by the instability of sodium 
N-acetylneuraminate under thermal alkaline conditions whereby the sialic acid ring structure 
is degraded.82 Bertozzi and Wu synthesized an N-alkyno-modified neuraminic acid analogue 
using a combination of chemical and enzymatic methods obtaining a good yield.83 Alkyno-
modified mannose derivative 34 84 reacted with sodium pyruvate in buffer (pH 7.4) to give the 
desired N-4-pentynoylneuraminic acid 35 (Scheme 14).  
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Scheme 14. Chemoenzymatic synthesis of N-functionalized neuraminic acid derivatives. Conditions: sodium 
pyruvate, 1% NaN3, KH2PO4 (pH = 7.4), 89%.  
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Structural variations at the oligohydroxylated side chain were prepared by Zbiral and cowork-
ers. They performed an array of useful approaches to synthesis of stereo and deoxy analogues 
of neuraminic acid.85 Various epimers of neuraminic acid including 7-epi-, 8-epi-, and 7,8-
bis(epi)-N-acetylneuraminic acids 86 and deoxy analogues like 7-deoxy-, 8-deoxy-, 9-deoxy-
N-acetylneuraminic acids 87 were synthesized and used as inhibitors or substrates of sialidase 
to investigate the profile of enzyme-substrate-interactions, their behaviours towards CMP-
sialate synthetase as well as structure information about neuraminic acid.88 
 
                                                 
85
 B. P. Bandgar, M. Hartmann, W. Schmid, E. Zbiral, Liebigs Ann. Chem. 1990, 1185-1195.  
86
 M. Hartmann, E. Zbiral, Monatsh. Chem. 1989, 120, 899-906. 
87
 a) M. Salunke, M. Hartmann, W. Schmid, E. Zbiral, Liebigs Ann. Chem. 1988, 187-189;  
b) E. Zbiral, H. H. Brandstetter, E. P. Schreiner, Monatsh. Chem. 1988, 119, 127-141.  
88
 E. Schreiner, R. Christian, E. Zbiral, Liebigs Ann. Chem. 1990, 93-97. 
Aims and Objectives                                                                                                                24 
2 Aims and Objectives 
Tissue engineering aims to develop functional substitutes for damaged or diseased tissues 
through constructs of living cells, bioactive molecules, and 3D porous scaffolds, which sup-
port cell attachment, proliferation, and differentiation. As a significant branch, the nervous 
system presents a challenge to the field of tissue engineering because some diseases such as 
Parkinson´s or injured nerves or reconnection of served neural pathway may require regenera-
tion of nervous tissue. One of the important tasks of tissue engineering is the synthesis of a 
biocompatible and nontoxic 3D-scaffold. Since polySia is present in the mammalian neural 
system as integral part of NCAM, this polysaccharide is an ideal starting material for the for-
mation of a novel 3D-scaffold for nerve tissue engineering.  
The natural occurring polySia such as colominic acid, which was isolated from capsules of 
Escherichia coli K1 (K1-polySia), is highly soluble in water. This limits the application in 
nerve tissue engineering. This work focuses on the chemical modifications of natural polySia, 
which is decorated with functional groups and subsequently transformed to water insoluble 
3D-scaffolds using different polymerization methodologies. The synthesized 3D-scaffolds 
will be first tested in vitro. In this context, the cell viability will be evaluated by incubation of 
cell lines such as PC12 and HepG2 on the scaffolds. These two cell lines are ideal in vitro 
model systems for the biological evaluation of synthetic scaffold materials. Successively the 
application of the 3D-scaffold material for nerve tissue engineering is planed. Here the 
degradation of the scaffolds should be investigated (Figure 8).  
 
Figure 8. Schematic description of the aims and objectives. 
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An additional part of this work is the synthesis of various neuraminic acid derivatives from 
commercially available N-acetylneuraminic acid. The synthesized neuraminic acid derivatives 
will be provided for biological applications like the enzymatic synthesis of modified polySia.  
2.1 Synthesis of 3D-scaffold based on modified polySia 
In the previous study, Berski has been developed a stable 3D-hydrogel based on polySia. 89 
For the formation of the insoluble hydrogel diepoxyoctane was used as a hydrophobic cross-
linking agent connecting the hydroxyl groups to form a 3D-network. However, the crosslink-
ing was not well defined since a high degree of the linker reacted with water giving “dead 
ends”. In the continuing study of this project, a selective crosslinking between polysaccharide 
chains will be attempted to achieve the 3D-scaffolds. For this purpose polySia (sodium salt) 3 
will be decorated with different functional groups including azido-, alkyno-, methacrylate-, 
aldehydo-, and hydrazido-group, respectively (Scheme 15). Then the modified polymers can 
be inter-connected to form stable networks through crosslinking reaction between the func-
tional groups. In this work three different strategies will be used to accomplish the formation 
of 3D-scaffolds, namely “click” chemistry, photocrosslinking, and hydrazone crosslinking.   
 
Scheme 15. Modification plan of polySia with crosslinkable functional groups.  
For the “click” chemistry strategy, polySia will be modified with azido- and alkyno-
functionalities respectively. The different modified polySia will be synthesized following pre-
viously reported methods from commercial polySia (sodium salt 3).89 The crosslinking reac-
tion occurs in the presence of a Cu catalyst. Considering the metal catalyst has a potential 
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toxicity which is problematic in later in vivo tests for nerve tissue engineering, metal-free 
“click” chemistry is desirable for this approach. Therefore, the alkyno-analogue oxanorborna-
diene, which has a bicyclic system and a trifluoromethyl group, will be prepared according to 
a known procedure. For the second strategy, methacrylate was selected as photoactive linker, 
which was attached through a new amide bond to the polymer. For hydrazone crosslinking, 
polySia will be decorated with aldehyde- and hydrazido-groups, respectively. The aldehyde-
group can be introduced via the following method. At first, the polymer is modified with a 
1,2-diol functionality and then oxidized with sodium periodate. The hydrazido containing 
polySia will be prepared by aminolysis of polySia methyl ester or of polySia lactone by hy-
drazide monohydrate. All of the functional groups will be linked to the polymer through am-
ide bonds at C-5 position except the hydrazido at C-1. The degree of derivatization will be 
controlled in range of 25-80% considering their degradability. Furthermore, improvement of 
the interaction between cells and synthesized cell matrix is anticipated. Hence cyclic RGD 
peptide as described earlier is used. Binding of the RGD peptide to the polySia will be at-
tempted by means of “click” chemistry or imine formation (Scheme 16). The reaction condi-
tions should not alter the structure and conformation of the RGD peptide. The RGD peptide 
modified polySia will be used for formation of 3D-scaffolds together with azido-/hydrazido-
modified polySia.  
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Scheme 16. Synthesis plan of RGD-modified polySia. 
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2.2 Synthesis of neuraminic acid derivatives 
The second major target of the project is the synthesis of different neuraminic acid derivatives 
including C1- and N-derivative from commercial N-acetylneuraminic acid 19 (Scheme 17).  
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Scheme 17. Synthesis plan for the purposed C1- and N- derivatives from N-acetylneuraminic acid.  
The synthesized derivatives will be provided to collaboration partner for the enzymatic syn-
thesis of polySia derivatives. Moreover, these neuraminic acid derivatives can also be applied 
for other biomedical purposes. 
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3 Description and Discussion 
3.1 Modification of polySia and preparation of 3D-scaffolds  
In this work, three innovative crosslinking strategies were applied to achieve a series of ap-
propriate structured 3D-scaffolds material from commercially available α-2,8-polysialic acid 
(polySia). The strategies used are “click” chemistry mediated crosslinking, photo-initiated 
crosslinking, and hydrazone crosslinking. This requires that the starting material was modified 
with the corresponding crosslinkable functional groups. The necessary groups can be attached 
to the polymer chains via amide bonds at the C-5 and the C-1 positions to yield N- and C1-
modified polySia. Afterwards these modifications were used to form flexible and stable 3D-
scaffolds material under mild conditions. Regarding the N-modification of polySia, polySia 
(sodium salt) 3 was deacetylated to form γ-amino polySia (sodium salt) 36. This allowed to 
introduce new functional groups by attaching various side chains to the free amino group of 
the polymer via amide bonds. However, the deacetylated polySia (sodium salt) 36 was not 
soluble in any organic solvent and therefore reactions in non-aqueous solvent were limited. 
To overcome this problem, 36 was converted into γ-amino polySia tetrabutylammonium 
(TBA) salt 37 through a dialysis process. TBA salt 37 can be dissolved in polar organic sol-
vents such as pyridine, DMF, and DMSO (Scheme18).  
 
Scheme 18. Synthesis of γ-amino polySia 36 and 37. Conditions: a) NaOH, EtOH/H2O, reflux, 16 h, 80-99%; 
b) Dialysis against TBA-Bromide (0.5 M), 24 h, then dialysis against distilled H2O.   
3.1.1 Formation of polySia hydrogels using “click” chemistry  
In order to generate 3D-scaffolds via “click” crosslinking, polySia derivatives with “click-
able” azido, alkyno or alkyno-analogues (as Rutjes´oxanorbornadiene) moieties were pre-
pared from γ-amino polySia (TBA salt) 37. 
3.1.1.1 Synthesis of azido- and alkyno-modified polySia  
For Cu-catalyzed generation of polySia hydrogel by multiple “click” reactions, the azido- and 
alkyno-modified polySia 41 and 44 derivatives were prepared according to Berski.89 For the 
Description and Discussion                                                                                                       29 
synthesis of azido-polySia, azido butyric acid chloride (40) was prepared. The acid chlo-
ride 40 was synthesized from 4-chloro butyryl methyl ester (38) over 3 steps.90 At first, ester 
38 was transferred into the azide via SN2 substitution in the presence of a catalytic amount of 
sodium iodide. Then, the methyl ester was treated with base to give carboxylic acid 39, which 
was finally converted into desired 4-azidobutyryl chloride 40 (Scheme 19).  
 
Scheme 19. Synthesis of 4-azidobutyryl chloride 40. Conditions: a) DMF, NaI (cat.), NaN3, 60 °C, 24 h; b) H2O, 
NaOH (1 M), r.t., 4 h; c) Thionyl chloride,  60 °C, 1 h, then 80 °C, 1 h. Quantitative conversion over three steps.   
Product 40 was identified by IR- analysis. Introduction of azido-functionality (2096 cm-1), 
and transformation of carboxylic acid (1709 cm-1) into acid chloride (1790 cm-1) were clearly 
detected. 
PolySia derivative 41 was gained from γ-amino polySia (TBA salt) 37 and azido acid chlo-
ride 40 under basic conditions. Anhydrous pyridine as basic organic solvent was suitable for a 
successful reaction. By changing the equivalents of acid chloride the product was obtained 
with different derivatization degrees in a range of 25-90 %. The unreacted amino groups were 
protected as N-acetyl group by treatment with acetic anhydride, which was important for the 
enzymatic degradation process. Undesired ester-bonds were cleaved by final basic treatment. 
After dialysis the desired product 41 was obtained (Scheme 20). The degree of derivatization 
could be evaluated by 1H-NMR. 
 
Scheme 20. Synthesis of N-4-azidobutytyl polySia 41. Conditions: a) Pyridine, r.t., 24 h; b) Acetic anhydride, 
r.t., 8 h; c) NaOH (1 M), r.t., 8 h; d) Dialysis against NaCl (pH = 9), 2 d, then against distilled H2O, 2 d, 92%.  
Azido-polySia derivative could be identified qualitatively by IR-measurement at 2096 cm-1 
(Figure 9).  
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Description and Discussion                                                                                                       30 
 
Figure 9. IR-spectra of azido-modified polySia 41. 
PolySia derivative 44, which was decorated with an alkyno-group, was synthesized from 
4-pentynoic chloride (43) and γ-amino polySia TBA salt 37 using the similar process as de-
scribed before for the synthesis of polySia 41. 4-Pentynoic chloride (43) was prepared from 
commercial available 4-pentinoic acid (42) by treatment with thionyl chloride (Scheme 21).91  
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Scheme 21. Synthesis of N-(4-pentynoyl) polySia 44. Conditions: a) Thionyl chloride, 60 °C, 1 h, then 80 °C, 
1 h; b) Pyridine, r.t., 24 h; c) Acetic anhydride, RT, 8 h; d) NaOH (1 M), r.t., 8 h; e) Dialysis against NaCl (pH = 
9), 2 d, then against distilled H2O, 2 d, 56%. 
3.1.1.2 Synthesis of oxanorbornadienyl-modified polySia 
In an alternative approach, polySia hydrogels shall be prepared via metal-free “click” chemis-
try. Therefore, oxanorbornadienyl-substituted polySia 52 was synthesized from γ-amino 
polySia (sodium salt) 36 or (TBA salt) 37 and oxanorbornadienyl acids 53. The oxanorborna-
dienyl-system was prepared according to modified literature procedures. The (carbethoxy-
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methyl)-triphenylphosphonium bromide (46) was prepared from triphenylphosphine and ethyl 
2-bromoacetate (45). Subsequently, the phosphonium salt 46 was treated with triethylamine to 
give in monosubstituted methylenephosphorane 48 in a reversible step. Acylation of phos-
phorane 48 with trifluoroacetic anhydride afforded phosphonium salt 49, which was con-
verted into the desired phosphorane 47 in the presence of base. This transformation was 
achieved in a one-pot reaction (Scheme 22). 92 
 
Scheme 22. Preparation of (α-acymethylene)phosphorane 47. Conditions: a) Toluene, r.t., 48 h; b) THF, Et3N, 
0 °C, 15 min; Trifluoroacetic anhydride (over 15 min, dropwise), 0°C, 1 h, 100%.   
Phosphorane 47 was converted into ethyl-2-flurobut-2-ynoate (16) by pyrolysis at 150-210 °C 
(14 mbar).93 As by-product triphenylphosphine oxide was produced. The oxanorbornadienyl-
ester 17 was obtained from the acetylene 16 and furan via Diels-Alder-reaction.94 The litera-
ture procedure for this step described that acetylene 16 and furan (1.2 eq.) were heated in di-
chloromethane under argon atmosphere at 40 °C for 4 d. After further optimization, the reac-
tion was carried out under microwave conditions at 60 °C in 30 min and without any decrease 
of yield. Different equivalents of furan were tested for the Diels-Alder-reaction. It was found 
that 1.5 equivalent of furan afforded best results. Ester 17 was treated with base to obtain ox-
anorbornadienyl carboxylic acid 18 (Scheme 23).    
 
Scheme 23. Synthesis of oxanorbornadienyl carboxylic acid 18. Conditions: a) 150-210 °C, 14 mbar, 2 h, 86%; 
b) Furan (1.5-2.0 eqval.), microwave oven, 60 °C, 0.5 h, 70%; c) H2O/THF (1:1), NaOH (1 M), r.t., 2 h, >90%.   
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In this thesis, various double cycloaddition by-products were observed like endo, exo-isomer 
and exo, exo-isomer, which were also described in detail in the literature.95 In this case, the 
obtained by-products could be easily transferred into the desired product via retro-Diels-Alder 
reaction. For example, the endo, exo-isomer 50 was heated in dioxane in a microwave oven at 
100 °C for 30 min to give the desired product 17 with practically complete conversion 
(Scheme 24).   
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Scheme 24. Conversion of endo, exo-isomer 50 to oxanorbornadienyl-ester 17. Condition: a) 1,4-dioxane mi-
crowave oven, 100 °C, 0.5 h, 100% (determined by 1H-NMR).  
Carboxylic acid 18 was directly tested for the coupling with the free amino group of γ-amino 
polySia (TBA salt) 37. However, the coupling reaction failed. A possible reason was the steric 
hindrance of the ring systems. Therefore, a suitable spacer was introduced for the coupling of 
both components. The spacer could be connected to oxanorbornadienyl carboxylic acid 18 via 
ester or amide bond formation. Different amino esters 51 were coupled to carboxylic acid 18 
catalyzed by peptide coupling reagent. After treatment with base, the elongated oxanorborna-
dienyl carboxylic acids 52a-c were prepared successfully in good to moderate yield over two 
steps (Scheme 25).  
 
Scheme 25. Synthesis of elongated oxanorbornadienyl carboxylic acids 52. Conditions: a) EDC·HCl, DMAP, 
DCM, 0 °C→r.t., 24 h, 57-70%; b) THF/H2O, LiOH (0.5 M), 2 h, 90-95%.   
Regarding the coupling between the deacetylated polySia and carboxylic acids 52a-c, differ-
ent methods were tested. The carboxylic acids 52a-c were directly attached to the amino 
group of the polySia in presence of coupling reagents, or the carboxylic acids 52a-c were first 
achieved as NHS active esters by treating with NHS, which will be described in chapter 3.2.2. 
Considering the solubility of the polymer in different solvents, the γ-amino polySia (sodium 
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salt) 36 or (TBA salt) 37 were used for the different reaction conditions. It was found that the 
use of NHS-esters or coupling reagents did not show significant difference. The degree of 
derivatization could be raised up to 25 % (entries 1 and 4, Table 1). Variation of the reaction 
conditions could not improve the degree of derivatization.     
Table 1. Synthesis of oxanorbornadienyl-group containing polySia derivative 53.  
 
Entry  PolySia (36 
or 37) 
Coupling method 
(Solvent, coupling reagent) 
Degree of derivati-
zationa 
1 36 H2O, ECD·HCl, HOBt, DIPEA 25 % 
2 36 H2O/dioxane, Et3N, NHS-ester of 52a 5-10 % 
3 37 DMF, ECD·HCl, HOBt, DIPEA 5-10 % 
4 37 DMF, DIPEA, NHS-ester of 52a 25 % 
5 37 DMF, ECD·HCl, DMAP 5-10 % 
a
 The degree of derivatization was determined by 1H-NMR. 
3.1.1.3 Modulation of “click” reaction  
Prior to the polymerization of modified polySia derivatives via “click” reaction, model reac-
tions of copper-catalyzed and metal-free “click” reactions were established. 
4-Azidobutanamide (54) and pent-4-ynamide (55) were prepared from the corresponding acid 
chlorides with treatment of ammonia. The fact, that both reactants showed good water solubil-
ity is important, because this is an essential requirement for the final hydrogelation process. 
The reaction of 4-azidobutanamide (54) and pent-4-ynamide (55) afforded the 1,2,3-triazole 
formation via [3+2] dipolar cycloaddition in the presence of Cu-catalyst. Under these condi-
tions, the reaction yielded selectively 1,4-triazole 56 (Scheme 26). 
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Scheme 26. Modulation of copper-catalyzed “click” reaction. Condition: a) H2O, CuSO4 (2 mol%), Na-ascorbate 
(3 mol%), r.t., 48 h, 80 %.  
The hydrogen of the triazole ring presented a unique proton signal by 1H-NMR analysis. The 
expected proton signal was found at 7.70 ppm which indicated that the “click” cyclization 
process was successful (Figure 10).   
 
Figure 10. 1H-NMR spectra for copper-catalyzed “click” model reaction.  
In comparison to the copper-catalyzed “click” reaction, a similar model reaction for the metal-
free “click” reaction was established from 4-azidobutanamide (54) and oxanorbornadienyl-
species 57, which was prepared from 52a and cyclohexane amine. The cyclohexane moiety 
simulated the pyranose ring system of polySia. Both molecules were connected via [3+2] 
cycloaddition retro-Diels-Alder reaction which led to the formation of stable 1,4,5-tri-
substituted 1,2,3-triazoles 58, 59 and furan as by-product (Scheme 27).   
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Scheme 27. Model reaction for metal-free “click” chemistry. Condition: a) H2O/MeOH, r.t., 24 h, 80%, mixture 
of 58 and 59).  
Final products 58 and 59 were analyzed by 19F-NMR analysis, which is a very useful method, 
since 19F is a sensitive nucleus and yields sharp signals. Analyses of 19F-NMR spectra showed 
very clear results for the reaction (Figure 11). The 19F signal of reactant was found 
at -61.6 ppm, while isomer 58 which was obtained as major product and appeared 
at -58.0 ppm and the isomer 59 appeared at -59.5 ppm. The ratio of both products 58 and 59 
can be easily determined by integration of 19F-signals. The results are useful to confirm the 
connection between azido- and oxanorbornadienyl-modified polySia derivatives, as well as 
polySia derivative immobilized with RGD peptide.  
 
Figure 11. 19F-NMR analysis for model reaction of metal-free “click” chemistry.  
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Besides the model reaction of metal-free “click” chemistry between the above-mentioned two 
small molecules, a model “click” reaction for polySia derivatives was also established. Gen-
erally, it is difficult to identify a successful “click” reaction of polymers using 1H-NMR due 
to overlap of signals. Therefore, a reagent with an aromatic-ring system was prepared for 
modulating of metal-free “click” reaction of polySia, since no signal of polySia disappeared 
in the area between 7 and 8 ppm. At first, the 4-azido-N-benzylbutanamide (60) was prepared 
from benzylamine and 4-azidobutanoic acid (39) under using peptide coupling reagents. Then, 
the 4-azido-N-benzylbutanamide (60) was coupled to polySia 53a to afford the “click” prod-
uct 61 under mild conditions (Scheme 28).  
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Scheme 28. Metal-free “click” reaction of oxanorbornadienyl-modified polySia 53a. Conditions: a) CH2Cl2, r.t., 
EDC·HCl, DMAP, 16 h, 90%; b) MeOH/H2O (1:9), r.t., 48 h, 100% conversion (1H-NMR). 
“Click” product 61 was easily confirmed by 1H-NMR analysis (Figure 12). Comparing the 
proton signals of the starting material and desired product, the two characteristic proton sig-
nals of the oxanorbornadienyl-system completely disappeared after the reaction. Instead, for-
mation of aromatic proton signals could be observed in the area of 7 to 8 ppm of the product 
spectra. The degree of derivatization of the polymer could be evaluated by integration of the 
signals. At high field, the proton signals of the side chains were also changed obviously. 
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Figure 12. 1H-NMR spectroscopic analysis of the metal-free “click” product 61 from oxanorbornadienyl-polySia 
53a with 4-azido-N-benzylbutanamide (60).  
3.1.1.4 Synthesis of polySia hydrogels using “click” chemistry 
For the preparation of 3D-scaffolds using Cu-catalyzed “click” reaction, azido- and alkyno-
functionalized polySia derivatives (41 and 44) were dissolved in aqueous solution. As cata-
lyst, copper sulphate and sodium ascorbate were added. After intensive mixing, a flexible 
hydrogel was slowly formed at room temperature (Figure 13). For the evaluation of the swell-
ing behaviour, the hydrogel was placed in 50 mM phosphate buffer (pH = 7.2) and allowed to 
equilibrate at 37 °C for 24 h. The diameter of the hydrogel was measured. After equilibration, 
the hydrogel size raised about a factor of 1.5.  
Figure 13. 3D-Hydogel based on azido-/alkyno-modified polySia 41 and 44 
via Cu-catalyzed “click” reaction. Condition: N-azido-polySia 41 (5 mg, 60% 
derivatization) and N-alkyno-polySia 44 (5 mg, 60% derivatization), dissolved 
in 80 µL H2O, addition of CuSO4 (8 µL, 0.1 M) and Na-ascorbate (12 µL, 
0.1 M), r.t., 24 h. (Ø = 0.9 cm, thickness, 0.1 cm).  
 
In general, the gelating process was depended on the amount of Cu-catalyst, the degree of 
derivatization of polySia, and the length of the used polySia chain (Table 2). The hydrogels 
were formed in a very short time when more than 8% Cu-catalyst was used (entries 1 and 2). 
In case of less then 1% of Cu-catalyst, gel formation was impossible (entry 6). Apparently, 
3D-hydrogel (Cu-catalyst)
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gel formation is faster from polymers with a higher molar mass. When polySia with a molecu-
lar mass of 45.000 Da (typical colominic acid has a molecular mass of 15.000 Da) was used, 
stable hydrogels could be formed using a low degree of derivatization (10%) and a low cata-
lyst loading (1%) (entry 8).  
Table 2. Results of the formation of polySia hydrogels based on azido- and alkyno-modified polySia 41 and 44 
using copper catalyzed “click” chemistry.  
 
Alkyno-polySia Azido-polySia Catalysta Entry 
DS c weight DS weight A B 
Time Result 
1 60% 10 mg 60% 10 mg 15% 10% 10 s Hydrogel 
2 60% 10 mg 60% 10 mg 12% 8% 30 min Hydrogel 
3 60% 10 mg 60% 10 mg 8% 6% 24 h Hydrogel 
4 60% 10 mg 60% 10 mg 3% 2% 48 h Hydrogel 
5 80% 10 mg 25% 25 mg 3% 2% 5 d Hydrogel 
6 25% 10 mg 25% 10 mg 3% 2% 7 d Hydrogel 
7 80% 10 mg 80% 10 mg 1.5% 1% 7 d Liquid 
8 60% 10 mg 10%b 10 mg 1.5% 1% 7 d Hydrogel 
a
 Cu-catalyst (mol%) A: Na-ascorbate (0.1 M), B: CuSO4(0.1 M); b The polySia was provided by Institute of 
Technical Chemistry of Leibniz University of Hannover, about 150 monomer units per chain; c DS: the degree of 
derivatization.  
For further analysis, hydrogels were placed in an aqueous solution containing 0.1 M 
trifluoroacetic acid and heated at 80 °C for 1 h. The hydrolyzed product was directly analyzed 
by UPLC-MS spectrometry (Figure 14). The desired mass m/z = 724.25 of the degraded 
polySia for “click” product was found. This result indicated that the Cu-catalyzed “click” re-
action of the polySia 41 and 44 was successful. Besides the “click” product, other hydrolyzed 
products of polySia were also found (Table 3).  
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Figure 14. UPLC-MS spectra of hydrolyzed products the “click” reaction between polySia 41 and 44. 
Table 3. Chemical hydrolysis of hydrogels based on azido-/alkyno-modified polySia formed by Cu-catalyzed 
“click” reaction. Condition: a) 0.1 M TFA, 80 °C, 1 h. 
 
Molecule Formula [M-H] Calcd. Mass (ES-) Found mass (ES-) 
63 C13H21N4O9 377.1309 377.1320 
35 C14H20NO9 346.1138 346.1151 
19 C11H18NO9 308.0982 308.0997 
Dimer (64)  C27H42N5O18 724.2525 724.2537 
PolySia hydrogels were also successful synthesized form N-azido-polySia 41 and oxanorbor-
nadienyl-polySia 53 by metal-free “click” chemistry mediated crosslinking. The functional-
ized polySia derivatives were dissolved in aqueous solution without any catalyst. The hy-
drogel formation was also dependent on the concentration of the starting materials, the deri-
vatization degree, and the reaction time (Table 4). High concentration of starting material re-
sulted in the formation of stable hydrogels in a short time (entry 1). However, the mechanical 
properties of the formed hydrogel were not sufficient. The hydrogel was easily broken into 
small pieces. On other side, very low concentration of starting material led to larger gelating 
times or failing of gel formation (entries 6 and 7). When starting material had a too low de-
gree of substitution, hydrogel formation was impossible (entries 11 and 12).  
Description and Discussion                                                                                                       40 
Table 4. 3D-Hydrogel based on polySia 41 and 53b using metal-free “click” chemistry.  
 
Starting material Entry 
5 (DS)a 10 mg 15 (DS) 10 mg 
H2O (µL) Time for gela-tion) 
1 25% 25% 90 5 h 
2 25% 25% 120 11 h 
3 25% 25% 150 20 h 
4 25% 25% 180 36 h 
5 25% 25% 200 3 d  
6 25% 25% 210 4 d 
7 25% 25% 240 Liquid (5 d) 
8 80% 25% 200 36 h 
9 60% 25% 200 36 h 
10 60% 20% 200 48 h 
11 60% 10% 100 Liquid (5 d) 
12 60% 7% 50 Liquid (5 d) 
  a DS: the degree of derivatization 
The optimal conditions for hydrogel formation were: N-azido-polySia 41 with a degree of 
derivatization 25%, N-oxanorbornadienyl-polySia 53b with a degree of derivatization 25%, 
and in a concentration of 50 mg/mL per component (entry 5, Table 4). Under this conditions, 
a suitable polySia hydrogel was formed (Figure 15), since it was stable and relative flexible at 
room temperature. In comparison to the Cu-catalyzed “click” chemistry mediated polySia 
hydrogels a similar swelling behaviour was obtained. Furthermore, the hydrogel showed good 
enzymatic degradation properties due to relatively high degree of acetyl residues present.  
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Figure 15. 3D-Hydrogel based on modified polySia using metal-free “click” 
chemistry. Gelation conditions: Azido-polySia (10 mg, DS: 25%) and oxano-
rbornadienyl-polySia (10 mg, DS:25%) were dissolved in 200 µL H2O and kept 
at room temperature for 3 days.  
The hydrogel was treated with 0.1 M trifluoroacetic acid under heating at 80 °C for 1 h. The 
hydrolyzed products were analyzed by UPLC-MS spectrometry, directly. The desired mass 
m/z 849.26 for the metal-free “click” reaction mediated dimer 67 was found (Figure 16).  
 
Figure 16. UPLC-MS spectra of hydrolyzed products of the “click” reaction between polySia 41 and 53b. 
N-Acetylneuraminic acid 19 (m/z = 308.09) and the unreacted monomer 63 (m/z = 377.13) 
were also found besides the dimer product 67 (Table 5). The oxanorbornadienyl-modified 
neuraminic acid 66 was not found. This might be due to the fact that the oxanorbornadienyl-
system is not stable under thermal acidic conditions.  
3D-hydrogel (Cu-free"click")
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Table 5. Chemical hydrolysis of the hydrogel based on azido-/oxanorbornadienyl-modified polySia using metal-
free “click” reaction and UPLC-MS analyse. Condition: a) 0.1 M TFA, 80 °C, 1 h. 
 
 
Molecule Formula [M-H] Calcd. Mass (ES-) Found mass (ES-) 
63 C13H21N4O9 377.1309 377.1302 
66 C21H27N2O11F3 539.1489 decomposed 
19 C11H18NO9 308.0982 308.0988 
Dimer (67)  C30H44N6O19F3 849.2613 849.2638 
 
3.1.2 Formation of polySia hydrogels using photopolymerization 
As an alternative to the synthesis of azido- and alkyno-modified polySia, which form hy-
drogels through 1,3 dipolar cycloadditions, polySia will also be decorated with methacrylate 
or acrylate groups. The methacrylated polySia will be photopolymerized to create crosslinked 
networks.  
3.1.2.1 Synthesis of N-methacryl-polySia 
Methacrylated polySia 68 was synthesized starting with γ-amino polySia (TBA-salt) 37 and 
commercially available methacrylic anhydride (Scheme 29). The remaining free amino groups 
were reacetylated by treating with acetic anhydride. Under these conditions, unprotected hy-
droxyl groups were also partially acylated to form esters, which can lead to lower water solu-
bility of the polymer. Therefore, the ester bonds were cleaved by treatment with sodium hy-
droxide solution (0.5 M). The degree of methacrylation could be adjusted in a range between 
10% and 80% by varying the amount of methacrylic anhydride.  
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Scheme 29. Synthesis of N-methacryl-polySia 68 from γ-amino polySia (TBA-salt) 37 and methacrylic anhy-
dride. Conditions: a) Anhydrous pyridine, 0 °C→r.t., 24 h; b) Ac2O, r.t., 8 h; c) NaOH (0.5 M), r.t., 8 h, over 3 
steps, 80% yield and the degree of derivatization 80%. 
Methacrylate modified polySia 68 was treated under photo-crosslinking conditions to form 
hydrogels. N-methacryl-polySia 68 was dissolved in an aqueous solution of photoinitiator 
Irgacure 2959 and irradiated with UV-light at 320 nm. Irgacure 2959 is light-sensitive and 
therefore the photoinitiator solution was freshly prepared before use. The reaction conditions 
were varied by changing the concentration of photoinitiator and starting material 68, exposure 
time, or the degree of derivatization of polySia 68. Unfortunately, the expected hydrogel was 
not formed under the applied conditions (Table 6).  
Table 6. Conditions for the attempted photopolymerization of N-methacryl-polySia 68.  
 
DS of 68a Irgacure 2959 [w/v] 
Conz. of 68b 
[mg/ µL] 
Exposure 
time [min] Result 
10% 0.5% 10 mg/100 µL 10 min no hydrogel 
10% 1.0% 10 mg/80 µL 10 min no hydrogel 
10% 2.0% 10 mg/100 µL 20 min no hydrogel 
80% 1.0% 10 mg/80 µL 10 min no hydrogel 
80% 2.0% 10 mg/100 µL 10 min no hydrogel 
80% 3.0% 10 mg/80 µL 20 min no hydrogel 
80% 5.0% 10mg/80 µL 60 min no hydrogel 
a
 DS: degree of derivatization; b Conz.: distilled water as solvent. 
The formation of the hydrogel from N-methacryl-polySia 68 might be hindered by the steric 
repulsion caused by the polySia backbone. In order to overcome this problem, an extension 
spacer was introduced between the functional methacrylate group and the polySia backbone. 
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Therefore, ß-alanine methylester (69) was reacted with methacrylic anhydride to form 
3-methacrylamidopropanoic acid (70) (Scheme 30). However, the desired product 70 was not 
obtained.  
H2N OMe
O
O
O O
+ NH
OH
OO
a, b
70
69
 
Scheme 30. Preparation of 3-methacrylamidopropanoic acid (70) from ß-alanine methylester and methacrylic 
anhydride. Condition: a) Pyridine, r.t., 24 h; b) H2O, NaOH (1 M), r.t., no product. 
Following a literature known procedure carboxylic acid 72 was prepared from 
γ-aminobutanoic acid (71) and methacrylic acid chloride.96 Subsequently, carboxylic acid 72 
was treated with NHS in the presence of DCC to give NHS activated ester 73 (Scheme 31).  
 
Scheme 31. Preparation of NHS-ester 73. Conditions: a) NaOH, dioxane/H2O, -10 °C, 1 h, 61%; b) THF, DCC, 
0 °C→r.t., 24 h, 60%.    
To synthesize N-methacryl-polySia 74 with an extended spacer, NHS-ester 73 reacted with γ-
amino-polySia (sodium salt) 36 at room temperature under basic conditions, followed by 
reacetylation of the remaining free amino groups and liberation of all alcohol groups. The 
desired N-methacryl-polySia 74 with extension spacer was obtained with a degree of derivati-
zation of 45% (Scheme 32).  
 
                                                 
96
 J. Drobník, J. Kopeček, J. Labskỳ, P. Rejmanová, J. Exner, V. Saudek, J. Kálal, Macromol. Chem. 1976, 177, 
2833-2848. 
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Scheme 32. Synthesis of N-methacryl-polySia 74 from γ-amino-polySia (sodium salt) 36 and NHS-ester 73. 
Conditions: a) Dioxane/H2O, DIPEA, 0 °C→r.t., 24 h; b) Ac2O, r.t., 8 h; c) NaOH (0.5 M), r.t., 8 h; over 3 steps, 
approx. 80% yield and the degree of derivatization approx. 45%. 
3.1.2.2 Synthesis of 3D-hydrogels using photocrosslinking  
N-Methacryl-polySia 74 was used to form 3D-scaffolds.Therefore, polySia-derivative 74 was 
dissolved in an aqueous solution of photoinitiator, and irradiated with UV-light at 320 nm. 
Hydrogel formation depends on parameters such as the concentration of photoinitiator and 
starting material, exposure time, as well as the degree of derivatization of polySia 74 (Ta-
ble 7). When the concentration of photoinitiator was lower than 2% (w/v), hydrogels did not 
form. The methacrylated polySia with a low degree of derivatization (< 10%) could also not 
generate a network structure. But, under appropriate conditions like 25% methacrylated start-
ing material, using 2% (w/v) photoinitiator, and 10 min exposure with UV-light led to the 
formation of stable and flexible hydrogels in variable sizes (Scheme 33). 
Table 7. Conditions for the photopolymerization of N-methacryl-polySia 74. 
DS of 74a Irgacure 2959 [w/v] 
Conz. of 74b 
[mg/ µL] 
Exposure 
time [min] Result 
10% 0.5% 10 mg/80 µL 10 min no hydrogel 
10% 1.0% 10 mg/80 µL 10 min no hydrogel 
10% 2.0% 10 mg/80 µL 20 min hydrogel 
20% 1.0% 10 mg/100 µL 10 min no hydrogel 
20% 2.0% 10 mg/100 µL 10 min hydrogel 
25% 2.0% 10 mg/80 µL 10 min hydrogel 
45% 0.5% 10 mg/100 µL 20 min no hydrogel 
45% 1.0% 80 mg/100 µL 20 min no hydrogel 
45% 2.0% 10 mg/80 µL 10 min hydrogel 
a
 DS: degree of derivatization; b Conz.: distilled water as solvent. 
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Scheme 33. 3D-Hydrogels based on N-methacryl-polySia 74 using photocrosslinking. Conditions: For gel pic-
ture (i: ø = 0.6 cm; ii: ø = 0.3 cm). The hydrogels were prepared in Culture Well Silicone Gaskests (BioCat, 
Germany). 
The formed hydrogel was equilibrated in PBS-buffer to evaluate the swelling behaviour. By 
comparing the diameter of the swollen gel with the original gel size from the N-methacryl-
polySia 74, it was found that the swelling ratio was inverse proportional to the degree of deri-
vatization. For example, the size of a hydrogel formed from polySia 74 with 10% of 
methacrylate groups increased about 10 times after swelling. Notably, the hydrogels from 
20% modified polySia swelled only 1.5 to 2 times. This indicated that materials with more 
methacrylate groups can create higher crosslinked gels with lower swelling capacity. Also, 
polySia hydrogel produced from highly substituted starting material was more stable than the 
low cross-linked hydrogel. 
The polymerization reaction could be analyzed by 1H-NMR spectroscopy. To achieve this, 
photopolymerization was performed using the N-methacryl-polySia 74 in very low concentra-
tion of 20 mg/mL. After UV-light irradiation, the polymer solution remained in liquid state. 
The sample was dried and directly measured by 1H-NMR spectroscopy without removing the 
photoinitiator. Comparing to the proton signals of starting material with the formed product, 
the proton signals of the double bond of the methacrylate group at 5.68 and 5.32 ppm com-
pletely disappeared after irradiation. Meanwhile, the methyl group of the methacrylate shifted 
to higher fields (Figure 17).  
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Figure 17. 1H-NMR spectra of the N-methacryl-polySia 74 in D2O (A), and photocrosslinked polySia containing 
photoinitiator in D2O (B). 
3.1.3 Formation 3D-hydrogels using hydrazone crosslinking 
The third approach for the preparation of polySia hydrogels was based on hydrazone 
crosslinking. For this purpose, polySia was functionalized with aldehydo- and hydrazido- 
groups, respectively. After mixing both components, a 3D–scaffold was formed without using 
any catalyst or additive.  
3.1.3.1 Synthesis of hydrazido-modified polySia 
The carboxyl group at C-1 can react under classic carbodiimide conditions with the hydroxyl 
group at C-9 of the neighboring sialic acid to form in polySia lactone 75 in quantitative 
yield.97 The lactone 75 could be aminolyzed with hydrazine monohydrate to form C-1 hy-
drazido-polySia 76 (Scheme 34). 
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Scheme 34. Synthesis of C-1 hydrazido-polySia 76. Conditions: a) EDC·HCl, H2O, pH 4.7; b) H2O, N2H4 
(64-65%), r.t., 2 h, over two steps 78%. 
                                                 
97
 M. R. Lifely, A. S. Gilbert, C. Moreno, Carbohydr. Res. 1981, 94, 193-203.  
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Formation of polySia hydrazide 76 could be confirmed by 13C-NMR spectroscopy. The 13C-
NMR spectra showed distinct carbon-signals for the starting material 3, PolySia lactone 75 
and C-1 hydrazido-polySia 76. Signal changes at three positions C-1, C-2, and C-9 could be 
easily observed, since the carbon atoms have different chemical environment (Figure 18). The 
C-1 signal of polySia 3 at 173.8 ppm shifted to 166.1 ppm in polySia lactone 75 as well as 
C-1 hydrazido-polySia 76. The C-2 and C-9 signals of polySia 3 and C-1 hydrazido-polySia 
76 had approximate same chemical shifts at 101.3 and 60.6 ppm, respectively. C-2 and C-9 of 
polySia lactone 75 moved to 96.4 and 66.7 ppm. Meanwhile, the spectra also demonstrated 
that the conversions of the both steps were quantitative.  
polySia sodium salt (3)
polySia lactone (75)
C-1 hydrazide polySia (76)
A
B
C
 
Figure 18. 13C-NMR spectra of polySia (sodium salt) 3 in D2O (A), polySia lactone 75 in DMSO (B), and hy-
drazido-polySia 76 in D2O (C).  
3.1.3.2 Synthesis of aldehydo-modified polySia 
Introduction of an aldehyde group into polySia can be achieved at positions C-1 or C-5 of the 
polySia molecule via amide bond formation. Aldehyde modified polySia could be synthesized 
in two steps. Firstly, a vicinal diol group was introduced into polySia 3 using carbodiimide 
chemistry. Subsequently, the 1,2-diol moiety could be oxidized with sodium periodate to give 
desired aldehyde group (Scheme 35). 
Description and Discussion                                                                                                       49 
OH
N
OH
OH
O
HO
O ONa
O
OH
N
OH
OH
O
HOO
H
O
OH
N
OH
OH
O
HO
O
O
C-1 aldehydo-polySia
N-aldehydo-polySia
SpacerR
R1 = COOH
H
N
Spacer
H
O
+
OH
OH
3 Coupling
Oxidation
R2 = NH2
O ONa
 
Scheme 35. Strategies for the synthesis of N-aldehydo-functionalized polySia derivatives.  
C-1 aldehydo-modified polySia derivative 79 was planed to be generated by oxidizing precur-
sor 78, which could be obtained from the polySia sodium salt 10 and a commercially avail-
able 3-aminopropane-1,2-diol (77) in the presence of coupling reagents (Scheme 36).  
 
Scheme 36. Synthesis plan for the formation of C-1 aldehydo-modified polySia derivative 79.  
The coupling of polySia 3 and the 3-aminopropane-1,2-diol (77) was investigated by using 
different coupling conditions by varying solvents and coupling reagents (Table 8). Unfortu-
nately, formation of the coupling product 78 was not observed. 
Table 8. The reaction conditions for the synthesis of C-1 vicinal diol modified polySia derivative 78. 
Entry Solventa Coupling reagent Result 
1 H2O ECD·HCl, DIPEA, HOBt no product 
2 DMF ECD·HCl, DMAP no product 
3 DMF ECD·HCl, DIPEA, HOBt no product 
4 DMSO ECD·HCl, DMAP no product 
3 DMSO ECD·HCl, DIPEA, HOBt no product 
a For the reactions in DMF and DMSO, polySia (TBA-salt) was used.  
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A second approach towards N-aldehydo-modified polySia was also carried out in two steps. 
At first, building block 80 containing the required carboxyl group and 1,2-diol moiety was 
prepared from glutaric anhydride and 3-aminopropane-1,2-diol (77) in excellent yield. Car-
boxylic acid 80 was successfully coupled to the free amino group of γ-amino polySia 37 using 
carbodiimide chemistry (Scheme 37). 1H-NMR spectra showed that approximately of 40% of 
all amino groups in the polySia chain were successfully decorated with diol 80 (Figure 19, A).  
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Scheme 37. Synthesis of 1,2-diol-modified polySia 81. Conditions: a) Pyridine, r.t., 16 h, quantitative; 
b) EDC·HCl, HOBt, DIPEA, DMF, r.t., 24 h; c) Acetic anhydride, r.t., 8 h; d) NaOH (1 M), r.t., 8 h; e) Dialysis 
against NaCl, r.t., 2 d, then against distilled H2O, r.t., 2 d, the degree of derivatization approx. 40%.  
The second step was the conversion of the 1,2-diol group into the corresponding aldehyde 
group without risking the decomposition of other groups of polymer. The 1,2-diol-
functionalized polySia 81 was oxidized with sodium periodate at 0 °C for 30 min in dark to 
yield N-aldehydo-polySia 82 (Scheme 38). 
 
Scheme 38. Conversion of 1,2-diol-functionalized polySia into N-aldehydo-modified polySia 82. Condition: a) 
NaIO4, H2O, 0 °C, 30 min, light exclusion, quantitative. 
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Formation of functionalized polySia derivatives 81 and 82 were confirmed by 1H-NMR-
analysis. The 1H-NMR spectra of the 1,2-diol-modified polySia 81 (Figure A) and oxidized 
product 81 (Figure 19 B) are shown in Figure 18. In aqueous media, the aldehyde group of 81 
was hydrated. Two proton signals [H1´and H2´, Figure 19 A] of polySia 81 at 3.35 and 
3.20 ppm disappeared in product 82 spectra. Instead of these, the signal at 3.30 ppm was as-
signed as CH2 protons [H2 and H2´, Figure 19 B] adjacent to the hydrated aldehyde group and 
the signal at 5.10 ppm was assigned the dominating CH(OH)2 signal [H1-hydrate, Figure 19 
B]. By comparing the two spectra, the conversion from 1,2-diol into its aldehyde was almost 
quantitatively and no decomposition could be observed.  
(ppm)
1.52.02.53.03.54.04.55.05.56.06.57.07.5
 
Figure 19. 1H-NMR spectra of the 1,2-diol-modified polySia 81 in D2O (A) and N-aldehydo-polySia 82 in 
D2O (B).  
3.1.3.3 Synthesis of polySia hydrogel using hydrazone crosslinking 
To investigate the hydrazone formation from hydrazido- and aldehydo-functionalized polySia 
76 and 82, a model reaction between aldehydo-functionalized polySia derivative 82 and 
commercially available benzoyl hydrazide was studied (Scheme 39). The hydrazone was 
formed between the two components in water at room temperature. After removal of excess 
benzoyl hydrazide, characteristic proton signals of the aromatic system 83 appeared and the 
signals for the aldehyde hydrate lost intensity in the 1H-NMR spectra. Notably, a model reac-
tion of the C-1 hydrazido-polySia 76 and benzaldehyde was also tried under same conditions, 
but the expected hydrazone formation was not observed.  
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Scheme 39. Model reaction of the N-aldehydo-polySia 82 and benzoyl hydrazide. Condition: a) H2O, r.t., 24 h; 
b) Dialysis against distilled H2O, r.t., 2 d, 50%, conversion rate 50%.  
Figure 20 shows the 1H-NMR spectra of polySia 83 (A) and the product of the model reaction 
between benzoyl hydrazide and polySia 83 (B). The success of the reaction was confirmed by 
the appearance of the characteristic signals at 7.4 to 7.8 ppm belonging to the aromatic sys-
tem. The proton signals at 5.10 and 3.30 ppm did not completely disappear but their signals 
were reduced significantly to about 50% (B).  
(ppm)
1.52.02.53.03.54.04.55.05.56.06.57.07.5
Figure 20. 1H-NMR analysis of the model reaction of N-aldehydo-polySia 82 and benzoyl hydrazide. 
N-aldehyde polySia 82 in D2O (A); hydrazone product 83 in D2O (B)   
Equal amounts of C-1 hydrazido-polySia 76 and N-aldehydo-polySia 82 were mixed in aque-
ous media in order to form a 3D-scaffold mediated through hydrazone crosslinkage between 
the terminal hydrazido- and aldehyde-groups of polySia derivatives (Scheme 40).  
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Scheme 40. Crosslinking reaction of C-1 hydrazido-polySia 76 and N-aldehydo-polySia 82 formation 
3D-scaffolds Condition: a) in H2O, r.t., several minutes. 
After mixing of the two components in water, a hydrogel was formed within a short period of 
time. However, the crosslinked hydrogel was not stable. Within several hours, the hydrogel 
turned liquid again (Figure 21, a). This might be due to the short chain length of polySia. To 
overcome this problem, hydrogel blended from polySia and high molecular weight polysac-
charides such as alginate and hyaluronate were investigated. Therefore, C-1 hydrazido-
polySia 76 and aldehyde functionalized alginate and hyaluronate as well as N-aldehydo-
polySia 82 with hydrazide functionalized alginate and hyaluronate were investigated to form 
composite scaffolds.98 Chemically stable and flexible hydrogel networks were obtained from 
the N-aldehydo-functionalized polySia 82 and hydrazide functionalized alginate or hyaluro-
nate (Figure 21, b and c). Still, the C-1 hydrazido-polySia 76 did not react with aldehydo-
functionalized alginate or hyaluronate to generate a stable hydrogel networks.  
 
                                                 
98
 Aldehydo- and hydrazido-functionalized alginate and hyaluronate were prepared by L. Möller and A. Krause, 
as part of their phD thesis (Institute of Organic Chemistry, Gottfried Wilhelm Leibniz University of Hannover).   
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Liquid
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Hydrogel Hydrogel
 
Figure 21. Hydrogel formation using hydrazone crosslinking: Hydrogel from C-1 hydrazido- and N-aldehydo-
functionalized polySia 76 and 82 (a); Hydrogels from N-aldehydo-polySia 82 blended with hydrazido-
functionalized alginate (b) and hyaluronate (c). 
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3.1.4 Decoration of polySia hydrogels with RGD peptide 
In order to improve the interaction between cells and the polySia hydrogels, RGD peptides 99 
were immobilized on the hydrogels. The ligation was enabled through different approaches 
such as coupling of azido-RGD peptide with alkyno- or oxanorbornadienyl-functionalized 
polySia 44, 53 using “click” chemistry as well as imine-mediated coupling of amino-RGD 
peptide with aldehydo-functionalized polySia derivative 82. Afterwards, the RGD peptide 
decorated polySia was used to form hydrogels.    
3.1.4.1 Modification of polySia with RGD peptide using “click” chemistry 
The reaction of N-(4-pentynoyl)-polySia 44 and azido-RGD peptide was performed in aque-
ous media containing copper sulphate as catalyst, which was reduced by sodium ascorbate in 
situ (Scheme 41). The coupling process under microwave irradiation condition proceeded 
quantitatively with respect to azido-RGD peptide, while no conversion could be observed by 
classical oil bath heating. 
 
Scheme 41. Synthesis of RGD peptide modified polySia 85 from N-(4-pentynoyl)-polySia 44 and azido-RGD 
peptide using Cu-catalyzed “click” chemistry. Condition: a) H2O, CuSO4 (8 mol%), Na-ascorbate (12 mol%), 
MW, 40 °C, 30 min. 
In order to confirm that the “click” reaction occurred, the crude product was purified and  
treated with trifluoroacetic acid (0.1 M) at 80 °C for 1 h (Scheme 42). The hydrolyzed prod-
ucts were analyzed using UPLC-MS as well as LC-MS/MS spectroscopy.  
                                                 
99
 Azido- and amino-RGD peptides were synthesized by J. Paleček (Institute of Organic Chemistry, Gottfried 
Wilhelm Leibniz University of Hannover). 
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Scheme 42. Hydrolysis of azido-RGD peptide modified polySia 85 with trifluoroacetic acid. Condition: a) TFA 
(0.1 M), 80 °C, 1 h.    
Figure 22 shows the mass spectra of polySia modified with azido-RGD peptide using 
Cu-catalyzed “click” chemistry. Due to the observed peak at m/z = 975.4186, which belongs 
to sialic acid-RGD conjugate 86, the ligation was proven.  
 
Figure 22. UPLC-MS spectra of the “click”-linked product 86. (calcd for C41H59N12O16 [M-H]-: 975.4172; 
found: 975.4186).  
Further analysis of the fragmentation pattern of the “click” product 86, the mass m/z = 975 
was further investigated with LC-MS/MS spectrometry. Different fragment ions were obsered 
as shown in figure 23.  
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Figure 23. LC-MS/MS spectra of “click” product 86.  
According to previous reports,100 the proposed fragmentation mechanisms corresponds to the 
ions as is illustrated in Scheme 43. At first, the anomer hydroxyl group was deprotonated 
leading to ring opening fragmentation ([M-H]-: m/z = 975), which was cleaved a water mole-
cule to give charged ion [M1-H2O]- (m/z = 957). Subsequently, via a retro-aldol rearrange-
ment mechanism it afforded fragment ion M2 ([M1-88]-) with a terminal aldehyde (m/z = 
887). The molecule was further cleaved to give enol M3 ([M2-88]-) at m/z = 767. The enol 
was dehydrated to generate ion M4 ([M3-H2O]-: m/z = 749). The [M4-42]- ion at m/z = 707 
was regarded to be the guanidine group of the RGD moiety losing a methane diimine to form 
fragment ion M5 (Scheme 43A). 
 
                                                 
100
 a) M. van der Ham, B. H. C. M. T. Prinsen, J. G. M. Huijimans, N. G. G. M. Abeling, B. Dorland, R. Berger, 
T. J. de Koning, M. G. M. de Sain-van der Velden, J. Chromatogr. B 2007, 848, 251-257.  
b) J. A. Carrol, D. Willard, C. B. Lebrilla, Anal. Chim. Acta 1995, 307,431-447. 
c) O. M. Saad, J. A. Leary, J. Am. Soc. Mass Spectrom 2004, 15, 1274-1287. 
d) S. P. Galuska, H. Geyer, C. Bleckmann, R. C. Röhrich, K. Maßes, A. K. Berfeld, M. Mühlenhoff, R. Geyer, 
Anal. Chem. 2010, 82, 2059-2066. 
e) T. Minamisawa, K. Suzuki, J. Hirabayashi, Anal. Chem. 2006, 78, 891-900. 
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Scheme 43A. Proposed fragmentation of “click” product 86 according to LC-MS/MS. 
The [M1-138]- ion at m/z = 837 might be created from the M1 ion via a retro-aldol rear-
rangement and cleavage of a water molecule in ketone form M6. Due to keto-enol tautomer-
ism, it generated the enol form, which could be further dehydrated to give fragment M7 ([M6-
H2O]-) at m/z = 819 (Scheme 43B). 
 
Scheme 43B. Proposed fragmentation pattern of “click” product 86 according to LC-MS/MS. 
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The second approach towards RGD-modified polySia used metal-free “click” conditions for 
the coupling of oxanorbornadienyl-functionalized polySia 53b and azido-RGD peptide. The 
“click” reaction was carried out in water under mild conditions to give “click” conjugate 87b 
(Scheme 44).  
 
Scheme 44. Synthesis of RGD peptide modified polySia 87b from oxanorbornadienyl-functionalized polySia 
53 b and azido-RGD peptide using metal-free “click” chemistry. Conditions: a) H2O, r.t., 2 d.  
In contrast to the Cu-catalyzed “click” reaction of N-alkyno-polySia 44 and RGD peptide, the 
process of metal-free “click” reaction could be monitored using 19F-NMR analysis (see model 
reactions in chapter 3.1.1.3). Figure 24 shows the 19F-NMR spectra of polySia 53a and “click” 
product 87a. The CF3 signal of the oxanorbornadienyl system of polySia 53a could be ob-
served at -62.3 ppm (left). After the “click” reaction, this signal shifted to -58.2 ppm (right).  
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Figure 24. 19F-NMR spectra of oxanorbornadienyl-functionalized polySia 53a (left), and azido-RGD peptide 
modified polySia 87a.  
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Further proofs for the successful “click” reaction towards RGD peptide modified polySia 87b 
were obtained from the UPLC-MS and LC-MS/MS analysis of its hydrolyzed products 
(Scheme 45). In this way, two different units including N-Acetylneuraminic acid 19 and the 
“click” product 88 containing a CF3-trazole linkage could be observed. 
 
Scheme 45. Hydrolysis of azido-RGD peptide modified polySia 87b with trifluoroacetic acid. Condition: a) TFA 
(0.1 M), 80 °C, 1 h. 
Both hydrolyzation products 19 and 88 were detected by UPLC-MS spectroscopy. Figure 25 
shows the “click” product 88 with m/z = 1100.4280.  
 
Figure 25. UPLC-MS spectra of the “click”-linked product 88. (calcd for C44H61N13O17F3 [M-H]-: 1100.4260; 
found 1100.4280). 
The “click” conjugate 88 was further analyzed with LC-MS/MS spectrometry (Figure 26). 
Similar to the Cu-catalyzed “click” reaction, alle corresponding fragments ions were found 
such as [M-H2O]- at m/z = 1082, [M-88]- at m/z = 1012, [M-138]- at m/z = 962, [M-208]- at 
m/z = 892, [M-208-H2O]- at m/z = 874, and [M-208-H2O-42]- at m/z = 832.  
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Figure 26. LC-MS/MS spectra of “click” product 88.  
3.1.4.2 Modification of polySia with RGD peptide using imine crosslinking 
At first, a model reaction for the cross-coupling of amino-RGD peptide with N-aldehydo-
polySia 80 was performed using commercially available benzylamine instead of amino-RGD 
peptide. The imine bond was further reduced to the corresponding amine 89 by treatment with 
sodium cyanoborohydride to improve the hydrolytic stability of the new material (Scheme 
46). 
 
Scheme 46. Model reaction for the cross-coupling of amino-RGD peptide and N-aldehydo-polySia 80 using 
benzyl amine instead of RGD peptide. Conditions: a) H2O, r.t., 24 h; b) NaCNBH3 (0.1 eq.), r.t., 16 h, 
quantitative conversion.  
The reductive amination product was analyzed using 1H-NMR spectroscopy. The characteris-
tic proton signals of the aromatic system could be observed between 7.30 and 7.50 ppm. The 
CH2 proton signals at 3.30 ppm adjacent to the aldehyde group and the CH(OH)2 proton sig-
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nal at 5.10 ppm, which were assigned to the polySia 82 (Figure 27A) disappeared completely 
in the product spectra (Figure 27B).   
(ppm)
1.52.02.53.03.54.04.55.05.56.06.57.07.5
 
Figure 27. 1H-NMR spectra of N-aldehydo-PolySia 82 in D2O (A) and benzylamino-polySia 89 in D2O (B). 
RGD peptide modified polySia 90 was generated from N-aldehydo-polySia 82 and 
amino-RGD peptide (Scheme 47). The reaction was carried out under very mild aqueous con-
dition without any catalyst. The solubility of RGD peptide played an important role for this 
process, since amino-RGD peptide was not very soluble in water. In contrast, addition of 
small amounts of organic solvents such as MeOH or DMF improved the solubility.  
 
 Scheme 47. Cross-coupling of N-aldehydo-polySia 82 and amino-RGD peptide. Condition: a) H2O (1% 
MeOH), r.t., 3 d. 
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The cross-coupling product 90 was investigated by 1H-NMR analysis (Figure 28). Compared 
to the 1H-NMR spectra of the starting material, characteristic signals between 7.20 and 
7.40 ppm appeared, which could be assigned to the aromatic protons of RGD peptide. Some 
weak signals at 3.20 and 1.50 ppm could be identified as RGD peptide proton signals. 
(ppm)
1.52.02.53.03.54.04.55.05.56.06.57.07.5
Figure 28. 1H-NMR spectra N-aldehydo-polySia 82 in D2O (A) and RGD peptide modified polySia 90 in 
D2O (B). 
The cross-coupling product 90 was further analyzed by applying UPLC-MS spectrometry. 
The polymer was treated with 0.1 M trifluoroacetic acid at 80 °C to hydrolyze the glycosidic 
bonds. The mass of monomers of aldehydo-modified polySia 91, and hydrated aldehyde 92 
were detected as well as neuraminic acid 19 and amino-RGD peptide (Table 9). 
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Table 9. Chemical hydrolysis of RGD-modified polySia 90. Conditions: a) TFA (0.1 M), 80 °C, 1 h.  
 
Molecule Formula [M-H] Calcd. Mass (ES-) Found mass (ES-) 
91 C16H25N2O11 421.1458 421.1474 
92 C16H27N2O12 439.1564 439.1572 
19 C11H18NO9 308.0982 308.0992 
Amino-RGD  C27H40N9O7 602.3051 602.3052 
Since the imine crosslinkage is not stable under acidic conditions, the mass of the coupling 
product between sialic acid and RGD peptide could not be found in the UPLC-MS spectra. 
Therefore, the polymer 90 was reduced with sodium cyanoborohydride to give amine 93 and 
then treated with trifluoroacetic acid (Scheme 48). Afterwards, the hydrolyzed products were 
analyzed by UPLC-MS (Figure 29). The mass of the cross-coupling product 94 (m/z = 
1008.4614) was detected. Thus, the polySia-RGD ligation was successfully performed. 
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Scheme 48. Reduction and hydrolysis of amino-RGD modified polySia 90. Conditions: a) H2O, NaCNBH3 
(0.1 eq), r.t., 8 h; b) TFA (0.1 M), 80 °C, 1 h. 
 
 
Figure 29. UPLC-MS spectra of the “click”-linked product 94. (calcd for C43H66N11O17 [M-H]-: 1008.4638; 
found 1008.4614). 
Additionally, the cross-coupling product 94 was further analyzed by LC-MS/MS (Figure 30). 
Good agreement with the “click” chemistry mediated coupling of RGD peptide and polySia, 
all charateristical fragmentation ions were found. ([M-H2O]- at m/z = 992, [M-88]- at m/z = 
920, [M-138]- at m/z = 870, [M-208]- at m/z = 800, [M-208-H2O]- at m/z = 782, and [M-208-
H2O-42]- at m/z = 740). 
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Figure 30. LC-MS/MS analysis of the cross-coupling product 94.  
.  
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3.1.5 Biological evaluation of the polySia hydrogels  
3.1.5.1 Enzymatic degradation of the polySia hydrogels 
A crucial property of an ideal scaffold for tissue engineering is that the scaffold should be 
biodegradable after fulfilling its purpose. PolySia can be enzymatically hydrolyzed through 
cleavage of the glycosidic bonds by a specific phage-borned endosialidase 101 (EndoNF, Fig-
ure 31).  
 
Figure 31. Enzymatic hydrolysis of α-2,8-polySia by phase-borned EndoNF.  
Previous studies demonstrated that various functionalized polySia derivatives as well as poly-
Sia hydrogels using diepoxyoctane as a hydrophobic cross-linking agent could be degraded in 
phosphate-buffer (pH = 7.4) containing endosialidase.89 It was carried out that the degree of 
derivatization plays a very important role for the degradability of this biomaterial. For exam-
ple, when more than 60% the N-acetyl group of polySia was substituted with other substitu-
ents, the polySia derivatives could not be hydrolyzed by the endosialidase. Therefore, for the 
synthesis of new generation polySia hydrogels, the derivatization degree should be adjusted 
under 60%.  
To study the enzymatic degradability of the polySia hydrogels synthesized in this work, the 
hydrogels were equilibrated with phosphate buffer (pH = 7.4) and treated with endosialidase. 
The degradation speed depended on many factors including activity of the enzyme, degree of 
derivatization of the modified polySia as well as the crosslinking method (Table 10). The hy-
drogel from N-azido-polySia 41 (60% derivatization) and alkyno-polySia 44 (60% derivatiza-
tion), which was prepared using copper catalyzed “click” chemistry, was not completely de-
graded by endosialidase within 20 days (entry 1). Hydrogels generated from less decorated 
polySia can be easily degraded by endosialidase (entries 2-5). Hydrogel based on 40% N-
methacryl-polySia 74 was partially degraded by endosialidase (entry 6). 
                                                 
101
 K. Stummeyer, A. Dickmanns, M. Mühlenhoff, R. Gerardy-Schahn, R. Ficner, Nat. Struct. Mol. Biol. 2005, 
12, 90-96. 
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Table 10. Enzymatic degradation of polySia hydrogels. 
Entry PolySia A PolySia B Approach Results 
1a 41 (60%)b 44 (60%) Cu-catalyzed “click” 20 d, hydrogel 
2a 41 (25%) 44 (25%) Cu-catalyzed “click” 3 d, liquid 
3 41 (25%) 53a (25%) Metal free “click” 3 d, liquid  
4 41 (60%) 53b (25%) Metal free “click” 20 d, liquid 
5c 74 (25%) Photopolymerization 5 d, liquid 
6c 74 (40%) Photopolymerization 30, hydrogel 
aThe polySia hydrogels were formed in the presence of CuSO4 (4 mol%) and Na-ascorbate (6 mol%); bThe per-
centage 60%, 40% , and 25% were the degree of derivatization of polySia; cThe polySia hydrogels were formed 
in the presence of photoinitiator Irgacure 2959 (2% w/v). 
The enzymatic degradation process could be analyzed using gel electrophoresis (PAGE). Here 
polySia hydrogel, which was generated from N-azido-polySia 41 (25% derivatization) and 
N-oxanorbornadienyl-polySia 53a (25% derivatization) using metal-free “click” chemistry, 
was treated with endosialidase. The degraded products were analyzed by electrophoresis us-
ing polyarylamide gel and followed by silver straining method (Figure 32). Within 24 hours, 
only the surface of the hydrogels was degraded by the enzyme. After 72 hours, most of them 
were completely degraded.   
 
Figure 32. Electrophoresis of the degraded polySia hydrogel by EndoNF. (Control: polySia hydrogel without 
treatment with EndoNF, Size Marker: TB: trypan blue; XC: xylencyanol; BPB: bromophenol blue; BCP: bro-
mocresol purple. Their mobility matched the numbers of sialyl residues: TB = 117; XC = 52; DPB = 19; and 
BCP = 11.5. The size marker should be signed on a paper after alcian blue staining, because they could not be 
enhanced by silver staining).    
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3.1.5.2 Cytotoxic evaluation of the polySia hydrogels 
The 3D-scaffolds based on modified polySia derivatives were evaluated by measuring the cell 
variability and proliferation behaviour of mammalian cells seeded on the different polySia 
hydrogels.102 In this case, a human hepatocellular carcinoma cell line (HepG2) was selected as 
an in vitro model system for the biological evaluation of polySia hydrogels. The HepG2 cells 
were cultured on the polySia hydrogels under suitable conditions for one or two weeks. The 
viability of the cells was measured by the MTT assay, which is widely used as previously 
described. 103   
 
Figure 33.  Cytotoxicity evaluation of polySia scaffolds by MTT assay. 
The MTT assay is a colorimetric method for measuring the activity of a reductase enzyme like 
mitochondrial dehydrogenase, which can reduce the yellow tetrazolium salt MTT (3-(4,5-
Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) to give a formazan dye with a purple 
color (Scheme 49). Only in living cells the mitochondrial dehydrogenase is active. The ab-
sorbance of the colored solution can be quantified precisely on a multiwell scanning spectro-
photometer (ELISA reader). A main application of this assay allows to assess the viability 
(cell counting) and the proliferation of cells (cell culture assays). It can also be used to 
determine the cytotoxicity of potential medicinal agents and toxic materials, since those 
agents would stimulate or inhibit cell viability and growth.104 
 
Scheme 49. Chemical reaction illustration of the MTT assay. 
The results presented in Figure 34 showed that the viability of the HepG2 cells on hydrogels 
based on modified polySia 41 (60% derivatization) and 44 (60% derivatization) was slightly 
                                                 
102
 The experiments were carried by S. Böhm, Institute of Technical Chemistry, Gottfried Wilhelm Leibniz Uni-
versity of Hannover 
103
 a) T. F. Slater, B. Sawyer, U. Straeuli, Biochim. Biophys. Acta 1963, 77, 383-393;  
b) F. Denizot, R. Lang, J. Immunol. Methods 1986, 89, 271-277. 
104
 T. Mosmann, J. Immunol. Methods 1983, 65, 55-63. 
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better than that in culture medium. It can be concluded that this novel type of polySia hy-
drogel is not cytotoxic.  
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Figure 34. Viability behaviour of HepG2 cells on the polySia hydrogel. Cells on the hydrogel (left column) and 
cells in culture medium (right column). (The hydrogels were prepared from azido-/alkyno-modified polySia 41 
and 44 using Cu-catalyzed “click” reaction). 
Because the cells could not be observed by normal phase contrast microscopy, they were 
stained with 4´,6-diamidino-2-phenyindole (DAPI) (Figure 35). The DAPI molecules bond to 
DNA molecules in the cell nucleus, and then the cells are visible in fluorescence microscopy. 
Comparing to the MTT assay, DAPI strain method could not differentiate between living and 
dead cells.  
B: DAPIA: Phase contrast
 
Figure 35. Cultivation of HepG2 cell line on the polySia hydrogel (the hydrogels were prepared from azido-
/alkyno-modified polySia using Cu-catalyzed “click” reaction).  
Besides the hydrogels formed from azido-/alkyno-modified polySia, all of the other polySia 
hydrogels prepared, including those with RGD peptides, were investigated using HepG2 cell 
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cultivation. Unfortunately, the current results did not show significant improvement of the 
cellular adhesion onto the scaffolds. 
3.2 Synthesis of neuraminic acid derivatives 
Two positions of neuraminic acid 19 could be modified with various functional groups like 
alkyno-, azido-, methacrylate or acrylate. At first, C-1 carboxyl group could be modified with 
the functional groups to give corresponding esters or amides. Generally, ester bonds are not 
stable under basic conditions so that amides are favoured due their stability and versatility. An 
alternative position for modification is C-5. The acetyl group can also be replaced by various 
functional groups.   
3.2.1 Synthesis of neuraminic acids derivatized at C-1 
For the C-1 modification of neuraminic acid, two strategies were applied. The first approach 
used the carboxyl group to attach different amines containing functional groups like alkyno 
and azido. In an alternative approach, the carboxyl group was first converted into a hydrazide. 
The hydrazide moiety was then reacted with functionalized aldehydes to give modified 
neuraminic acids (Scheme 50).  
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Scheme 50. Synthetic approach to C-1 modification of neuraminic acid. 
According to the first approach, C-1 azido-modified neuraminic acid 97 was synthesized from 
neuraminic acid 19 and 3-azidopropan-1-amine (95), which was prepared from 3-aminopropyl 
bromide according to a literature method.105 The coupling reaction was established using car-
bodiimide chemistry. Under identical conditions, the commercially available propargylamine 
(96) could be coupled with neuraminic acid 19 to afford the C-1 alkyno-modified neuraminic 
acid 98. The reactions were achieved in moderate yields without the necessity of installing 
any protecting groups (Scheme 51). 
                                                 
105
 B. Carboni, A. Benalil, M. Vaultier, J. Org. Chem. 1993, 58, 3736-4741. 
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Scheme 51. Synthesis of the C-1 derivatives of neuraminic acid 97 and 98. Conditions a) DAMP, EDC·HCl, 
anhydrous DMF, r.t., 36 h, 60-70%.  
For the preparation of the C-1 hydrazido-neuraminic acid 100, methyl ester of neuraminic 
acid 99 was firstly prepared according to a literature known procedure from neuraminic acid 
19 and methanol in the presence of catalytic amounts of trifluoroacetic acid. 106 The obtained 
ester was treated with an excess of hydrazine monohydrate to give C-1 hydrazido-neuraminic 
acid 100 in 95% yield (Scheme 52).107  
 
Scheme 52. Synthesis of C-1 hydrazido-neuraminic acid 100. Condition: a) TFA, MeOH, r.t., 24 h, quantitative; 
b) H2N-NH2·H2O, H2O, r.t., 2 h, 95%.  
In order to investigate the reaction between C-1 hydrazido-neuraminic acid 100 and different 
aldehydes, hydrazide 100 was coupled with benzaldehydo-, isobutyl- aldehyde-, and 
5-hexynal. 108  Generally, the hydrazone linkage was not stable. Therefore, the hydrazone 
crosslinked products were reduced with sodium cyanoborohydride. The products were ana-
lysed by UPLC-MS spectrometry, and showed good rates of conversion. However, HPLC 
chromatography of substituted neuraminic acid 101 gave only 7% of the product as a mixture 
of α and ß anomers. Other products could also not be isolated.   
                                                 
106
 B. P. Bandgar, M. Hartmann, W. Schmid, E. Zbiral, Liebigs Ann. Chem. 1990, 1185-1195. 
107
 J. Becher, I. Seidel, W. Plass, D. Klemm, Tetrahedron 2006, 62, 5675-5681. 
108
 T. Böttcher, S. A. Sieber, Angew. Chem. Int. Ed. 2008, 47, 4600–4603. 
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Scheme 53. C-1 Modification of neuraminic acid via hydrazone linkage. Conditions: a) MeOH/H2O, 0 °C→r.t., 
8 h, and then NaCNBH3 (0.1 eq.), r.t., 8 h.  
3.2.2 Synthesis of neuraminic acids derivatized at the nitrogen 
To introduce various substituents at position C-5 of the neuraminic acid 19, the N-acetyl 
group was firstly deacetylated to give a free amino group. Furthermore, it turned out to be 
necessary to protect the anomeric hydroxyl group, requiring a two step approach to γ-amino 
methoxyneuraminic acid 106. At first, the neuraminic acid 19 was heated in anhydrous 
methanol in the presence of Amberlite IR 120 (H+-form) to give the methyl ester of meth-
oxyneuraminic acid 105. Subsequently, the ester was treated with sodium hydroxide to give γ-
amino methoxyneuraminic acid 106 in a good yield (Scheme 54). 
 
Scheme 54. Synthesis of γ-amino methoxyneuraminic acid 106. Conditions: a) Amberlite 120 (H+-form), dry 
MeOH, reflux, 16 h, >90%; b) NaOH, H2O/EtOH, reflux, 16 h, 85%.   
γ-Amino methoxyneuraminic acid 106 was used as starting material to prepare of N-acyl-
modified neuraminic acid derivatives. Due to the very high polarity, the neuraminic acid 106 
turned out to be insoluble in any organic solvent. In aqueous media, neuraminic acid 106 was 
coupled with different carboxylic acids such as pentinoic acid, pent-4-ynoic acid, and 4-azido 
butanoic acid but only very low or no conversion was obtained. 
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Therefore, γ-amino methoxyneuraminic acid methylester 107 was prepared according to a 
preciously reported one-pot procedure.109 Here, the carboxyl group was protected with methyl 
ester to improve the solubility in organic solvents. Different conditions were tried to prepare 
deacetylated γ-amino methoxyneuraminic acid methyl ester 107 (Table 11). The starting ma-
terial was heated in the microwave oven in methanol containing 0.6-1.25 M hydrochloric acid 
(entry 1). The conversion was only moderate. Changing the concentration of the acid or ex-
tension of reaction time did not improve of conversion. The use of acetyl chloride instead of 
hydrochloric acid resulted in a little improvement of the yield (entry 2). The reactions under 
pressure in sealed tube or autoclave leaded to higher yields (entries 3 and 4).  
Table 11. Synthesis of γ-amino methoxyneuraminic acid methyl ester 107. 
 
Entry Condition (solvent, method, temperature, time) Result 
1 HCl (0.9-1.25 M), MeOH, microwave oven, 120 °C, 30 min 30% 
2 CH3COCl, MeOH, microwave oven, 120 °C, 30 min 50% 
3 CH3COCl, MeOH, sealed tube (pressure), 100 °C, 3 h 80% 
4 CH3COCl, MeOH, autoclave, 100 °C, 3 h 80% 
To obtain N-derivatives of neuraminic acid, three strategies were applied starting with the γ-
amino methoxyneuraminic acid methyl ester 107 (Scheme 55). At first, the amino group of 
neuraminic acid 107 was reacted with different carboxylic acids in presence of coupling re-
agents. In a second approach, anhydrides were used instead of carboxylic acids to react with 
the amino sugar without activation reagents. Finally, the amino sugar was reacted with active 
NHS-esters under basic conditions.  
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Scheme 55. Synthesis of N-acyl-modified neuraminic acid derivatives. Conditions: i) EDC·HCl, DIPEA, DMF, 
r.t., 24 h; ii) Pyridine, r.t., 24 h; iii) DMF, DIPEA, 0→40 °C, 24 h. 
                                                 
109
 N. E. Byramoca, Carbohydr. Res. 1982, 237, 161-175. 
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Comparing the results obtained from the three approaches, the third strategy gave best yields. 
The active esters were prepared from the corresponding carboxylic acids and NHS according 
to literature known procedures (Table 12).110  
R OH
O
R O
N
O
O
Oa
108 a-g
 
Table 12. Preparation of NHS active esters 108a-g. Conditions: a) NHS, EDC·HCl, dry CH2Cl2 or THF, 
0→4 °C, 16 h. 
N-hydroxysuccinimide esters (NHS-esters) 
 
108a  108e 
 
108b 
 
108f 
 
108c  
108g 
 
108d 
 
NHS active esters 108a,c,d were prepared from commercial available carboxylic acids. Esters 
containing azido-group 108b or oxanorbornadienyl-linker 108e-g groups were prepared from 
the carboxylic acids, whose syntheses were described in chapter 3.1.1.2.  
The coupling reaction of the 4-pentynoyl NHS-ester 108a and the γ-amino methyl ester of 
methoxyneuraminic acid 107 were carried out in anhydrous DMF under basic conditions. 
Subsequently, the crude products were treated with sodium hydroxide to liberate the C-1 car-
                                                 
110
 a) K. Shimizu, K. Nakayama, M. Akiyama, Bull. Chem. Soc. Jpn. 1984, 57, 2456-2462;  
b) H. G. Batz, J. Koldehoff, Makromol. Chem. 1976, 177, 683-689. 
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boxylic group. To remove the sodium salt, the reaction mixture was treated with Amberlyst 
15 (H+-form). 
 
Scheme 56. Synthesis of N-alkyno-methoxyneuraminic acid 109. Condition: a) DIPEA, dry DMF, r.t.→40 °C, 
24 h; b) NaOH (0.5 M), 0 °C→r.t., 30 min. 
Cleavage of the glycosidic bond was not easily accomplished. In the early 1960s, Karkas and 
Chargaff had discussed this reaction in detail.111 The pH value plays a very important role in 
the removal of the glycosidic methoxy group. Between pH 5 and 7, methoxysialic acid was 
not hydrolyzed in appreciable amounts. Moderate cleavage took place at pH = 4. The optimal 
condition for the hydrolysis of the glycosidic bond was at pH = 3, since the cleavage was 
completed in a relatively short time, without the destruction of sialic acid. At low pH values, 
cleavage occurs more rapidly. However, the free sialic acid evidently is degraded further. 
They found that the formation of a hydrogen bond between the hydrogen of the carboxyl and 
the glycosidic oxygen has an intramolecular catalytic effect. As a result formation of the 
5-membered ring can increase the rate of the reaction overall and avoid the risk of decomposi-
tion of the ring structure (Figure 36).  
 
Figure 36. Formation of 5-membered ring under acidic conditions during the cleavage of the methyl glycoside. 
In this work, different conditions were tested to cleave the glycosidic bond of alkyno-
modified methoxyneuraminic acid 109 (Table 13). Under strong acidic conditions (entries 
1-3), no conversion could be observed. The reactions catalyzed by ion exchange resin 
                                                 
111
 J. D. Karkas, E. Chargaff, J. Biol. Chem. 1964, 239, 949-957. 
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Dowex 50 (H+-form) or Amberlite 120 (H+-form) in the presence of 0.025 M hydrochloric 
acid as hydrogen source leaded to little conversion (entries 5-7). With the ion exchange resin 
Amberlyst 15 (H+-form) best results were obtained. The conversion was almost complete (en-
tries 8 and 9). The reaction was also tested under microwave condition at 100 °C. The cleav-
age occurred more rapidly, but decomposition of the material was observed. 
Table 13. Demethoxylation of N-4-pentynoyl-methoxyneuraminic acid 105. 
 
Entry  Conditions Result (ESI)a  
1 AcOH:H2O (4:1) reflux 2 h SM 
2 1 M HCl, reflux, 2 h SM 
3 0.1  M TFA, 80 °C, 2 h SM 
4 0.025 M HCl, Dowex 50 (H+-form), 80 °C, 2 h SM 
5 0.025 M HCl, Dowex 50 (H+-form), MW, 100 °C, 2 h SM + P (trace) 
6 0.025 M HCl, Amberlite 120 (H+-form), 80 °C, 2 h SM + P (trace) 
7 0.025 M HCl, Amberlite 120 (H+-form), 100 °C, 2 h SM + P (trace) 
8 0.025 M HCl, Amberlyst 15 (H+-form), 80 °C, 2h P 
9 0.025 M HCl, Amberlyst 15 (H+-form), MW, 100 °C, 10 min  SM (trace) + P  
a
 SM: starting material, P: product  
According to the optimized procedure, the following N-modified neuraminic acid derivatives 
were obtained, which were N-4-azidobutytyl-neuraminic acid 63, N-methacryl-neuraminic 
acid 110 and N-pent-4-enoyl-neuraminic acid 111 (Scheme 57).  
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Scheme 57. Synthesis of N-functionalized neuraminic acid derivatives with azido-butanoyl group 63, methacryl-
group 106 and pent-4-enoyl group 107. Conditions: a) NHS-ester, DMF, DIPEA, 40 °C, 16 h; b) NaOH (0.5 M), 
r.t., 2 h; c) HCl (0.0125 M), Amberlyst 15 (H+-form), 80 °C, 2 h, 60-70% over 3 steps; d) Pyridine, methacrylic 
anhydride, 0→r.t., 24 h, then the same steps b and c, over 3 steps 70%. 
Additionally, the two NHS-esters 108d/108e, which contained thiol- and oxanorbornadienyl-
functional groups, were coupled the neuraminic acid 107 to synthesis of new neuraminic acid 
derivatives (Scheme 58). Although the thiol-functionalized product 112 could be detected by 
UPLC-MS, it could not be isolated. The oxanorbornadienyl-modified neuraminic acid deriva-
tive 114 was not obtained from glycoside 113 because the oxanorbornadienyl-system decom-
posed under the demethoxylation conditions. 
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Scheme 58. Synthesis of N-functionalized neuraminic acid derivatives with thiol-group 112 and oxanorbornadi-
enyl-group 114. Conditions: a) NHS-ester, DMF, DIPEA, 40 °C, 16 h; b) NaOH (0.5 M), r.t., 2 h; c) HCl 
(0.0125 M), Amberlyst 15 (H+-form), 80 °C, 2 h, no pure desired product was isolated. 
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4 Conclusion and Outlook 
In this thesis two general projects were investigated. The first part focused on the decoration 
of the α-2,8-linked polySia with various functional groups. The different functionalized poly-
Sia batches were used as macromolecular precursor to form 3D-hydrogel networks, which 
serve as scaffolds in the field of tissue engineering. Furthermore, polySia was successfully 
decorated with RGD peptides via different covalent linkages in order to improve the interac-
tions of cells and scaffold. The second project aimed at the synthesis of various neuraminic 
acid analogues. The neuraminic acid plays a crucial role in many biological events and was 
widely investigated for applications in novel pharmaceutical agents, inhibitors for neuraminic 
acid aldolase, and other biological applications. The neuraminic acid derivatives were trans-
ferred to Hannover Medical School for further biological applications. These N-acyl-modified 
sialic acids will be used as starting material for the enzymatic synthesis of polySia derivatives 
and as substrates to study the polySia synthetase involved in this polymerization.  
4.1 Modification of polySia and generation of novel scaffolds for tissue engineering 
Commercially available colominic acid sodium salt and the polySia provided by the Institute 
of Technical Chemistry at the Leibniz university Hannover (TCI, Uni-Hannover) were used as 
starting material for the synthesis of polySia derivatives. Two major types of novel polySia 
derivatives were successfully synthesized in this work (Figure 37). The first class aimed at the 
polySia decoration at position C-1. The polySia lactone was synthesized and further converted 
into polySia hydrazide 80, which can be used for hydrogel preparation by cross-linking with 
aldehydes. The second class consists of N-derivatives of polySia by replacing the acetyl-group 
at C-5 with various functional groups. Azido- and alkyno-functionalized polySia (41 and 44) 
were synthesized from deacetylated polySia (TBA-salt) 37 using the corresponding acid chlo-
rides. In order to perform metal-free “click” chemistry, oxanorbornadienyl-modified polySia 
53 was synthesized as alkyno-analogue. N-methacryl-polySia 74 was prepared from deacety-
lated polySia 37. The formation of aldehydo-functionalized polySia 82 was achieved by a 
building block, which contained a terminal carboxyl group as well as a 1,2-diol moiety. The 
building block was coupled to the amino group of polySia using carbodiimide chemistry. Af-
terwards, the 1,2-diol moiety was oxidized with sodium periodate to give the N-aldehydo-
polySia 82. 
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Figure 37. PolySia derivatives decorated with functional groups. 
The degree of substitution has significant influence on the properties of the formed polySia 
derivatives such as hydrogel formation, enzymatic degradability, and stability of hydrogel. 
Thus, degree of derivatization was adjusted in a range of 25-60%. Additionally, the N-acetyl 
group plays a crucial role in the process of enzymatic degradation and had to be reconstructed 
for each derivative by reacetylation of the remaining amino groups with acetic anhydride. 
The modified polySia derivatives were used to prepare hydrogels, which were applied as 
3D-scaffolds for neural tissue engineering. PolySia hydrogels were formed via different 
crosslinking methods (Figure 38). Azido- and alkyno-decorated polySia derivatives (41 and 
44) were used as “clickable” macromolecular precursors and in the presence of Cu-catalyst, 
triazoles were formed which led to crosslinkage and therefore hydrogel formation (A). Since 
copper is potentially cytotoxic for organisms, the metal-free “click” linkage is more favoured 
for the generation of polySia hydrogels. Oxanorbornadienyl-modified polySia 53 reacted with 
azido-modified polySia 41 to create a network structure based on a CF3-triazole linckage in 
the absence of any catalyst (B). Photoinitiator induced radical crosslinking is also an appro-
priate approach for preparation of hydrogels. N-Methacryl-polySia 74 was irradiated with 
UV-light in the presence of Irgacure 2959 to give flexible polySia hydrogels (C). Besides the 
crosslinking approaches, molecular weight of polySia plays a crucial role by the Gelation 
process. Comparing to the commercial polySia (molecular mass: 15.000 Da), the polySia 
from TCI with a molecular mass of 45.000 Da could easily lead to hydrogel formation, even 
though it was less functionalized.  
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Figure 38. PolySia hydrogels based on different crosslinking techniques: Cu-catalyzed “click” reaction (A), 
metal-free “click” reaction (B), and photo-induced radical polymerization (C). 
An alternative method for the synthesis of 3D-scaffolds is the formation of hydrazones. 
Therefore, hydrazido- and aldehydo-functionalized polySia (76 and 80) were prepared. Based 
on the hydrazone formation a hydrogel was formed within a few minutes. The hydrazones 
turned out to be labile towards hydrolysis and the hydrogel liquefied within several hours. 
Nevertheless, blends of aldehydo-modified polySia and hydrazido-decorated alginate or hya-
luronate can generate very stable and flexible hydrogels. 
In addition, biological properties of polySia hydrogels were evaluated. The biodegradability 
was studied by enzymatic degradation experiments. PolySia hydrogels were treated with En-
doNF for 3 to 30 days. The rates of degradation especially depend on the degree of derivatiza-
tion of the starting materials. Cytotoxicity and biocompatibility was evaluated using the hu-
man hepatocellular carcinoma cell line (HepG2) as in vitro model. The results demonstrated 
that polySia hydrogels caused no cytotoxicity, but also did not afford significant increase of 
cell adhesion. 
In order to improve cell adhesion, polySia was decorated with unique RGD peptides via 
“click” reaction or imine formation (Figure 39). PolySia hydrogels decorated with RGD pep-
tides were also tested in cell cultures. Unfortunately, the current results did not present sig-
nificant improvement of cell adhesion.  
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Figure 39. RGD peptide modified polySia derivatives afforded by different crosslinking strategies. 
4.2 Sythesis of N-neuraminic acid derivatives 
In this project, neuraminic acid was successfully modified at two positions (C-1 and C-5) with 
various functional groups (Figure 40). C-1 Modification was accomplished via coupling of 
neuraminic acid 19 and 3-azidopropan-1-amine or propargylamine to give products 97 and 98, 
respectively. N-Acyl derivatizations were established from various substituents and deacety-
lated neuraminic acid. At first, the functionalized carboxylic acids were transferred into their 
corresponding NHS-esters. Subsequently, the NHS-esters were coupled to the amino group of 
neuraminic acid to afford different neuraminic acid derivatives (35, 63 and 111). Methacryl-
modified neuraminic acid 110 was synthesized directly from methacrylic anhydride and 
deacetylated neuraminic acid under mild conditions.  
  
Figure 40. Neuraminic acid derivatives decorated with various functional groups. 
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4.3 Outlook 
For the optimization of polySia hydrogels, the polySia can be modified with an appropriate 
substitution degree in a range of 40-50%. Accompanied polySia hydrogels should have better 
stability and degradability. Additional coating of polySia hydrogels with collagen (I/II) or 
poly-L-lysine (PLL) should be tested to improve cell adhesion. Another optimization possibil-
ity is the combination of polySia with other macromolecular precursor like alginate or hyalu-
ronate to give blended scaffolds with combined properties. PolySia is favoured due to its good 
biodegradability and chemical versatility. Alignate and hyaluronate can generate improved 
mechanically stable hydrogels due to their high-molecular weight. For example, 3D-scaffolds 
could be prepared form aldehydo- or RGD peptide decorated polySia and alginate or hyaluro-
nate hydrazide (Figure 41).  
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Figure 41. Composite 3D-scaffolds from alginate or hyaluronate hydrazide with aldehydo- or RGD peptide 
modified polySia. 
As a final goal of this project, polySia hydrogels with optimal properties will be applied as 
cell scaffolds for the investigation of neural cell regeneration. The obtained neuraminic acid 
derivatives will be probed for the synthesis of different polySia derivatives or used for other 
biological applications. 
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5 Experimental Parts 
5.1 General methods 
Reactions 
Unless otherwise stated, all experiments were performed under room atmosphere and tem-
perature. All reactions involving air- or/and moisture-sensitive reagents were carried out un-
der nitrogen or argon atmosphere. The glassware was heated in vacum before use.  
Solvent and reagents 
All solvents were dried with conventional methods. Unless otherwise stated, all chemicals 
were obtained from commercial sources and used without further purification. 
Thin layer and silica gel chromatography 
Analytical thin layer chromatography (TLC) was performed using precoated silica gel 60 F-
254 plates (layer thickness 0.25 mm) from Merk. Spots were visualized with (UV) irradiation 
at 254 nm or 366 nm or staining with KMnO4. Preparative thin layer chromatography (Prep-
TLC) was performed on Merck precoated silica gel 60 F-254 plates (layer thickness 1.00 mm) 
with concentration zone and visualization by UV irradiation at 254 nm or 366 nm. Flash col-
umn chromatography was performed on silica gel Acros (0.035-0.070 mm, pore diameter ca. 
6 nm) with slight overpressure.  
Ion exchange chromatography and HPLC 
Ion exchange chromatography was performed with an AG®1-X2 resin (50-110 mesh, chlo-
ride-form) purchased from BIO-RAD. The resin is sold in the chloride form so it had to be 
converted to the OH- form. The resin is loaded into a column and converted the resin to the 
OH- form by washing it with 5 to10 bed volumes of 1 to 2 M sodium hydroxide. Subse-
quently, the resin is washed with distilled water until the pH is near neutral. Finally, the resin 
is eluted with 5 bed volumes of 1 to 2 M formic acid and rinse off the excess formic acid with 
distilled water.   
For reversed phase HPLC applications, bidistilled water as well as commercially available 
HPLC-quality methanol were used as elution solvents (formic acid was added as additive in 
0.1%v/v). Preparative HPLC was performed with a VARIAN HPLC system (pump prepstar 
model 218, variable wavelength detector Prostar (λmax = 248 nm) equipped with a mass detec-
tor (MICROMASS ZMD ESI-Quad-Spectrometer) on a C-18 (TRENTEC, Reprosil-Pur 120 
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C18 AQ 5 µm, 250 mm * Ø 25 mm) HPLC column. The applied elution program and corre-
sponding retentions time (tR) were given in the experimental section.  
NMR-spectroscopy 
1H-NMR spectra were recorded on a Bruker DPX-200 (200 MHz) and AM-400 (400 Hz) 
spectrometer. Chemical shifts are reported in ppm (parts per million) relative to internal 
tetramethylsilane (δ = 0.00), chloroform (δ = 7.26), Methanol (δ = 3.31), dimethylsulphoxide 
(δ = 2.50), acetone (δ = 2.05) and deuterium oxide (δ = 4.79). Coupling constants are given in 
Herz (Hz). Multipilicities are described by using the following abbreviations: s = singulet, d = 
doublet, t = triplet, q = quartet, m = multiplet, br = broad. 
13C-NMR spectra were recorded on a Bruker AM-400 (100 Hz) spectrometer. Chemical shifts 
are reported in ppm (parts per million) relative to internal standards such as chloroform (δ = 
77.0), Methanol (δ = 49.0), dimethylsulphoxide (δ = 39.7), acetone (δ = 29.8). Multiplicities 
refer to the resonance in the off-resonance spectra and was elucidated using the distortionless 
enhancement by polarization transfer (DEPT) spectral editing technique, with secondary 
pulses at 90° and 135°. For the degree of substitution are described by using the following 
abbreviations: s = singlet (quaternary carbon), d = doublet (tertiary carbon), t = triplet (secon-
dary carbon), q = quartet (primary carbon). Complete assignments of structures were per-
formed employing a combination of homo- and heteronuclear correlation experiments (H, H-
COSY, HMBC, and HSQC).  
Mass spectrometry  
Mass spectra were obtained on a micromass LCT with a Lock-Spray dualo ion source coupled 
with a Waters Alliance 2695 HPLC (injection in a “loop” mode without chromatographic 
separation). Alternatively measurement was carried out using an Acquity-UPLC (Column: 
BEH C18 1.7 µm, [SN 0473711315545], elution solvent A: water + 0.1%[v/v] formic acid; 
Elution solvent B: MeOH + 0.1%[v/v]; Flow rate: 0.4 mL/min; Gradient: {t[min]/B[%]}: 
{0/5}{2.5/95}{6.5/95}{6.6/5} {8/5}) coupled with a Q-Tof premier mass spectrometer.  
Infraredspectroscopy  
Infrared (IR) spectra were recorded with a Bruker vector 22 FT-IR spectrophotometer 
(Golden Gate ATR unit). 
Experimental Parts                                                                                                                  87 
Polarimeter  
Optical rotations were measured with a Perkin-Elmer model 341 polarimeter at 589 nm (so-
dium D-line) and given concentration in g per 100 mL. 
Melting point 
Melting points were determined with a SRS OptiMelt apparatus and were not corrected.  
CHN-analysis  
All combustion analyses (CHN) were measured on a Elementar Vario EL (Version F, Analyse 
System, Germany): Due to the hygroscopic properties of polySia and polySia based materials, 
the measured and theoretical carbon and nitrogen content differ as shown for commercial 
α-2,8-polySia (lyophilized sodium salt, 98% purity, obtained from Nacali Tesque, Inc., Ja-
pan):  
Cmeasured = 34.02%  Ctheorical = 45.21% 
Nmeasured = 3.63%  Ntheorical = 4.79% 
The quotient C/N was used to draw conclusions from the measured data in this way, the water 
content of the polymer was not taken into account. 
C/Nmeasured = 9.36  C/Ntheorical = 9.44 
The theoretical C/N quotient was corrected by the degree of derivatization measured by inte-
gration of 1H-NMR spectra. 
Dialysis 
PolySia products were purified with a dialyse membrane Visking (Carl Roth, Germany, Kars-
ruhe). Molecular weight cut off (MWCO) 14000 g/mol and diameter 21.5 mm.  
Microwave oven 
Reactions under microwave irradiation conditions were performed with a microwave oven 
Discover (CEM, USA). The processes were controlled with software “synergy”.  
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5.2 Synthesis of polySia derivatives 
5.2.1 Experiments towards azido- and alkyno-modified polySia 
γ-Amino polySia (sodium salt) 3689 
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PolySia (sodium salt) 3 (3 g, 9.6 mmol) was dissolved in 200 mL solvent, which was a mix-
ture of NaOH (7.5 g), H2O (12 mL), and EtOH (188 mL). The reaction mixture was refluxed 
and stirred over night. Afterwards, the reaction mixture was neutralized with HCl (0.5 M). 
EtOH was evaporated under reduced pressure and the crude product was desalted by dialysis 
against distilled H2O. The solution was lyophilized to afford γ-amino polySia (sodium salt) 36 
as a colorless, amorphous solid (2.4 g, 8.3 mmol, 91%). 
1H-NMR (400 MHz, D2O) δ: 4.20-4.08 (3H, H-4, H-6 & H-9a), 3.75-3.64 (1H, H-8), 
3.63-3.56 (1H, H-9b), 3.55-3.45 (1H, H-7), 2.80 (0.92H, H-5), 2.63 (1H, H-3eq), 2.09 (0.24H, 
NHCOCH3), 1.68 (1H, H-3ax) ppm. 
13C-NMR (100 MHz, D2O) δ: 173.8 (s, C-1), 101.3 (s, C-2), 77.6 (d, C-8), 75.1 (d, C-6), 69.9 
(d, C-7), 69.6 (d, C-4), 61.4 (t, C-9), 53.5 (d, C-5), 39.9 (t, C-3), 22.4 (q, NHCOCH3) ppm. 
Degree of derivatization: 92% (According to integrations of H-5 at 2.80 ppm and 
NHCOCH3). 
γ-Amino polySia (TBA salt) 37   
 
γ-Amino polySia (sodium salt) 36 (2.3 g, 8.5 mmol) was dialyzed against an aqueous solution 
of TBA bromide (500 mL, 0.25 M) at room temperature for 24 h. To remove of excess TBA 
bromide, the product was dialyzed against demineralized H2O (pH = 10, adjusted with 
TBAOH) at room temperature for 24 h. The aqueous layers were concentrated and lyophilized 
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to afford γ-amino polySia (TBA) salt 37 as a colorless amorphous solid (3.3 g, 6.8 mmol, 
80%). 
1H-NMR (400 MHz, D2O) δ: 4.20-4.04 (3H, H-4, H-6 & H-9a), 3.72-3.65 (1H, H-8), 
3.64-3.58 (1H, H-9b), 3.57-3.42 (1H, H-7), 3.18 (6.8H, N+(CH2CH2CH2CH3)4), 2.85 (0.98H, 
H-5), 2.62 (1H, H-3eq), 2.09 (0.06H, NHCOCH3), 1.68 (1H, H-3ax), 1.63 (6.8H, 
N+(CH2CH2CH2CH3)4), 1.34 (6.8H, N+(CH2CH2CH2CH3)4), 0.93 (10.2H, 
N+(CH2CH2CH2CH3)4) ppm. 
13C-NMR (100 MHz, D2O) δ: 173.7 (s, C -1), 101.1 (s, C-2), 77.4 (d, C-8), 74.8 (d, C-6), 
69.6 (d, C-7), 69.0 (d, C-4), 61.2 (t, C-9), 58.8 ( N+(CH2CH2CH2CH3)4), 53.5 (d, C-5), 39.4 (t, 
C-3), 23.1 (t, N+(CH2CH2CH2CH3)4), 19.1 (t, N+(CH2CH2CH2CH3)4), 12.8 (q, 
N+(CH2CH2CH2CH3)4) ppm. 
For free amino group (degree of derivatization): 98% (According to integrations of H-5 at 
2.85 ppm and NHCOCH3); For TBA group (degree of derivatization): 85% (According to 
integrations of HTBA). 
N-(4-Azidobutyryl)-polySia 4189  
 
γ-Amino polySia (TBA salt) 37 (50 mg, 0.102 mmol) was dissolved in anhydrous pyridine 
(2 mL) and cooled to 0 °C. Subsequently, 4-azidobutyric chloride (40) (70 µL, 0.5 mmol), 
which was prepared according to known procedure was added and the reaction mixture was 
stirred at room temperature over night. To reacetylate the remaining free amino-groups the 
reaction mixture was cooled to 0 °C and acetic anhydride (1 mL) was added. After stirring at 
room temperature for 8 h, the solvent was evaporated under reduced pressure and treated with 
NaOH (3 mL, 1 M). After stirring for 8 h, the mixture was neutralized with HCl (1 M) and 
dialyzed against aqueous NaCl solution (0.5 M) for 2 days (pH = 9) and against distilled H2O 
for 2 days. The aqueous layers were concentrated and lyophilized to give the product 41 as a 
colorless, amorphous solid (36 mg, 0.094 mmol, 92%).    
1H-NMR (400 MHz, D2O) δ: 4.20-4.01 (2H, H-4 & H-6), 3.91-3.81 (2H, H-5 & H-9a), 
3.72-3.58 (3H, H-7, H-8 & H-9b), 3.41 (1.86H, NHCOCH2CH2CH2N3), 2.63 (1H, H-3eq), 2.42 
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(1.86H, NHCOCH2CH2CH2N3), 2.09 (0.21H, NHCOCH3), 1.91 (1.86H, 
NHCOCH2CH2CH2N3), 1.75 (1H, H-3ax) ppm. 
13C-NMR (100 MHz, D2O) δ: 176.6 (s, NHCOCH2CH2CH2N3), 173.2 (s, C-1), 101.1(s, C-2), 
77.5 (d, C-8), 73.2 (d, C-6), 69.2 (d, C-7), 68.3 (d, C-4), 61.2 (t, C-9), 52.3 (d, C-5), 50.4 (t, 
NHCOCH2CH2CH2N3), 40.0 (t, C-3), 33.12 (t, NHCOCH2CH2CH2N3), 24.5 (t, 
NHCOCH2CH2CH2N3) ppm. 
Combustion analysis: C/N = 3.22 (theoretical: C/N = 2.98). 
Degree of derivatization: 93% (According to integrations of CH2 at 3.41 ppm and 
NHCOCH3). 
N-(4-Pentynoyl)-polySia 44 89 
 
γ-Amino polySia (TBA salt) 37 (55 mg, 0.1 mmol) was dissolved in anhydrous pyridine 
(2 mL) and cooled to 0 °C. After addition of 4-pentynoic acid chloride (43) (55 µl, 0.5 mmol), 
which was prepared according to reported procedure, the reaction mixture was slowly warmed 
up to room temperature and stirred over night. The reacetylation and purification processes 
were carried out according to the synthesis of N-(4-azidobutyryl)-polySia 41. The desired 
N-(4-pentynoyl)-polySia 44 was afforded as a colorless amorphous solid (20 mg, 0.056 mmol, 
56%)  
1H-NMR (400 MHz, D2O) δ: 4.20-4.05 (2H, H-4 & H-6), 3.91-3.78 (2H, H-5 & H-9a), 
3.72-3.52 (3H, H-7, H-8 & H-9b), 2.65 (1H, H-3eq), 2.50 (2.4H, 2xCH2), 2.40 (0.6H, CCH), 
2.09 (1.2H, NHCOCH3), 1.75 (1H, H-3ax) ppm. 
13C-NMR (100 MHz, D2O) δ: 175.4 (s, NHCOCH2CH2CCH), 173.2 (s, C-1), 101.1(s, C-2), 
84.0 (s, NHCOCH2CH2CCH), 77.6 (d, C-8), 73.2 (d, C-6), 70.1 (d, NHCOCH2CH2CCH), 
69.2 (d, C-7), 68.3 (d, C-4), 61.2 (t, C-9), 52.3 (d, C-5), 40.0 (t, C-3), 34.6 (t, 
NHCOCH2CH2CCH), 14.3 (t, NHCOCH2CH2CCH) ppm. 
Combustion analysis: C/N = 11.01 (theoretical: C/N = 11.44). 
Experimental Parts                                                                                                                  91 
Degree of derivatization: 60% (According to integrations of CH2 at 2.50 ppm and 
NHCOCH3). 
5.2.2 Experiments towards oxanorbornadienyl-modified polySia 
Ethoxycarbonylmethyl-triphenyl-phosphonium bromide (46) 
 
A mixture of bromoacetic acid ethyl ester 45 (28.5 mL, 256.2 mmol), triphenylphosphine 
(61.10 g, 232.94 mmol) and catalytic amounts of KI in anhydrous toluene (500 mL) was 
stirred at room temperature for 48 h. After filtration the residue was washed twice with tolu-
ene. The colorless solid was dried under reduced pressure to afford the desired product 46 
(232 g, 100%).  
1H-NMR (400 Hz, CDCl3) δ: 7.53-7.56 (m, 6H, Ar-H), 7.69-7.68 (m, 3H, Ar-H), 7.67-7.64 
(m, 6H, Ar-H), 5.58 (d. J = 13.6 Hz, 2H, Ph3P+CH2), 4.02 (q, J = 7.16 Hz, CH2CH3), 1.06 (t, 
J = 7.16 Hz, 3H, CH3) ppm. 
13C-NMR (100 MHz, CDCl3) δ: 164.7 (s, CO), 135.3 (d, Ar-C), 134.2 (d, Ar-C), 130.3 (d, 
Ar-C), [118.7, 117.8] (d, Ar-C-P), 63.0 (t, CH2), [33.7-33.2] (d, Ph3P+CH2), 13.73 (q, 
CH3) ppm 
Melting point: 152.0-154.5 °C. 
Trifluoro-3-oxo-2-(triphenyl-phosphanylidene)-butyric acid ethyl ester (47) 
 
Phosphonium salt 46 (20 g, 46.6 mmol) was suspended in anhydrous THF (50 mL) and 
cooled to 0 °C. Afterwards, the reaction mixture was treated with Et3N (14.3 mL). After stir-
ring for 15 min, trifluoroacetic anhydride (7.90 mL, 55.91 mmol) was added dropwise to the 
reaction mixture and stirring was continued for 1 h. The mixture was filtered and the residue 
was washed three times with cold THF. The filtrate was concentrated under reduced pressure 
to afford a yellow oily residue. Cold distilled H2O (50 mL) was added to the residue and fil-
tered to give the desired product 47 which was dried under reduced pressure (20.62 g, 
46.0 mmol, quantitative).  
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1H-NMR (400 Hz, D2O,) δ: 7.53-7.56 (m, 6H, Ar-H), 7.49-7.51 (m, 3H, Ar-H), 7.45-7.48 (m, 
6H, Ar-H), 3.82 (q. J = 7.16 Hz, 2H, CH2), 0.88 (t, J = 7.16 Hz, 3H, CH3) ppm. 
13C-NMR (100 MHz, CDCl3) δ: 165.9 (s, CO), 165.8 (s, CO), [132.6, 132.5, 129.1, 128.9] 
(Cph), [124.8, 123.8] (d, PCCOCF3), [119.6, 119.5, 116.8, 116.6] (q, CF3), 60.0 (t, CH2), 
13.73 (q, CH3) ppm. 
ESI: calcd for C24H21O3F3P [M+Na]+: 445.1180; found: 445.1185. 
Melting point: 129-130 °C. 
Trifluoro-butynoic acid ethyl ester (16) 
 
Phosphorane 47 (20.6 g, 46.36 mmol) was heated to 180-230 °C at 14 mbar for 40 min. The 
desired product 16 was collected at -78°C as a yellow oil (6.39 g, 38.48 mmol, 83%). 
1H-NMR (400 Hz, CDCl3) δ: 4.32 (q. J = 7.16 Hz, 2H, CH2), 1.35 (t, J = 7.16 Hz, 3H, 
CH3) ppm. 
13C-NMR (100 MHz, CDCl3) δ: 150.9 (s, COCH2CH3), [117.3, 114.7, 112.1, 109.5] (q, CF3), 
[75.6, 75.5] (d, CCCF3), [70.2-69.6] (q, CCCF3), 63.5 (t, CH2), 13.97 (q, CH3) ppm. 
Oxanorbornadienyl ethyl ester 17 
 
A mixture of trifluoro-butynoic acid ethyl ester 16 (2 g, 12 mmol) and furan (1.8 mL, 
24 mmol) was heated under microwave irradiation conditions at 60 °C for 30 min. The result-
ing mixture was concentrated under reduced pressure. The crude mixture was purified by col-
umn chromatography (CH2Cl2) resulting in the desired product 17 as a slightly reddish oil 
(2.20 g, 9.36 mmol, 78%).  
1H-NMR (400 MHz, CDCl3) δ: 7.30 (dd, J = 5.3, 1.9 Hz, 1H, 6-H), 7.19 (dd, J = 5.3, 1.9 Hz, 
1H, 5-H), 5.69 (m, 1H, 4-H), 5.65 (m, 1H, 1-H), 4.27 (m2H, CH2), 1.32 (t, J = 7.16 Hz, 3H, 
CH3) ppm. 
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13C-NMR (100 MHz, CDCl3) δ: 161.9 (s, CO), [151.8-151.2] (q, C-3), 151.16 (d, C-2), 144.0 
(d, C-6), 142.8 (d, C-5), [125.7, 123.1, 120.5, 117.8] (q, CF3), 85.3 (d, C-1), 84.1 (d, C-4), 
61.9 (t, CH2), 14.0 (q, CH3) ppm. 
Rf = 0.63 (CH2Cl2). 
ESI: calcd for C10H10O3F3 [M+H]+: 234.0506; found: 234.0510. 
Oxanorbornadienyl carboxylic acid 18 
 
Oxanorbornadienyl ethyl ester 17 (2 g, 8.55 mmol) was dissolved in a mixture solvent of THF 
(15 mL) and water (100 mL). The reaction mixture was cooled to 0 °C. To the mixture was 
added NaOH (30 mL, 1 M) and stirred at 0 °C for 30 min, and stirring was continued at room 
temperature for 2 h. The reaction was tested by thin-layer chromatography. After complete 
conversion, EtOAc (20 mL) was added. The layers were separated and the aqueous layer was 
acidified to pH = 3 with HCl (1 M). The aqueous layers were extracted with MTB ether 
(3x30 mL). The organic layers were dried over MgSO4 and evaporated to dryness. The de-
sired oxanorbornadienyl carboxylic acid 18 was obtained as a colorless solid (1.6 g, 
7.7 mmol, 90%).  
1H-NMR (400 MHz, CDCl3) δ: 7.31 (dd, J = 5.1, 1.9 Hz, 1H, 6-H), 7.22 (dd, J = 5.1, 1.9 Hz, 
1H, 5-H), 5.66 (s, 1H, 4-H), 5.55 (s, 1H, 1-H) ppm. 
13C-NMR (100 MHz, CDCl3) δ: 175.2 (s, COOH), 165.3 (s, NHCO), 156. (s, C-2), 143.7 (s, 
C-3), 143.1 (d, C-6), 142.1 (d, C-5), [128.0, 125.5, 122.7, 119.4] (q, CF3), 87.3 (d, C-1), 84.6 
(d, C-4) ppm.  
ESI: calcd for C8H4O3F3 [M-H]-: 205.0113; Found 205.0110. 
Melting point: 107.5-109.5 °C. 
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Oxanorbornadienyl propanoic acid 52a   
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Oxanorbornadienyl carboxylic acid 18 (618 mg, 3 mmol), ß-alanine methyl ester 
hydrochloride (460.61 mg, 3.3 mmol) and DMAP (733.02 mg, 6 mmol) were dissolved in 
anhydrous CH2Cl2 (6 mL) and cooled to 0 °C. Subsequently, EDC·HCl (573.45 mg, 
3.3 mmol) was added. After 30 min the reaction mixture was warmed up to room temperature 
and stirred for 16 h. The reaction was hydrolyzed with HCl (6 mL, 1 M) and the layers were 
separated. The organic layer was washed with saturated NH4Cl solution as well as saturated 
NaOH solution. The aqueous layers were extracted with EtOAc (3x10 mL). The organic layer 
was dried over MgSO4 and concentrated under reduced pressure. The crude mixture was puri-
fied by column chromatography (CH2Cl2/MeOH = 9:1) as a colorless solid. The saponifica-
tion process was performed as described for the acid 18. After work up the desired product 
52a was obtained as a colorless solid (432.4 mg, 1.56 mmol, 52% over 2 steps) 
1H-NMR (400 MHz, CDCl3) δ: 7.31 (dd, J = 5.1, 1.7 Hz, 1H, 6-H), 7.22 (dd, J = 5.1, 1.7 Hz, 
1H, 5-H), 5.66 (s, 1H, 4-H), 5.55 (s, 1H, 1-H), 3.53 (m, 2H, 7-H), 2.55 (t, J = 6.8 Hz, 2H, 
8-H) ppm. 
13C-NMR (100 MHz, CDCl3) δ: 175.2 (s, COOH), 165.3 (s, NHCO), 156. (s, C-2), 143.7 (s, 
C-3), 143.1 (d, C-6), 142.1 (d, C-5), [128.0, 125.5, 122.7, 119.4] (q, CF3), 87.3 (d, C-1), 84.6 
(d, C-4), 36.7 (t, C-7), 34.5 (t, C-8) ppm.  
ESI: calcd for C11H10O4NF3 [M-H]-: 276.0484; found 276.0490. 
Rf = 0.48 (CH2Cl2/MeOH = 9:1). 
Melting point: 145.5-149.0 °C. 
Oxanorbornadienyl butanoic acid 52b 
 
Preparation of methyl 4-aminobutanoate: 4-aminobutanoic acid (10.3 g, 0.1 mmol) was 
dissolved in anhydrous methanol (40 mL) and cooled to 0 °C. To the solution was added 
dropwise thionyl chloride (22 ml, 0.3 mol) over 15 min. The resulting solution was then 
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heated to reflux over night. The solvent and excess of thionyl chloride were then removed 
under reduce pressure. The solid product was used for the next step without further purifica-
tion.  
Oxanorbornadienyl butanoic acid 52b was obtained from oxanorbornadienyl carboxylic acid 
18 and methyl 4-aminobutanoate in 60% yield according to the procedure as described for 
52a. 
1H-NMR (400 MHz, CDCl3) δ: 7.31 (dd, J = 5.1, 1.7 Hz, 1H, 6-H), 7.22 (dd, J = 5.1, 1.7 Hz, 
1H, 5-H), 5.66 (s, 1H, 4-H), 5.55 (s, 1H, 1-H), 3.58 (m, 2H, 7-H), 2.55 (t, J = 6.8 Hz, 2H, 
9-H), 2.04 (m, 2H, 8-H) ppm. 
13C-NMR (100 MHz, CDCl3) δ: 173.6 (s, COOH), 163.7 (s, NHCO), 154.1 (s, C-2), 143.7 (s, 
C-3), 143.1 (d, C-6), 142.1 (d, C-5), [126.4, 123.7, 121.1, 118.4] (q, CF3), 86.0 (d, C-1), 83.6 
(d, C-4), 35.1 (t, C-7), 32.9 (t, C-9), 25.5 (t, C-8) ppm. 
ESI: calcd for C12H11O4NF3 [M-H]-: 290.0640; found: 290.0641. 
Melting point: 145.0-148.0 °C. 
Oxanorbornadienyl hexanoic acid 52c 
 
Oxanorbornadienyl hexanoic acid 52c was obtained from oxanorbornadienyl carboxylic acid 
18 and methyl 6-aminonate hydrochloride in 70% yield according to the procedure as is de-
scribed for 52a. 
1H-NMR (400 MHz, CDCl3) δ: 7.30 (dd, J = 5.3, 1.9 Hz, 1H, 6-H), 7.19 (dd, J = 5.3, 1.9 Hz, 
1H, 5-H), 5.66 (m, 1H, 4-H), 5.55 (m, 1H, 1-H), 3.57 (m, 1H, 7-H), 2.61 (t, J = 7.2 Hz, 2H, 
11-H), 1.77 (m, 2H, 10-H ), 1.58 (m, 2H, 8-H), 1.47 (m, 2H, 9-H) ppm.  
13C-NMR (100 MHz, CDCl3) δ: 173.6 (s, COOH), 163.7 (s, CONH), [154.8-154.1] (d, C-2), 
143.7 (d, C-6), 143.1 (q, C-3), 142.1 (d, C-5), [126.4, 123.7, 121.1, 118.4] (q, CF3), 86.0 (d, 
C-1), 83.6 (d, C-4), 38.7 (t, C-7), 31.0 (t, C-11), 28.6 (t, C-8), 25.6 (t, C-9), 24.2 (t, 
C-10) ppm.  
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Oxanorbornadienyl NHS-ester 108e 
 
Oxanorbornadienyl propanoic acid 52a (1.28 g, 4 mmol) was dissolved in CH2Cl2, and cooled 
to 0 °C. DCC (0.92 g, 4.8 mmol), N-hydroxysuccinimide (0.55 g, 4.8 mmol) were added to 
the solution, respectively. The reaction mixture was stirred at 0 °C for 1 h and continued at 
room temperature for 24 h. After filtering of the precipitate, the solvent of the filtrate was 
removed under reduced pressure. The crude product was purified by column chromatography 
(CH2Cl2/MeOH = 9:1) to give desired active oxanorbornadienyl NHS-ester 108e (0.99 g, 
2.4 mmol, 60%). 
1H-NMR (400 MHz, CDCl3) δ: 7.31 (dd, J = 5.3, 1.9 Hz, 1H, 6-H), 7.13 (dd, J = 5.3, 1.9 Hz, 
1H, 5-H), 6.64 (b, NHCO), 5.63 (m, 2H, 4-H, 1-H), 3.75 (q, 2H, J = 6.2 Hz, 7-H), 2.91 (t, 2H, 
J = 6.2 Hz, 8-H), 2.85 (s, 4H, 2xCH2NHS) ppm. 
13C-NMR (100 MHz, CDCl3) δ: 169.1 (s, CONHS), 167.4 (s, COON), 162.7 (s, NHCO), 
[153.7-153.8] (d, C-2), [144.1-143.8] (q, C-3), 143.7 (d, C-6), 142.1 (d, C-5), [126.4, 123.7, 
121.1, 118.4] (q, CF3), 86.0 (d, C-1), 83.6 (d, C-4), 35.1 (t, C-7), 32.9 (t, C-8), 25.7 (t, 
CH2NHS) ppm.  
Rf = 0.5 (CH2Cl2/MeOH = 9:1). 
ESI: calcd for C16H16N2O6F3 [M+H]+: 375.0804; found: 375.0816. 
Melting point: 131.5-134.0 °C. 
Oxanorbornadienyl NHS-ester 108f 
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Oxanorbornadienyl NHS-ester 108f was obtained from oxanorbornadienyl butanoic acid 52b 
and N-hydroxyl succinimide in 65% yield according to the procedure as described for 108e. 
1H-NMR (400 MHz, CDCl3) δ: 7.32 (dd, J = 5.1, 1.7 Hz, 1H, 6-H), 7.14 (dd, J = 5.1, 1.7 Hz, 
1H, 5-H), 6.26 (b, NHCO), 5.63 (s, 1H, 4-H), 5.63 (s, 1H, 1-H), 3.49 (m, 2H, 7-H), 2.84 (s, 
4H2xCH2NHS), 2.62 (t, J = 7.2 Hz, 2H, 9-H), 2.04 (m, 2H, 8-H) ppm.  
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13C-NMR (100 MHz, CDCl3) δ: 169.1 (s, CONHS), 168.4 (s, COONH), 162.9 (s, NHCO), 
154.4 (s, C-2), 143.7 (d, C-6) 143.1 (s, C-3), 142.1 (d, C-5), [126.4, 123.7, 121.1, 118.4] (q, 
CF3), 86.0 (d, C-1), 83.6 (d, C-4), 38.7 (t, C-7), 28.7 (t, C-9), 25.7 (t, CH2NHS ), 24.5 (t, 
C-8) ppm.  
ESI: calcd for C16H16N2O6F3 [M+H]+: 389.0960; found: 389.0951. 
Melting point: 133.5-137.0 °C. 
Oxanorbornadienyl NHS-ester 108g 
 
Oxanorbornadienyl NHS-ester 108g was obtained from oxanorbornadienyl hexanoic acid 52c 
and N-hydroxyl succinimide in 56% yield according to the procedure as described for 108e. 
1H-NMR (400 MHz, CDCl3) δ: 7.32 (dd, J = 5.5, 2.1 Hz, 1H, 6-H), 7.12 (dd, J = 5.5, 2.1 Hz, 
1H, 5-H), 6.13 (b, NHCO), 5.62 (s, 1H, 4-H), 5.59 (s, 1H, 1-H), 3.36 (m, 2H, 7-H), 2.82 (s, 
4H, 2xCH2NHS), 2.61 (t, J = 7.2 Hz, 2H, 11-H), 1.77 (m, 2H, 10-H ), 1.58 (m, 2H, 8-H), 1.47 
(m, 2H, 9-H) ppm.  
13C-NMR (100 MHz, CDCl3) δ: 169.4 (s, CONHS), 168.5 (s, COON), 162.4 (s, NHCO), 154.4 
(s, C-2), 143.8 (d, C-6), 143.1 (q, C-3), 141.9 (d, C-5), [126.4, 123.8, 121.1, 118.4] (q, CF3), 
86.0 (d, C-1), 83.6 (d, C-4), 39.4 (t, C-7), 31.0 (t, C-11), 28.6 (t, C-8), 25.7 (t, CH2NHS ), 25.6 
(t, C-9), 24.2 (t, C-10) ppm.  
ESI: calcd for C18H19N2O6F3Na [M+Na]+: 439.1093; found 439.1111. 
Melting point: 147.5-149.0 °C. 
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Method A: 
γ-Amino polySia (sodium salt) 36 (500 mg, 1.84 mmol) was dissolved in demineralized H2O 
(40 mL) and stirred at 5 °C. Subsequently, oxanorbornadienyl propanoic acid 52a (2.6 g, 
9.2 mmol), HOBt (1.24 g, 9.2 mmol), DIPEA (1.9 mL, 11.04 mmol) and EDC·HCl (1.76 g, 
9.2 mmol) were added. Thereafter, the reaction mixture was stirred at room temperature for 
24 h. To reacetylate the remaining free amino groups the reaction mixture was cooled to 0 °C 
and acetic anhydride (1 mL) was added. After stirring at room temperature for 8 h, the mix-
ture was dried under reduced pressure and treated with NaOH solution (3 mL, 1 M). After 
stirring for 8 h, the mixture was neutralized with HCl (1 M) and dialyzed against aqueous 
NaCl solution (0.5 M) for 2 days (pH = 9) and against distilled H2O for 2 days. The aqueous 
layers were concentrated and lyophilized to give the desired product 53a as a colorless amor-
phous solid (470 mg, 1.29 mmol, 70%).  
Methode B: 
γ-Amino polySia (TBA salt) 37 (460 mg, 0.94 mmol) was dissolved in anhydrous DMF 
(3 mL) and cooled to 0 °C. Subsequently, NHS-ester 108e (449.2 mg, 1.2 mmol) and DIPEA 
(261 µL, 1.5 mmol) was added. At first, the reaction mixture was stirred at room temperature 
for 24 h, and then the mixture was slowly warmed up to 40 °C for 8 h. The solvent was re-
moved under reduced pressure. The residue was dissolved in water and dialyzed against 
aqueous NaCl (0.5 M) for 2 days and against distilled H2O for 2 days, the aqueous layers were 
pooled and lyophilized giving a colorless solid.  
To reacetylate the remaining amino groups, the residue was dissolved in Na2CO3 solution 
(40 mL, 5%w/v) and cooled to 0 °C. Subsequently, acetic anhydride (2 mL) was slowly added 
and the reaction mixture was stirred at room temperature for 4 h. Another portion of Na2CO3 
solution (1.0 g) and acetic anhydride (2 mL) were added to the solution. After stirring under 
the same condition for 8 h, NaOH solution (10 mL, 1 M) was added to the mixture and stirred 
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for additional 8 h. The mixture was neutralized with HCl (1 M) and dialyzed against H2O 
(pH = 9) for 2 day at room temperature. The aqueous layers were concentrated and lyophi-
lized giving product 53a as an amorphous solid (218 mg, 0.60 mmol, 65%).  
1H-NMR (400 MHz, D2O) δ: 7.34 (0.25H, H-6´), 7.26 (0.25H, H-5´), 5.84 (0.25H, H-4´), 
5.73 (0.25H, H-1´), 4.35-4.10 (2H, H-4 & H-6), 3.90-3.58 (5.5H, H-5, H-9a, H-8, H-7, H-9b, 
H-7´), 2.75-2.45 (1.5H, H-8´ & H-3eq), 2.07 (1H, NHCOCH3), 1.75 (1H, H-3ax) ppm. 
13C-NMR (100 MHz, D2O) δ: [174.9, 173.8, 173.2] (s, 4xCO), 165.0 (s, C-1), 153.7 (q, C-2´), 
143.7 (d, C-3´), 142.9 (d, C-6´), 142.8 (d, C-5´) [120.5–123.2] (q, CF3), 101.0 (s, C-2), 85.6 (d, 
C-1´), 83.0 (d, C-4´), 77.3 (d, C-8), 73.5 (d, C-6), 70.1 (d, C-7), 69.2 (d, C-4), 61.3 (t, C-9), 
52.4 (d, C-5), 39.9 (t, C-3), 35.4 (t, C-7´), 34.7 (t, C-8´), 22.4 (d, NCOCH3) ppm. 
Combustion analysis: C/N = 7.16 (theoretical: C/N = 8.40).  
Degree of derivatization: 25% (According to integrations of CH at 7.34 ppm). 
19F-NMR δ: -63.37 ppm. 
N-Oxanorbornadienyl-polySia 53b 
 
N-Oxanorbornadienyl-polySia 53b was obtained from γ-amino polySia (TBA salt) 37 and 
oxanorbornadienyl NHS-ester 108f according to the synthesis of N-oxanorbornadienyl-
polySia 53a using method B in 60 % yield. 
1H-NMR (400 MHz, D2O) δ: 7.31 (0.25H, H-6´), 7.25 (0.25H, H-5´), 5.84 (0.25H, H-4´), 
5.73 (0.25H, H-1´), 4.25-4.02 (2H, H-4 & H-6), 3.90-3.75 (4H, H-5, H-9a),* 3.70-3.60 (4H, 
H-8, H-9b, H-7, H-7´),* 2.75-2.45 (1.5H, H-8´ & H-3eq), 2.07 (2H, NHCOCH3), 1.75 (1H, 
H-3ax) ppm. 
13C-NMR (100 MHz, D2O) δ: 176.8 (s, PSA-NHCOR), 173.2 (s, NHCO-R), 169.5 (s, 
NCOCH3), 164.9 (s, C-1), 153.8 (s, C-2´), 142.9 (q, C-6´), 140.6 (s, C-3´), 139.9 (d, C-5´), 
[120.5–123.2] (q, CF3), 101.1 (s, C-2), 85.6 (d, C-1´), 83.0 (d, C-4´), 77.6 (d, C-8), 73.1 (d, 
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C-6), 69.3 (d, C-7), 69.5 (d, C-4), 62.4 (t, C-9), 52.4 (d, C-5), 40.0 (t, C-3), 38.9 (t, C-7´), 28.7 
(t, C-9´), 24.5 (t, C-8´), 22.4 (q, NHCOCH3) ppm.  
*EDC could not be completely removed. 
Degree of derivatization: 25% (According to integrations of CH at 7.31 ppm). 
N-Oxanorbornadienyl-polySia 53c 
 
Synthesis of N-oxanorbornadienyl-polySia 53c was performed according to the synthesis of 
52a using method B. However, after the reacetylation, it was found that the integrations of the 
special proton signals of the oxanorbornadienyl-system were reduced by NMR-measurement.  
1H-NMR (400 MHz, D2O) δ: 7.35 (0.27H, H-6´), 7.34 (0.27H, H-5´), 5.84 (0.27H, H-4´), 
5.71 (0.27H, H-1´), 4.20-4.05 (2H, H-4 & H-6), 3.90-3.78 (2H, H-5 & H-9a), 3.70-3.51 (3H, 
H-8, H-7 & H-9b), 3.33 (0.54H, H-7´), 2.68 (0.54H, H-11´), 2.34 (1H, H-3eq), 2.07 (0.1H, 
NHCOCH3), 1.73 (0.54H, H-10´), 1.62-1.55 (1.54H, H-3ax, H-8´)*, 1.32 (0.27H, H-9´) ppm. 
[Before reacetylation] 
13C-NMR (100 MHz, D2O) δ: [177.8, 175.0, 173.2] (s, 3CO), 173.2 (s, NCOCH3), 169.5 (s, 
C-1), 153.8 (s, C-2´), 145.8 (s, C-3´), 143.8 (d, C-6´), 142.0 (d, C-5´), [120.5–123.2] (q, CF3), 
101.1 (s, C-2), 85.6 (d, C-1´), 83.0 (d, C-4´), 77.3 (d, C-8), 73.5 (d, C-6), 70.1 (d, C-7), 69.2 
(d, C-4), 61.3 (t, C-9), 52.4 (d, C-5), 39.6 (t, C-3), 39.4 (t, C-7´) , 35.8 (t, C-11´), 27.8 (t, 
C-8´), 25.5 (t, C-9´), 24.8 (t, C-11´) ppm. [Before reacetylation]  
*Overlapped by polySia backbone. 
Degree of derivatization: = 27% (According to integrations of CH at 7.35 ppm). 
Experimental Parts                                                                                                                  101 
5.2.3 Experiments towards the synthesis of polySia hydrogels using “click” reaction 
Model reaction of the Cu-catalyzed “click” chemistry  
4-Azidobutanamide (54) 
 
4-Azidobutyric chloride 40 (280 mg, 1.9 mmol) was dissolved in THF (1 mL) and cooled 
to -78 °C. Ammonia (0.8 mL, 25% in methanol) was added, and the reaction mixture was 
slowly warmed up to room temperature and stirred over night. After removing of the solvent 
the reaction mixture was dissolved in H2O and extracted with EtOAc (3x10 mL). The organic 
layer was separated, dried over MgSO4, filtered, and concentrated under reduced pressure. 
Recrystallization in CH2Cl2/hexane gave the desired product 54 as a colorless solid (205 mg, 
1.60 mmol, 84%).   
1H-NMR (400 Hz, D2O) δ: 3.36 (t, J = 6.8 Hz, 2H, CH2N3), 2.37 (t, J = 7.5 Hz, 2H, CH2CO), 
1.92 (m, 2H, CH2CH2CO) ppm. 
13C-NMR (100 MHz, D2O) δ: 178.9 (s, CO), 50.4 (t, CH2N3), 32.2 (t, CH2CH2CO), 24.4 (t, 
CH2CH2CO) ppm.  
Melting point: 71.3-72.5°C. 
Pent-4-ynamide (55) 
 
A solution of pentynoic acid (42) (2 g, 20 mmol) in anhydrous THF (50 mmL) was cooled to 
0 °C. Et3N (2.1 mL, 20 mmol) and isobutyl chloroformate (IBCF) (2.58 mL 20 mmol) were 
added subsequently. After the addition was completed, the resulting suspension was stirred at 
0°C for 30 min. Afterwards, the reaction was treated with condensed ammonia (2.1 mL, 
26% in water) and stirred at -78 °C for 1 h. The reaction mixture was warmed up to room 
temperature and stirred for additional 11 h (ammonia was evaporated). At the end of this pe-
riod the resulting mixture was diluted with saturated NaCl solution (20 mL) and extracted 
with EtOAc (3x10 mL). The organic layers were dried over MgSO4, filtered, and concentrated 
under reduced pressure. Then, the crude product was purified by column chromatography 
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(EE/PE = 1:1) to afford 55 as a colorless solid (0.42 g, 4.4 mmol, 22%).1H-NMR data were 
identical with those given in literature.112 
1H-NMR (200 Hz, CDCl3) δ: 5.74 (b, NH2, 2H),) 2,51 (m, 4H, 2xCH2), 2.01 (t, J = 2.4 Hz, 
1H, CCH) ppm. 
Melting point: 112.5-113.0 °C. 
4-(4-(3-Amino-3-oxopropyl)-1H-1,2,3-triazol-1-yl)butanamide (56) 
 
As a model reaction for the copper-catalyzed “click” reaction, 4-azidobutanamide (54) 
(128.12 mg, 1.0 mmol) and Pent-4-ynamide (55) (97 mg, 1.0 mmol) were dissolved in demin-
eralized H2O (1 mL). An aqueous CuSO4 solution (100 µL, 0.1 mM) as well as aqueous Na-
ascorbate solution (150 µL, 0.1 mM) were added and the reaction mixture was stirred at room 
temperature for 2 days. Then, the solvent was removed under reduced pressure and the crude 
product was purified by column chromatography (CH2Cl2 = 5:1) resulting in the desired 
product 56 as a colorless solid (180 mg, 0.8 mmol, 80%).  
1H-NMR (400 Hz, D2O) δ: 7.79 (s, 1H, CHtriazole), 4.42 (t, J = 6.5 Hz, 2H, 3-H), 2.99 (t, J = 
6.5 Hz, 2H, 2´-H), 2.62 (t, J = 7.5 Hz, 2H, 1´H), 2.22 (q, J = 7.5 Hz, 2H, 1-H), 2.17 (m, 2H, 
2-H) ppm. 
13C-NMR (100 MHz, D2O) δ: [178.0, 177.9] (s, 2xCO), 146.5 (s, Ctriazole), 123.3 (d, Ctriazole), 
49.4 (t, C-3), 34.4 (t, C-1´), 31.5 (t, C-1), 25.4 (t, C-2´), 20.8 (t, C-2) ppm. 
ESI: calcd for C9H15O2N5Na [M+Na]+: 248.1123; found: 248.1123. 
Rf = 0.57 (CH2Cl2 = 5:1). 
Melting point: decomposition > 130 °C. 
                                                 
112
 P. A. Jacobi, H. L. Brielmann, S. I. Hauck, J. Org. Chem. 1996, 61, 5013-5023. 
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Model reaction of the metal-free “click” chemistry  
Alkyno-analogue 57 
 
NHS-ester 108e (37.4 mg, 0.1 mmol) was dissolved in a mixture of dioxane/H2O = 1:1 
(1 mL) and stirred at room temperature over night. Subsequently, cyclohexylamine (12.57 µL, 
0.11 mmol) and Et3N (13.9 µL, 1.2 mmol) were added and stirring was continued at room 
temperature for 24 h. The aqueous layers were extracted with EtOAc (3x10 mL). The organic 
layer was dried over MgSO4, filtered and the filtrate was concentrated under reduced pressure. 
Recrystallization from EE/PE (2:1) gave the desired product 57 as a colorless solid (35.6 mg, 
0.9 mmol, 90%).   
1H-NMR (400 Hz, CDCl3) δ: 7.30 (dd, J = 5.3, 2.1 Hz, 1H, 6-H), 7.19 (dd, J = 5.3, 2.1 Hz, 
1H, 5-H), 6.8 (bs, 1H, NH), 5.63 (m, 1H, 4-H), 5.60 (m, 1H, 1-H), 5.33 (bs, 1H, NH), 3.76 
(m, 1H, NCHCy), 3.6 (m, 2H, H-7), 2.38 (m, 2H, H-8), 1.08-2.40 (m, 10H, CH2cy) ppm. 
13C-NMR (100 MHz, CDCl3) δ: 170.0 (s, CONcy), 163.7 (s, CO), [154.8-154.1] (q, C-2), 
143.7 (d, C-6), 143.1(q, C-3), 142.1 (d, C-5), [126.4, 123.7, 121.1, 118.4] (q, CF3), 86.2 (d, 
C-1), 83.7 (d, C-4), 48.5 (d, C-7), 33.3 (t, C-8), [35.7, 35.3, 25.6, 24.9] (Ccy) ppm.  
ESI: cald for C17H21O3N2F3Na [M+Na]+: 381.1402; found: 381.1397. 
Melting point: 165.0-166.0 °C. 
 “Click” product: CF3-1,2,3-triazole 58 and 59 
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4-Azidobutanamide (54) (6.8 mg, 1 mmol) and alkyno-analogue 57 (36 mg, 1 mmol) were 
dissolved in MeOH/H2O = 1:1 (200 µL). The reaction mixture was stirred at room tempera-
ture for 2 days. Then, the solvent was removed under reduced pressure and the crude product 
was purified by column chromatography (CH2Cl2/MeOH = 5:1). The “click” product was 
obtained as an inseparable mixture of regioisomers (58:59 = 4:1, 23.5 mg, 0.8 mmol, 80%).  
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The reaction mixture was analyzed by 19F-NMR: -58.03 ppm (58), -59.5 ppm 
(59), -61.3 ppm (57).  
Melting point: 70.5-71.5 °C. 
4-Azido-N-benzylbutanamide (60) 
 
Benzylamine (0.5 ml, 5.0 mmol) and 4-azidobutanoic acid (39) (0.65 g, 5.0 mmol) were dis-
solved in anhydrous CH2Cl2 (20 mL) and cooled to 5 °C. Subsequently, DMAP (0.92 g, 
7.5 mmol) and EDC·HCl (1.15 g, 6.0 mmol) were added to the reaction mixture were added. 
The reaction mixture was warmed up to room temperature and stirred for 24 h. The reaction 
mixture was hydrolyzed with HCl (10 mL, 1 M), layers were separated, and the organic layer 
was washed with saturated NH4Cl solution and saturated NaCl solution. The combined aque-
ous layers were extracted with EtOAc (3x20 mL), dried over MgSO4, filtrated, and the filtrate 
was concentrated under reduced pressure. The crude mixture was purified by column chroma-
tography (CH2Cl2/MeOH = 5:1) to give the desired product 60 as a colorless solid (0.98 g, 
4.5 mmol, 90%).  
1H-NMR (400 MHz, MeOD) δ: 7.23-7.28 (m, 5H, Har), 4.36 (s, 2H, H-1), 3.32 (t, J = 6.8 Hz, 
H-4), 2.32 (t, 2H, J = 6.8 Hz, H-4), 1.88 (m, 2H, H-3) ppm. 
13C-NMR (100 MHz, MeOD) δ: 174.8 (s, NHCO), 140.0 (s, Ar-C), 129.5 (d, Ar-C), 128.5 (d, 
Ar-C), 128.2 (d, Ar-C), 51.8 (t, C-4), 44.1 (t, C-1), 33.9 (t, C-2), 26.1 (t, C-3) ppm.   
Rf = 0.3 (CH2Cl2/MeOH = 5:1). 
ESI: calcd for C9H15O2N5Na [M+H]+: 219.1246; found: 219.1254. 
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Benzylbutanamido-polySia 61 
 
N-Oxanorbornadienyl-polySia 53a (40 mg, 0.11 mmol) was dissolved in demineralized H2O 
(5 mL), and cooled to 0 °C. A solution of 4-azido-N-benzylbutanamide (60) (40 mg, excess) 
in MeOH (1 mL) was added and the reaction mixture was stirred at room temperature for 
2 days. Afterwards, the reaction mixture was dialyzed against demineralized H2O for 2 days. 
Product 61 was obtained after lyophilization as a colorless, amorphous solid (32 mg, ca. 
80%).  
1H-NMR (400 MHz, D2O) δ: 7.71 (0.25H, Ar-H), 7.34 (1.0H, Ar-H), 4.43 (0.5H, 1´-H), 
4.20-4.05 (2H, H-4 & H-6), 3.95-3.78 (2H, H-5 & H-9a), 3.75-3.45 (3H, H-7, H-8 & H-9b), 
3.05-2.91 (0.5H, H-3´), 2.71-2.25 (2.5H, H-1´, H-5´, H-2´ & H-3eq), 2.07 (1H, NHCOCH3), 
1.75 (1H, H-3ax) ppm. 
13C-NMR (100 MHz, D2O) δ: 175.4 (s, NHCO-R), 173.2 (s, NHCO-R), 173.2 (s, NHCOCH3), 
168.4 (s, C-1), 153.7 (q, CCF3), 147.0 (s, Ctriazole), 146.7 (s, Ctriazole), [128.7, 127.9, 123.4] (d, 
Ar-C), 123.2 (q, CF3), 101.1 (s, C-2), 77.3 (d, C-8), 73.5 (d, C-6), 70.1 (d, C-7), 69.3 (d, C-4), 
61.3 (C-9), 52.4 (d, C-5), 49.4 (t, C-4´), 43.0 (t, C-1´), 39.9 (t, C-3), 35.1 (t, C-2´), 34.6 (t, 
C-5´), 32.3 (t, C-6´), 25.5 (t, C-3´), 20.5 (d, NHCOCH3) ppm. 
Degree of derivatization: 25% (According to integrations of CH at 7.71 ppm). 
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Hydrogel formation based of modified polySia using “click” chemisty 
A) PolySia hydrogel formation using Cu-catalyzed “click” chemistry 
 
N-(4-Azidobutyryl)-polySia 41 (10 mg, ds = 60% and N-(4-pentynoyl)-polySia 44 (10 mg, 
ds = 60%) were dissolved in demineralized H2O (160 µl). An aqueous CuSO4 solution 
(16 µL, 0.1 M) as well as a Na-ascorbate solution (24 µL, 0.1 M) were added. After vigorous 
shaking, the reaction mixture was kept at room temperature for 2-3 days. A stable hydrogel 
was formed.  
In order to analyse the “click” reaction, the polySia hydrogel (20 mg) was hydrolyzed by im-
merging it in an acidic aqueous solvent (1.0 mL, 0.1 M TFA). The heterogeneous system was 
heated at 80 °C for 1 h and the sample was analyzed directly by QPLC-MS measurement (see 
chapter 3.1.1.4).  
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B) PolySia hydrogels formation using metal-free “click” chemistry 
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N-(4-Azidobutyryl)-polySia 41 (10 mg, ds = 25-60%) and N-oxanorbornadienyl-polySia 53b 
(10 mg, ds = 20-25%) were dissolved in demineralized H2O (200 µl). After short time vigor-
ous shaking the reaction mixture was incubated at room temperature for 2-3 days. A stable 
hydrogel was formed.  
For confirming the outcome of the “click” coupling reaction, the polySia hydrogel (20 mg) 
was immerged in an acidic aqueous solvent (1.0 mL, 0.1 M TFA) and heated at 80 °C for 1 h. 
The sample was analyzed directly by QPLC-MS measurement.  
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5.2.4 Experiments towards N-methacryl-polySia 
N-methacryl-polySia 68 
 
The γ-amino polySia (TBA salt) 37 (53.7 mg, 0.109 mmol) was dissolved in anhydrous pyri-
dine (2 mL) and cooled to 0 °C. After dropwise addition of methacrylic anhydride (75.60 µL, 
0.5 mmol) the mixture was slowly warmed up to room temperature and stirred over night. The 
reacetylation and purification processes were carried out according to the synthesis of N-(4-
azidobutyryl)-polySia 41. Product 68 was afforded as a colorless, amorphous solid (32.39 mg, 
0.092 mmol, 92%). 
1H-NMR (400 MHz, D2O) δ: 5.80 (0.7H, CH3CCH2cis), 5.50 (0.7H, CH3CCH2trans), 4.21-4.05 
(2H, H-4 & H-6), 4.04-3.95 (1H, H-5), 3.94-3.55 (4H, H-9a, H-8, H-7 & H-9b), 2.72 (1H, 
H-3eq), 2.10 (0.9H, NHCOCH3), 1.97 (2.1H, CH3CCH2), 1.81 (1H, H-3ax) ppm. 
13C-NMR (100 MHz, D2O) δ: 175.0 (s, NHCOCH3), 172.9 (s, C-1), 138.9 (s, CH3CCH2), 
121.7 (t, CH3CCH2), 101.0 (s, C-2), 77.1 (d, C-8), 72.5 (d, C-6), 69.9 (d, C-7), 68.7 (d, C-4), 
61.2 (t, C-9), 53.5 (d, C-5), 39.9 (t, C-3), 22.3 (d, NHCOCH3), 17.9 (q, CH3CCH2) ppm. 
Combustion analysis: C/N = 10.50 (theoretical: C/N = 10.74). 
Degree of derivatization: 70% (According to integrations of CH at 5.80 ppm). 
4-Methacrylamidobutanoic acid (72) 
 
To a mixture of ω-amino butanoic acid (71) (4 g, 38.78 mmol) and sodium hydroxide (1.55 g, 
38.78 mmol) in demineralized H2O (2 mL), a small amounts of hydroquinone was added and 
cooled to -10 °C. Under stirring sodium hydroxide (1.55 g, 38.78 mmol) in demineralized 
H2O (2 mL) and methacryloyl chloride (4.36 mL, 38.8 mmol) in dioxane (2 mL) was added 
over a period of 10 min. After stirring for 1 h at the same temperature the reaction mixture 
was acidified to pH = 3 with hydrochloride acid. The crude product was extracted with EtOAc 
and washed with distilled H2O. The organic layer was concentrated under reduced pressure to 
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afford a faint purple oily product 72 (4.6 g, 26.8 mmol, 70%). 1H-NMR data were identical 
with those given in literature.110b 
1H-NMR (200 MHz, CDCl3) δ: 5.69 (m, 1 H, CCH2cis), 5.33 (m, 1H, CCH2trans), 3.38 (q, J = 
6.9 Hz, 2H, NHCH2), 2.43 (t, J = 6.9 Hz, 2H, CH2CO), 1.94 (m, 3H, CH3), 1.89 (t, J = 6.9 Hz, 
2H, NHCH2CH2) ppm. 
2,5-Dioxopyrrolidin-1-yl-4-methacrylamidobutanoate (73) 
 
N-Hydroxysuccinimide (0.51 g, 3.3 mol) and 4-methacrylamidobutanoic acid (72) (0.38 g, 
3 mmol) were dissolved in anhydrous THF (2 mL) at 5 °C. To the reaction mixture a solution 
of DCC (0.68 g, 3.3 mmol) in anhydrous CH2Cl2 (2 mL) was added dropwise. The reaction 
mixture was warmed up to room temperature and stirring continued for 12 h. Precipitated 
DCU was removed by filtration and the filtrate was evaporated to give an oily residue. The 
residue was diluted in acetonitrile (2 mL) and kept over night at 4 °C to remove additional 
DCU. After filtration the filtrate was concentrated to give a colorless oil. Recrystallization in 
CH2Cl2/hexane (1:2) at 4 °C gave the product 73 as a colorless solid (0.44 g, 1.64 mmol, 
50%). 1H-NMR data were identical with those given in literature.110b 
1H-NMR (200 MHz, CDCl3) δ: 5.68 (s, 1H, COCCH3CH2cis), 5.32 (s, 1H, COCCH3CH2trans), 
3.41 (m, 2H, CONHCH2), 2.83 (s, 4H, 2xCH2NHS), 2.63 (t, J = 6.9 Hz, 2H, CH2CONHS), 2.04 
(m, 2H, NHCH2CH2CH2CO), 1.96 (t, 3H, CH3) ppm.  
Melting point: 96-99 °C. 
N-Methacryl-polySia 74 
 
γ-Amino polySia (sodium salt) 36 (330 mg, 0.82 mmol) was dissolved in 8 mL H2O/dioxane 
(1:1) and cooled to 0 °C. To the mixture the NHS-ester 73 (375 mg, 1.4 mmol) was added and 
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the reaction mixture was stirred at room temperature over night. The reacetylation and purifi-
cation processes were carried out according to the synthesis of N-(4-azidobutyryl)-polySia 41. 
Product 74 was collected as a colorless solid (212 mg, 85%). 
1H-NMR (400 MHz, D2O) δ: 5.61 (0.45H, CCH2cis), 5.38 (0.45H, CCH2trans), 4.18-3.95 (2H, 
H-4 & H-6), 3.82-3.71 (2H, H-5 & H-9a), 3.61-3.45 (3H, H-8, H-7 & H-9b), 3.25-3.15 (0.9H, 
H-1´), 2.65-2.55 (0.9H, H-3´), 2.35 (1H, H-3eq), 2.06 (1.0H, NHCOCH3), 1.85 (1.35H, 
CH3CCH2), 1.80-1.71 (0.9H, H-2´), 1.65 (1H, H-3ax) ppm. 
13C-NMR (100 MHz, D2O) δ: [176.9, 175.0, 173.4, 173.1] (s, 4xCO), 171.9 (C-1), 138.9 (s, 
CH3CCH2), 120.9 (t, CH3CCH2), 101.0 (s, C-2), 77.1 (d, C-8), 72.5 (d, C-6), 69.9 (d, C-7), 
68.7 (d, C-4), 61.2 (t, C-9), 52.4 (d, C-5), 39.9 (t, C-3), 38.9 (t, C-1´), 33.2 (t, C-3´), 24.6 (t, 
C-4´), 22.3 (d, NHCOCH3), 17.9 (q, CH3CCH2) ppm. 
Combustion analysis: C/N = 8.22 (theoretical: C/N = 8.55).  
Degree of derivatization: 45% (According to integrations of CH at 5.61 ppm). 
PolySia hydrogels formation using photopolymerization reaction 
Photoinitiator Irgacure 2958 (20 mg) was dissolved in demineralized H2O (1 mL) and warmed 
up to 60 °C for about 10 min. The photoinitiator solution (2%w/v) was freshly prepared to 
avoid inactivation by photo exposure. N-methacryl-polySia 74 (20 mg) was dissolved in 
photoinitiator solution (200 µL), and transferred into culture well silicone gasket. The polym-
erization was completed by UV-light irradiation at 320 nm for about 5 min. The obtained hy-
drogel was equilibrated in phosphate buffer solution (pH = 5.1) and could be stored for some 
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5.2.5 Experiments towards the hydrazido- and aldehydo-modified polySia  
PolySia lactone 75 
 
PolySia (sodium salt) 3 (0.5 g, 1.6 mmol) was dissolved in demineralized H2O (20 mL) con-
taining EDC·HCl (2.5 g, 13 mmol). After adjustment to pH = 4 with aqueous HCl (1 M) the 
solution was stirred at room temperature for 4 h. The yellow precipitate was filtrated and fur-
ther purified by repeated ultrasonic-assisted suspension in a mixture of acetone (10 mL, 
twice) and CH2Cl2 (10 mL, seven cycles) followed by centrifugation and drying under re-
duced pressure to yield a colorless, amorphous solid 75 (401 mg, 1.44 mmol, 92%).   
1H-NMR: according to starting material 3. 
13C-NMR (100 MHz, DMSO-d6) δ: 172.7 (s, NHCOCH3), 165.7 (s, C-1), 96.0 (s, C-2), 72.6 
(d, C-8), 69.8 (d, C-6), 69.3 (d, C-7), 67.9 (d, C-4), 66.2 (t, C-9), 51.7 (d, C-5), 40.7 (t, C-3), 
22.6 (q, NHCOCH3) ppm. 
Degree of derivatization: 100%. 
PolySia hydrazide 76 
 
PolySia lactone 75 (360 mg, 1.30 mmol) was suspended in demineralized H2O (15 mL). After 
dropwise addition of hydrazine monohydrate (96 µL), the reaction mixture was stirred for 2 h 
at room temperature. The crude product was dialyzed against distilled H2O for 2 d and lyophi-
lized to yield a colorless, amorphous solid 76 (330 mg, 1.02 mmol, 78%). 
1H-NMR: according to starting material 3. 
13C NMR (100 MHz; D2O) δ: 170.7(s, NHCOCH3), 166.0 (s, C-1), 101.3 (s, C-2), 74.9 (d, 
C-8), 74.4 (d, C-6), 66.6 (d, C-7), 65.5 (d, C-4), 60.0 (t, C-9), 52.5 (d, C-5), 40.1 (t, C-3), 23.0 
(q, NHCOCH3). 
Combustion analysis: C/N = 3.37 (theoretical: C/N = 3.14). 
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Preparation of 5-(2,3-dihydroxypropylamino)-5-oxopentanoic acid (80) 
 
A solution of glutaric anhydride (1.60 g, 14 mmol) and 3-amino-1,2-propandiol (77) (1.41 g, 
15 mmol) in anhydrous pyridine (10 mL) was stirred at room temperature for 12 h. The pyri-
dine was removed under reduced pressure to give a colorless solution. The solution was di-
luted in H2O (10 mL) and extracted with CH2Cl2 (5x10 mL) in order to eliminate the water 
insoluble compound. The aqueous layer was finally concentrated to yield product 80 as a col-
orless oil (2.34 g, 11.4 mmol, 82%).  
1H-NMR (400 MHz, D2O) δ: 3.75-3.70 (m, 1H, H-2), 3.52 (dd, J = 12.0, 4.1 Hz, 1H, H-1a), 
3.43 (dd, J = 11.2, 6.5 Hz, 1H, H-3a), 3.26 (dd, J = 14.0, 4.8 Hz, 1H, H-1b), 3.43 (dd, J = 11.2, 
7.2 Hz, 1H, H-3b), 2.32 (t, J = 3.4 Hz, 2H, H-4), 2.24 (t, J = 7,5 Hz, 2H, H-5), 1.80 (tt, J = 
7.5 Hz, 3.4 Hz, 2H, H-6) ppm 
13C-NMR (100 MHz, D2O) δ: 178.5 (s, COOH), 176.1 (s, NHCO), 70.1 (t, C-2), 63.2 (t, C-1), 
41.6 (t, C-3), 34.7 (t, C-4), 33.1 (t, C-6), 20.1 (t, C-5) ppm.  
ESI: calcd for C8H14O5 [M-H]-: 204.0872; found: 204.0865. 
N-(1,2-diol) polySia 81 
 
γ-Amino polySia (TBA salt) 37 (1.10 g, 2.2 mmol) was dissolved in anhydrous pyridine 
(20 mL) and cooled to 0 °C. Carboxylic acid 80 (861 mg, 4.2 mmol) and DIPEA (980 µL, 
6.3 mmol) were added to the reaction mixture and stirred at room temperature over night. The 
solvent was removed under reduced pressure and the obtained residue was resolved in dis-
tilled H2O and dialyzed against NaCl solution (0.5 M) (pH = 9) for 2 days and against distilled 
H2O for 2 days at room temperature. The layers were concentrated and lyophilized to result a 
colorless amorphous solid. 
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The reacetylation was done according to 53b. Product 81 was collected as a colorless amor-
phous solid (714.0 mg, 1.9 mmol, 87%).  
1H-NMR (400 MHz, D2O) δ: 4.21-4.05 (2H, H-4 & H-6), 3.90-3.71 (2H, H-5 & H-9a), 
3.70-3.42 (3H, H-8, H-7 & H-9b) 3.48-3.58 (0.8H, H-1´a & H-3´a)*, 3.34 (0.4H, H-1´b), 3.22 
(0.4H, H-3´b), 2.66 (1H, H-3eq), 2.33 (1.6H, H-4´ & H-6´), 2.07 (1.8H, NHCOCH3), 1.90 
(0.8H, H-5´), 1.72 (1H, H-3ax) ppm. 
13C-NMR (100 MHz, D2O) δ: [176.6, 176.4, 174.9, 173.2] (s, 4xCO), 100.9 (C-2), 77.8 (d, 
C-8), 73.1 (d, C-6), 70.2 (d, C-2´), 69.0 (d, C-7), 68.3 (d, C-4), 63.3 (t, C-1´), 61.2 (t, C-9), 
52.4 (d, C-5), 41.7 (t, C-3´), 39.8 (t, C-3), 35.1 (t, C-4´), 34.9 (t, C-6´), 22.5 (q, NHCOCH3), 
21.5 (t, C-5´) ppm.  
*Overlapped by polySia backbone and H-2´ (3.75 ppm) was also overlapped by polySia 
backbone. 
Degree of derivatization: 40% (According to integrations of CH at 3.34 ppm and NHCOCH3). 
N-Aldehydo-polySia 82 
 
PolySia 81 (713 mg, 1.9 mmol) was dissolved in demineralized H2O (10 mL) and cooled to 
0 °C. An aqueous solution of NaIO4 (5 g in 70 mL water) was added to the reaction mixture in 
the dark ([NaIO4]: 0.3 M) and the reaction mixture was stirred at 5 °C for 15 min. To stop the 
reaction, ethylene glycol (25 mL) was added to the solution. The solution was dialyzed 
against distilled H2O at room temperature for 4 days. After lyophilization a colorless, amor-
phous solid 82 was obtained (470 mg, 1.3 mmol, 68%). 
1H-NMR (400 MHz, D2O) δ: 5.10 (0.4H, CH(OH)2)*, 4.25-4.09 (2H, H-4 & H-6), 3.95-3.70 
(2H, H-5 & H-9a), 3.69-3.51 (3H, H-8, H-7, H-9b), 3.29 (0.8H, CH2CHO), 2.66 (1H, H-3eq), 
2.31 (1.6H, H-1´ & H-3´), 2.07 (1.8H, NHCOCH3), 1.90 (0.8H, H-2´), 1.73 (1H, H-3ax) ppm. 
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13C-NMR (100 MHz, D2O) δ: [176.6, 176.4, 174.9, 173.0] (s, 4xCO), 100.9 (C-2), 88.2 (t, 
CH2CHO), 77.7 (d, C-8), 73.1 (d, C-6), 69.0 (d, C-7), 68.2 (d, C-4), 61.2 (t, C-9), 52.4 (d, 
C-5), 39.8 (t, C-3), 35.0 (t, C-1´), 34.8 (t, C-3´), 22.4 (q, NHCOCH3), 21.5 (t, C-2´) ppm.  
*Hydrated aldehyde in D2O. 
Combustion analysis: C/N = 8.91 (theoretical: C/N = 8.43). 
Degree of derivatization: = 40% (According to integrations of CH at 5.10 ppm). 
Model reaction: hydrazone and imine formation of N-aldehydo-polySia 82 
Benzyhrazone-polySia 83  
 
N-Aldehydo-polySia 82 (37 mg, 0.1 mmol) and benzhydrazide (13 mg, 0.1 mmol) were dis-
solved in demineralized H2O (2 mL) and stirred at room temperature for 2 days. Then, the 
solution was dialyzed against distilled H2O (pH = 9) at room temperature for 2 days. The 
aqueous layers were concentrated and lyophilized to yield a colorless, amorphous solid 83 
(26 mg, 0.067 mmol, 67%). 
1H-NMR (400 MHz, D2O) δ: 7.71-7.46 (1H, Ar-H), 4.99 (0.2H, CH(OH)2)*, 4.25-4.09 (2H, 
H-4 & H-6), 3.91-3.70 (2.6H, H-5, H-9a, H-1´ & H-2´), 3.69-3.51 (3H, H-8, H-7, H-9b), 3.29 
(0.4H, CH2CHO)*, 2.57 (1H, H-3eq), 2.24 (1.6H, H-3´ & H-5´), 1.98 (1.8H, NHCOCH3), 
1.82 (0.8H, H-4´), 1.64 (1H, H-3ax) ppm. 
13C-NMR (100 MHz, D2O) δ: [176.6, 176.4, 174.9, 173.0] (s, 4xCO), 150.5 (d, C-1´), [132.8, 
128.9, 128.8, 127.5] (Ar-C), 101.0 (s, C-2), 88.2 (t, CH2CHO)*, 77.7 (d, C-8), 73.1 (d, C-6), 
69.1 (d, C-7), 68.4 (d, C-4), 61.2 (t, C-9), 52.4 (d, C-5), 43.1 (t, C-2´), 39.9 (t, C-3), 35.0 (t, 
C-3´), 34.8 (t, C-5´), 22.4 (q, NHCOCH3), 21.5 (t, C-4´) ppm.  
* Belongs to non-reacted N-aldehydo-polySia 82. 
Combustion analysis: C/N = 7.22 (theoretical: C/N = 8.27). 
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Degree of derivatization: 20% of polySia 83 and 20% of non-reacted N-aldehydo-polySia 82 
(According to integrations of CH at 4.99 and 3.29 ppm). 
Benzylamino-polySia 89 
 
N-Aldehydo-polySia 82 (37 mg, 0.1 mmol) was dissolved in demineralized H2O (2 mL). Ben-
zylamine (17 µL, 0.1 mmol) and a catalytic amount of NaCNBH3 were added to the solution. 
The reaction was stirred at room temperature for 2 days. The mixture was dialyzed against 
distilled H2O (pH = 9) at room temperature for 2 day. The aqueous layer was concentrated 
and lyophilized to yield a colorless, amorphous solid 89 (29 mg, 0.078 mmol, 78%). 
1H-NMR (400 MHz, D2O) δ: 7.46 (2H, Ar-H), 4.15-3.95 (2.8H, H-4, H-6 & CH2Ph), 
3.95-3.70 (2.8H, H-5, H-9a & H-2´), 3.69-3.51 (3.8H, H-8, H-7, H-9b & H-1´), 2.66 (1H, 
H-3eq), 2.31 (1.6H, H-3´ & H-5´), 2.07 (1.8H, NHCOCH3), 1.90 (0.8H, H-4´), 1.72 (1H, 
H-3ax) ppm. 
13C-NMR (100 MHz, D2O) δ: [176.6, 176.4, 174.9, 173.0] (s, 4xCO), [129.8, 129.3, 129.2, 
128.8] (Ar-C), 100.9 (C-2), 77.6 (d, C-8), 73.1 (d, C-6), 69.1 (d, C-7), 68.4 (d, C-4), 68.2 (t, 
CH2Ph), 68.0 (t, C-1´), 61.2 (t, C-9), 52.4 (d, C-5), 43.1 (t, C-2´), 39.8 (t, C-3), 35.0 (t, C-3´), 
34.7 (t, C-5´), 22.4 (q, NHCOCH3), 21.5 (t, C-4´) ppm.  
*Overlapped by polySia backbone. 
Degree of derivatization: 40% (According to integrations of Ar-H at 7.46 ppm). 
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5.2.6 Experiments towards the synthesis of RGD peptide modified polySia 
A) Preparation of RGD-polySia 85 via Cu-catalyzed “click” reaction  
 
N-(4-Pentynoyl)-polySia 44 (5 mg, 0.016 mmol) and azido-RGD (2 mg, 0.003 mmol) were 
dissolved in demineralized H2O (1 mL). Aqueous CuSO4 solution (40 µL, 0.1 M) and 
Na-ascorbate solution (60 µL, 0.1 M) were added to the reaction mixture. The reaction was 
heated under microwave irradiation conditions up to 40 °C for 30 min. Subsequently, TFA 
(9.7 µL, 0.1 mmol) was added and the mixture was heated up to 80 °C for 1 h. The hydro-
lyzed products were directly analyzed by using UPLC-MS and LC-MS/MS. 
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B) Preparation of RGD-polySia (87b) via metal-free “click” reaction  
Metal-free “click” reaction mediate RGD-polySia 87b 
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N-Oxanorbornadienyl-polySia 53b (5 mg, 0.015 mmol) and azido-RGD (2 mg, 0.003 mmol) 
were dissolved in demineralized H2O (1 mL). The reaction was heated under microwave irra-
diation conditions up to 40 °C for 60 min. Subsequently, TFA (9.7 µL, 0.1 mmol) was added 
and the reaction mixture was heated up to 80 °C for 1 h. The hydrolyzed products were di-
rectly analyzed by using UPLC-MS and LC-MS/MS. 
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C) Preparation of RGD-polySia 90 via imine-bond formation 
 
N-aldehydo-polySia 82 (26 mg, 0.07 mmol) was dissolved in demineralized H2O (5 mL) and 
cooled to 0 °C. Amino-RGD peptide (5 mg, 0.008 mmol) and one drop of MeOH was added 
to give of better solubility. The mixture was stirred at room temperature for 24 h. The mixture 
were dialyzed against distilled H2O at room temperature (pH = 9) for 2 days. The aqueous 
lays were concentrated and lyophilized to obtain product 90 as a colorless solid (24 mg).  
Reduction of imine to amine, RGD-polySia 90 (2 mg) was dissolved in demineralized H2O 
(1 mL). A catalytic amount of NaCNBH3 was added to the solution. The reaction was stirred 
at room temperature over night. Subsequently, TFA (9.7 µL, 0.1 mmol) was added. The reac-
tion was heated up to 80 °C for 1 h. The hydrolyzed products were directly analyzed by using 
UPLC-MS and LC-MS/MS. 
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5.3 Biological evaluation of polySia hydrogels 
5.3.1 Experiments on the enzymatic degradation of polySia hydrogels 
Enzyme degradation procedure 
PolySia hydrogels were prepared via copper-catalyzed and metal-free “click” reaction as well 
as photopolymerization. Hydrogels (100 mg, dry material about 10 mg) were equilibrated in 
phosphate buffer (1 mL, pH = 7.2) at 37 °C for 3-4 h. The buffer solution was carefully re-
moved and fresh buffer (400 µL) was added to the gel samples. Subsequently, 10 µL enzyme 
(EndoNF) were added and all samples were incubated at 37 °C in a period of 2-30 days. In 
order to analyse degradation process 20 µL samples were collected regularly. Cold EtOH 
(20 µL) was added to the collected samples to stop the enzyme reaction. Before analysis, the 
analytic samples were cooled down to -18 °C.  
Analysis by electrophoresis 
In order to analyse the enzymatic degradation of the polySia hydrogels, a polyarylamide gel 
electrophoresis (PAGE) method was used.  
Buffers and solutions 
a. 50 % acrylamide stock solution 
        49.6 g acrylamide  
        0.4 g bisacrylamide 
        Filled with water to 100 mL 
 b. 10 fold TBE-buffer 
0.98 M tris base 
0.98 M boric acid  
0.02 M EDTE 
c. Size marker 
        0.05% trypan blue 
0.02% xylenecyanol 
0.02% bromophenol blue 
0.02% phenol red  
0.02% bromocresol purple 
d. Loading buffer 
2 M sucrose  
in 10 fold TBE-buffer 
 
 
 
Preparation of 25% polyacrylamide gel: 50% acylamide stock solution (15 mL), 10-fold TBE-
buffer (3 mL) and water (12 mL) were mixed well. To the mixture 125 µl of 10% ammonium 
persulphate solution and 25 µL of N,N,N´,N´-tetramethylethylenediamine were added. The 
mixture (15 mL) was subjected electrophoresis chamber. After complete polymerization, the 
gel was pre-electrophorized at 10 V/cm for 1 h at 4 °C. The samples were mixed with a solu-
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tion of sucrose (2 M in TBE-buffer) and TBE-buffer (10-fold) in a ratio of 1:1. Electrophore-
sis was performed at 6 V/cm for 12-14 h at 4 °C. Then, the gel was dyed with an alcian blue 
silver staining method. 
Alcian blue silver stain 
Buffers and solutions 
a. Fixing solution 
40% ethanol 
5% acetic acid 
 b. Periodic acid solution 
0.7 g periodic acid 
100 mM fixing solvent (a) 
c. Silver nitrate solution 
1.6 mL ammonia (25%) 
1.0 mL sodium hydroxide (2 M) 
Filled with water to 100 mL 
Addition of silver nitrate (0.6 g)  
d. Formaldehyde developer solution 
 100 mL 240 µM zitronic acid 
135 µL formaldehyde (37%) 
f. Dry solution 
 10% glycerine  
 20% ethanol 
Alcian blue (0.5 g) was dissolved in distilled water (50 mL) under stirring at 40 °C for 
15 min. After filtration, the gel was stained for 30 min and washed with distilled H2O until 
polysaccharides were able to detect. Afterwards, the gel was treated with a fixing solution for 
60 min, periodic acid solution for 5 min, and intense washing with distilled water for 3 times 
(3x15 min). The gel was incubated in silver nitrate solution for 10 min and washed with dis-
tilled waster 3 times (3x10 min). After treatment with formaldehyde developer solution for 1 
to 3 min, the staining process was ended by addition a solution of 5% acetic acid in water. 
The dyed gel was treated with dry solution for 30 to 60 min, covered with cleophane film and 
dried at 45 °C.  
5.3.2 Experiments on the cytotoxic evaluation of polySia hydrogels 
Preparation of cell cultures (HepG2 cell line) 
All cell culture procedures were done in a flow hood. Materials were autoclaved or sterilized 
by using isopropyl alcohol. Solutions and media were autoclaved or sterile filtered. Cells were 
cultured in dulbecco´s modified Eagles medium (DMEM) containing 10% fetal calf serum 
(FCS), Penicillin (100 U/ml) and Streptomyin (100 µg/mL) and were incubated at 37 °C with 
5% CO2 in a humidified atmosphere. First, hydrogels formed in 96 Well plates were sterilized 
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by exposure to UV-light for 1 h. Cells were then seeded on the polySia hydrogels (3000 cells 
/wells) and cultivated for 14 days in culture  medium (200 µL). 
MTT Assay 
Samples were covered in MTT solution (100 µL, 50 mg/ml in distilled water) and incubated 
for 4 h at 37 °C and 5% CO2 before adding SDS solution (90 µL, 5%w/v in 0.01 M HCl). Af-
ter incubation over night at 37 °C and 5% CO2 the samples were homogenized by pipetting. 
The samples (100 µL) were moved to a 96 well plate and absorption (570-630 nm) was meas-
ured on a plate reader.  
DAPI staining 
Cells were fixed with ethanol (95%). Therefore, medium was removed from the samples, cells 
were rinsed twice with PBS-buffer and incubated in ice cold ethanol at 4 °C for 1 h. After-
wards, cells were rinsed twice with PBS-buffer, and the samples were covered in 
4´,6-diamidino-2-phenyindole (DAPI) solution and incubated at 37 °C for 15 min in the dark 
before rinsed twice and covered in PBS-buffer. Cells were visualized under the microscope at 
a wavelength of 460 nm. 
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5.4 Synthesis of neuraminic aicd derivatives  
5.4.1 Experiments towards the synthesis of neuraminic acid C-1 derivatives 
C-1 Azido-neuraminic acid 97 
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N-Acetylneuraminic acid (100 mg, 0.32 mmol) was dissolved in anhydrous DMF (5 mL) and 
cooled to 0 °C. Subsequently, 3-azido-1-aminopropane (95) (50 mg, 0.5 mmol), EDC·HCl 
(96 mg, 0.5 mmol), and DMAP (62 mg 0.5 mmol) were added. The reaction was stirred at 
room temperature for 36 h. The solvent was removed under reduced pressure. The residue 
was dissolved in H2O (5 mL) and the aqueous solution was washed with EtOAc (3x5 mL) to 
remove water insoluble compound. The product was obtained by reversed phase HPLC puri-
fication. (HPLC program: H2O/MeOH (%) 100:0, 10 min, 50:50, 20 min, tR = 9-10 min: α-
anomer, tR = 14-15 min: ß-anomer, flow rate 16 mL min-1) (70 mg, 0.18 mmol, 56%). 
For ß-anomer: 
1H-NMR (400 MHz, D2O) δ: 4.04-4.06 (m, 2H, H-4 & H-6), 3.90-3.93 (appt, J = 10.2 Hz, 
1H, H-5), 3.81-85 (dd, J = 12.0, 2.7 Hz, 1H, H-9a), 3.72-3.76 (dd, J = 12.0, 9.0 Hz, 1H, H-8), 
3.64 (dd, J = 9.0, 2.7 Hz, 1H, H-9b), 3.57 (dd, J = 12.0, 6.5 Hz, 1H, H-7), 3.37 (t, J = 6.8 Hz, 
2H, CH2CH2CH2N3), 3.31 (t, J = 6.8 Hz, 2H, CH2CH2CH2N3), 2.31 (dd, J = 12.8, 4.8 Hz, 1H, 
H-3eq), 2.04 (s, 3H, NHCOCH3), 1.81 (quintet, 2H, CH2CH2CH2N3), 1.68 (dd, J = 12.8, 
11.6 Hz, 1H, H-3ax) ppm.  
13C-NMR (100 MHz, D2O) δ: 174.8 (s, NHCOCH3), 172.6 (s, C-1), 95.5 (s, C-2), 70.4 (d, 
C-6), 70.0 (d, C-8), 68.2 (d, C-7), 66.7 (d, C-4), 63.1 (t, C-9), 52.8 (d, C-5), 48.7 (t, 
CH2CH2CH2N3), 39.5 (t, C-3), 36.7 (t, CH2CH2CH2N3), 27.4 (t, CH2CH2CH2N3), 22.0 (q, 
NHCOCH3) ppm. 
ESI: calcd for C14H26O8N5 [M+H]+: 392.1781; found: 392.1776. 
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C-1 Alkyno-neuraminic acid 98 
 
N-Acetylneuraminic acid (100 mg, 0.32 mmol) was dissolved in anhydrous DMF (5 mL) and 
cooled to 0 °C. Subsequently, propargyl amine (86) (21 mg 0.37 mmol), EDC·HCl (96 mg, 
0.5 mmol), and DIPEA (62 mg 0.5 mmol) were added. The reaction was stirred at room tem-
perature for 36 h. The solvent was removed under reduced pressure and the residue was dis-
solved in H2O (5 mL). The aqueous solution was washed with EtOAc (3x5 mL) to remove 
water insoluble impurities. The product was obtained by reversed phase HPLC purification 
(HPLC program: H2O/MeOH (%) 100:0, 5 min, 50:50, 20 min, tR = 10 min: α-anomer, tR = 
14-17 min: ß-anomer, flow rate 16 mL min-1) (65 mg, 0.19 mmol, 59%).   
1H-NMR (400 MHz, D2O) δ: 4.04-4.07 (m, 2H, H-4 & H-6), 3.99-4.0 (m, 2H, CH2CCH), 
3.90-3.93 (appt, J = 10.2 Hz, 1H, H-5), 3.81-3.85 (dd, J = 12.0, 2.7 Hz, 1H, H-9a), 3.72-3.76 
(m, 1H, H-8), 3.63 (dd, J = 12.0, 1.0 Hz, 1H, H-9b), 3.57 (dd, J = 12.0, 6.5 Hz, 1H, H-7), 2.60 
(s, 1H, CH2CCH), 2.32 (dd, J = 12.8, 4.8 Hz, 1H, H-3eq), 2.04 (s, 3H, NHCOCH3), 1.68 (dd, 
J = 12.8, 11.3 Hz, 1H, H-3ax) ppm.  
13C-NMR (100 MHz, D2O) δ: 174.8 (s, NHCOCH3), 172.5 (s, C-1), 95.4 (s, C-2), 79.1 (s, 
CH2CCH), 71.8 (d, CH2CCH), 70.4 (d, C-6), 70.0 (d, C-8), 68.2 (d, C-7), 66.7 (d, C-4), 63.1 
(t, C-9), 52.0 (d, C-5), 39.5 (t, C-3), 28.7 (t, CH2CCH), 22.0 (q, NHCOCH3) ppm. 
ESI: calcd for C14H23O2N8 [M+H]+: 347.1298; found: 347.1311. 
Neuraminic acid methyl ester 99  
 
N-Acetylneuraminic acid 19 (1.6 g, 5.15 mmol) was dissolved anhydrous MeOH (100 mL) 
and stirred at room temperature. A catalytic amount of TFA (400 µL) was added and the reac-
tion was stirred for 48 h under the same conditions. Following the solvent was removed under 
reduced pressure. After complete drying, product 99 was obtained as a colorles amorphous 
solid (1.48 g, 4.82 mmol, 94%). 
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1H-NMR (400 MHz, CD3OD) δ: 4.06-3.98 (m, 2H, H-4 & H-6), 3.83-3.79 (m, 2H, H-8, 
H-9a), 3.82 (s, 3H, COOCH3), 3.72-3.68 (m, H-8), 3.67 (dd, J = 12.0, 1.0 Hz, 1H, H-9b), 3.52 
(d, J = 12.9 Hz, 1H, H-7), 2.36 (dd, J = 12.8, 4.9 Hz, 1H, H-3eq), 2.03(s, 3H, NHCOCH3), 
1.66 (dd, J = 12.8, 11.3 Hz, 1H, H-3ax) ppm.  
13C-NMR (100 MHz, CD3OD) δ: 175.1 (s, NHCOCH3), 171.8 (s, C-1), 96.7 (s, C-2), 72.1 (d, 
C-6), 71.7 (d, C-8), 70.2 (d, C-7), 67.9 (d, C-4), 64.8 (t, C-9), 54.3 (d, C-5), 53.1 (q, 
COOCH3), 40.7 (t, C-3), 22.6 (q, NHCOCH3) ppm. 
ESI: calcd for C11H22N3O8 [M+Na]+: 324.1294; found: 324.1289. 
C-1 Hydrazido-neuraminic acid 100 
 
Neuraminic acid methyl ester 99 (300 mg, 1.07 mmol) was suspended in distilled H2O 
(10 mL) and stirred at room temperature. Hydrazine monohydrate (88 µL, 65%, 1.18 mmol) 
was added to the suspension. The reaction mixture was stirred at room temperature for 1 h. 
The solvent was removed under reduced pressure. The desired product 100 was obtained as a 
colorless, amorphous solid (290 mg, 0.90 mmol, 84%) 
1H-NMR (400 MHz, D2O) δ: 4.02 (m, 1H, H-4), 3.92-3.78 (m, 4H, H-8, H-5, H-9a, H-6), 
3.67 (dd, J = 12.0, 6.0 Hz, 1H, H-9b), 3.52 (d, J = 12.9 Hz, 1H, H-7), 2.36 (dd, J = 12.8, 
4.9 Hz, 1H, H-3eq), 2.03 (s, 3H, NHCOCH3), 1.66 (dd, J = 12.8 Hz, 11.3 Hz, 1H, H-3ax) ppm.  
13C-NMR (100 MHz, D2O) δ: 173.8 (s, NHCOCH3), 169.9 (s, C-1), 99.4 (s, C-2), 71. 3 (d, 
C-6), 70.4 (d, C-8), 69.2 (d, C-7), 66.7 (d, C-4), 60.3 (t, C-9), 52.8 (d, C-5), 40.6 (t, C-3), 21.8 
(q, NHCOCH3) ppm. 
ESI: cald for C11H22N3O8 [M+H]+: 324.1407; found: 324.1400. 
Experimental Parts                                                                                                                  125 
C-1 Benzylhydrazido-neuraminic acid 101 
 
Hydrazido-neuraminic acid 100 (100 mg, 0.31 mmol) was dissolved in distilled H2O (5 mL) 
and stirred at room temperature. Benzaldehyde (35 µL, 0.34 mmol) was diluted in MeOH 
(1 mL) and slowly added to the reaction mixture. Subsequently, NaCNBH3 (19.5 mg, 
0.31 mmol) was added and the reaction was stirred under the same conditions for 16 h. The 
solvent was removed by evaporation under reduced pressure. The product was obtained by 
reversed phase HPLC purification (HPLC program: H2O/MeOH (%) 100:0, 10 min, 70:30, 20 
min, 50:50, 30 min, tR = 50-55 min, a mixture of α and ß anomers, flow rate 16 mL min-1). 
Two anomeric products were obtained at same time (10 mg, 0.02 mmol, 7 %, α/ß 2:1 from 
1H-NMR). 
For ß anomer 
1H-NMR (400 MHz, D2O) δ: 7.78 (d, J = 6.2 Hz, 2H, Ar-H), 7,51 (3H, m, Ar-H), 4.02 (m, 
1H, H-4), 3.92-3.78 (m, 4H, H-8, H-5, H-9a & H-6), 3.67 (dd, J = 12.0, 6.0 Hz, 1H, H-9b), 
3.60 (m, 2H, CH2Ph) 3.52 (d, J = 12.9 Hz, 1H, H-7), 2.42 (dd, J = 12.8, 4.9 Hz, 1H, H-3eq), 
2.03(s, 3H, NHCOCH3), 1.79 (dd, J = 12.8 Hz, 11.3 Hz, 1H, H-3ax) ppm. 
13C-NMR (100 MHz, D2O) δ: 174.9 (s, NHCOCH3), 169.1 (s, C-1), [132.7, 131.5, 129.0, 
127.8] (Ar-C), 95.5 (s, C-2), 70.6 (d, C-6), 70.3 (d, C-8), 70.1 (d, C-7), 70.0 (t, NHNHCH2Ph 
), 68.1 (d, C-4), 66.6 (t, C-9), 63.2 (CH2Ar), 52.1 (d, C-5), 39.7 (t, C-3), 22.0 (q, 
NHCOCH3) ppm. 
ESI: calcd for C18H27N3O8Na [M+Na]+: 436.1696; found: 436.1685. 
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5.4.2 Experiments towards the synthesis of neuraminic acid N-derivatives 
Methoxyneuraminic acid methyl ester 105 
OH
N
OH
OH
HO
HO
OMe
O OMe
O
 
An ion exchange resin Amberlite IR-120 (H+-form) was applied for preparation of methylgly-
coside. At first, the resin was pre-treated by washing with MeOH and H2O until the filtrate 
became clear. After completely drying the resin could be used for the reaction.  
Dried neuraminic acid 19 (1 g, 3.2 mmol) was dissolved in anhydrous MeOH, which con-
tained fresh pre-treated Amberlite IR-120 (H+-form,1.7 g) and orthoformic acid methyl ester 
(0.71 mL, 6.4 mmol). The reaction was stirred and refluxed for 24 h. After cooling to room 
temperature, the resin was filtrated and washed with MeOH. The solvent was removed under 
reduce pressure. The crude product was purified by column chromatography 
(CH2Cl2/MeOH = 4:1). Both anomers were isolated whereas the major product was obtained 
as was ß-anomer (0.86 g, 2.56 mmol, 80%).   
1H-NMR (400 MHz, CD3OD) δ: 4.03-3.97 (m, 1H, H-4), 3.92-3.78 (m, 4H, H-8, H-5, H-9a & 
H-6), 3.82 (s, 3H, COOCH3), 3.67 (dd, J = 12.0, 6.0 Hz, 1H, H-9b), 3.49 (d, J = 12.9 Hz, 1H, 
H-7), 3.28 (s, 3H, OCH3), 2.36 (dd, J = 12.8, 4.9 Hz, 1H, H-3eq), 2.03(s, 3H, NHCOCH3), 
1.66 (dd, J = 12.8, 11.5 Hz, 1H, H-3ax) ppm.  
13C-NMR (100 MHz, CD3OD) δ: 174.8 (s, NHCOCH3), 170.9 (s, C-1), 100.4 (s, C-2), 72.3 
(d, C-6), 71.4 (d, C-8), 70.1 (d, C-7), 66.7 (d, C-4), 65.3 (t, C-9), 53.8 (d, C-5), 53.1 (q, 
COOCH3), 51.6 (q, OCH3), 41.6 (t, C-3), 22.7 (q, NHCOCH3) ppm. 
Rf = 0.2 for ß-anomer (CH2Cl2/MeOH = 4:1). 
ESI: calcd for C13H24O9N [M+H]+: 338.1451; found: 338.1445. 
N-Amino methoxyneuraminic acid 106  
O
H2N
OH
OH
HO
HO
OMe
O OH
 
Methoxyneuraminic acid methyl ester 105 (1.6 g, 4.7 mmol) was dissolved in a solvent con-
taining NaOH (7.5 g), demineralized H2O (12 mL) and EtOH (188 mL) and heated under re-
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fluxing conditions over 24 h. The reaction was allowed to cool to room temperature. The reac-
tion mixture was acidified (pH = 3) with Amberlyst 15 (H+-form), filtered and the filtrate was 
concentrated and lyophilized. The crude product was recrystallized from MeOH/CH2Cl2 and 
afforded a colorless amorphous solid (0.8 g, 2.8 mmol, 60%) 
1H-NMR (400 MHz, CD3OD) δ: 4.15 (dt, J = 10.5, 5.0 Hz, 1H, H-4), 4.10 (d, J = 10.2 Hz, 
1H, H-6), 3.99-3.95 (m, 1H, H-9a), 3.86 (dt, J = 12.1, 2.6 Hz, 1H, H-8), 3.75(d, J = 5.1 Hz. 
1H, H-9b), 3.68 (d, J = 8.5 Hz, 1H, C-7), 3.29 (t, J = 10.5 Hz, 1H, H-5), 3.18 (s, 3H, OCH3), 
2.38 (dd, J = 13.1, 5.0 Hz, 1H, H-3eq), 1.68 (dd, J = 13.1, 11.5 Hz, 1H, H-3ax) ppm. 
13C-NMR (100 MHz, CD3OD) δ: 174.6 (s, C-1), 100.3 (s, C-2), 69.6 (d, C-6), 68.7 (d, C-8), 
67.9 (d, C-7), 65.12 (d, C-4), 63.1 (t, C-9), 52.5 (d, C-5), 50.7 (q, OCH3), 39.8 (t, C-3) ppm. 
ESI: calcd for C10H18O8N [M-H]-: 280.1032; found: 280.1044. 
N-Amino methoxyneuraminic acid methyl ester 107 
O
H2N
OH
OH
HO
HO
OMe
O OMe
 
N-Acetylneraminic acid 19 (241 mg, 0.75 mmol) was dissolved in a solution of a freshly pre-
pared solution of acetyl chloride (1.2 mL) in anhydrous MeOH (15 mL) at 0 °C and then 
heated in a sealed tube at 100 °C for 3 h. The solution was concentrated and the solvent was 
evaporated to afford the crude product. The crude product was used without further purifica-
tion. For analyzing the sample, the brown crude product was dissolved in distilled H2O and 
added a little active coal to eliminate colored substances. After filtration through CeliteTM, the 
aqueous solution was lyophilized to obtain a colorless solid. The solid was dissolved in a 
small amount of MeOH and then precipitated in Et2O. Product 107 was obtained as a 
colorless solid (150 mg, 0.51 mmol, 68%).  
1H-NMR (400 MHz, D2O) δ: 4.14-4.16 (m, 2H, H-4 & H-6), 3.92-3.95 (appt, J = 10.2 Hz, 
1H, H-9a), 3.83 (s, 3H, CO2CH3), 3.81-3.85 (dd, J = 12.0, 2.7 Hz, 1H, H-8), 3.76 (d, J = 
10.2 Hz, 1H, H-9b), 3.63 (dd, J = 9.0, 1.0 Hz, 1H, H-7), 3.35 (dd, J = 12.0, 6.5 Hz, 1H, H-5), 
3.31 (s, 3H, OCH3), 2.43 (dd, J = 12.8, 4.8 Hz, 1H, H-3eq), 1.82 (dd, J = 12.8, 11.6 Hz, 1H, 
H-3ax) ppm.  
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13C-NMR (100 MHz, D2O) δ: 169.8 (s, C-1), 99.1 (s, C-2), 69.5 (d, C-6), 69.1 (d, C-8), 67.6 
(d, C-7), 64.6 (d, C-4), 62.9 (t, C-9), 53.6 (q, COOCH3) 52.1 (d, C-5), 51.3 (q, OCH3), 39.2 (t, 
C-3) ppm. 
ESI: calcd for C11H22O8N [M+H]+: 296.1345; found: 296.1336.  
Synthesis of NHS-esters 108a-c 
The corresponding carboxylic acid was dissolved in anhydrous THF (or CH2Cl2) and cooled 
to 0 °C. Peptide coupling reagent DCC (1.1 eq.) and N-hydroxysuccinimide (1.1 eq.) were 
added to the resulting solution. The reaction mixture was stirred at room temperature over-
night and was filtered to separate precipitated the DCU. In order to remove additional DCU 
the filtrate was evaporated to give a residue, which was diluted with EtOAc.  
4-Pentynoyl NHS-ester 108a 
 
4-Pentynoyl NHS-ester 108a was obtained from 4-pentynoic acid (42) and 
N-hydroxysuccinimide as a colorless solid in a yield of 80%.  
1H-NMR (400 MHz, CD3Cl) δ: 2.89 (t, 2H, J = 7.0 Hz, CH2CH2CCH), 2.84 (s, 4H, 
COCH2CH2CO), 2.61 (dt, 2H, J = 7.0, 2.7 Hz, CH2CH2CCH), 2.05 (t, J = 2.7 Hz, 
CH2CH2CCH) ppm. 
13C-NMR (100 MHz, CD3Cl) δ: 169.1(s, COCH2CH2CO), 167.2 (s, COCH2CH2CCH), 81.0 
(s, CH2CH2CCH), 70.2 (d, CH2CH2CCH), 30.4 (t, CH2CH2CCH), 25.7 (t, COCH2CH2CO), 
14.2 (t, CH2CH2CCH) ppm. 
ESI: calcd for C9H10O4N [M+H]+:196.0610; found: 196.0621.  
Melting point: 80.3-81.5 °C 
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4-Azidobutanoyl NHS-ester 108b 
 
4-Azidobutanoyl NHS-ester 108b was obtained from 4-azidobutyric acid (39) and 
N-hydroxysuccinimide as a colorless oil in a yield of 60%.  
1H-NMR (400 MHz, CD3Cl) δ: 3.42 (t, J = 6.5 Hz, 2H, CH2CH2CH2N3), 2.48 (s, 4H, 
COCH2CH2CO), 2.70 (t, J = 7.2 Hz, 2H, CH2CH2CH2N3), 1.98 (tt, J = 6.5, 7.2 Hz, 2H, 
CH2CH2CH2N3) ppm. 
13C-NMR (100 MHz, CD3Cl) δ: 169.3 (s, COCH2CH2CO), 168.0 (s, COCH2CH2CH2N3), 
50.0 (t, COCH2CH2CH2N3), 28.3 (t, COCH2CH2CH2N3), 25.6 (t, COCH2CH2CO), 24.1 (t, 
COCH2CH2CH2N3) ppm. 
ESI: calcd for C8H11O4N4 [M+H]+: 227.0780; found: 227.0785. 
4-Pentenoyl NHS-ester 108c 
 
4-Pentenoyl NHS-ester 108c was obtained from 4-pentenoic acid and N-hydroxysuccinimide 
as a colorless solid in a yield of 70%.  
1H-NMR (400 MHz, CD3Cl) δ: 5.85 (m, 1H, CH2CH2CHCH2), 5.15 (dd, J = 10.2, 1.0 Hz, 
1H, CH2CH2CHCH2cis), 5.09 (dd, J = 10.2, 4.8 Hz, 1H, CH2CH2CHCH2tran), 2.83 (s, 4H, 
COCH2CH2CO), 2.71 (t, J = 7.5 Hz, 2H, COCH2), 2.48 (dt, J = 6.8, 7.5 Hz, 2H, 
COCH2CH2) ppm. 
13C-NMR (100 MHz, CD3Cl) δ: 169.2 (s, COCH2CH2CO), 168.2 (s, COCH2CH2CHCH2), 
135.3 (d, COCH2CH2CHCH2), 116.8 (t, COCH2CH2CHCH2), 30.4 (t, COCH2CH2CHCH2), 
28.5 (t, COCH2CH2CHCH2), 25.7 (t, COCH2CH2CO) ppm. 
Melting point: 47.5-49.5 °C. 
ESI: calcd for C9H12O4N [M+H]+: 198.0766; found: 198.0778. 
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N-4-Pentynoyl-neuraminic acid 35 
 
Method A:  
N-Amino methoxyneuraminic acid methyl ester 107 (100 mg, 0.34 mmol) was dissolved in 
anhydrous DMF (2 mL) and cooled to 0 °C. NHS-ester 108a (132.2 mg, 0.68 mmol) and 
DIPEA (291 µL, 1.7 mmol) were added to the mixture, subsequently. The reaction mixture 
was warmed up to 40 °C, and stirred for 24 h. After removal of the solvent in vacuum, the 
residue was re-dissolved in distilled H2O (1 mL) and cooled to 0 °C, followed by addition of 
NaOH solution (1 mL, 1 M). The reaction mixture was stirred at room temperature for 30 min. 
To stop the reaction, Amberlyst 15 (H+-form) was added and adjusted to pH = 3.0. After fil-
trating of the Amberlyst, the aqueous phase was concentrated and lyophilized to furnish a 
colorless solid. The solid was dissolved in an aqueous solution containing HCl (0.025 M), 
followed by addition of Amberlyst 15 (H+-form, 1 g). The mixture was stirred at 80 °C for 
2 h, and separated by ion exchange chromatography (BIO-Rad GX2 HCOO-) using the pro-
gram: [Double distilled water (20 mL), 1 M HCOOH (20 mL), 2 M HCOOH (20 mL), and 2.5 
M HCOOH (20 mL)]. Solvent was removed under reduced pressure and lyophilized to give N-
4-pentynoyl-neuraminic acid 35 (75 mg, 0.22 mmol, 64%). For analysis, the sample was re-
crystallized from ethanol and diethyl ether.  
Method B:  
A solution of N-amino methoxyneuraminic acid methyl ester 107 (150 mg, 0.51 mmol) in 
anhydrous pyridine (4 mL) was cooled to 4 °C. Subsequently, 4-pentynoic acid (42) (49.9 mg, 
0.51 mg) and DCC (157.8 mg, 0.75 mmol) were added to the solution. The reaction mixture 
was placed at 4 °C over night. Pyridine was azeotropically removed under reduced pressure 
by addition of absolute toluene. The dry residue was dissolved in a mixture of water and Et2O 
(20 mL, 1:1). Precipitated DCU was removed by filtration. The aqueous solution was ex-
tracted with Et2O (10x10 mL) to eliminate unreacted reagents. The aqueous layers were col-
lected and lyophilized to give a slightly brown solid. The solid was dissolved in MeOH 
(1 mL) and was precipitated in Et2O (20 mL). After centrifugation, a colorless solid was ob-
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tained. Deprotection steps were carried out according to method A. However, this approach 
afforded reduced yield in comparison to method A. 
1H-NMR (400 MHz, D2O) δ: 4.04-4.07 (m, 2H, H-4 & H-6), 3.93-3.97 (appt, J = 10.2 Hz, 
1H, H-5), 3.83 (dd, J = 12.0, 2.7 Hz, 1H, H-9a), 3.72-3.74 (m, 1H, H-8), 3.66 (dd, J = 12.0, 
1.0 Hz, 1H, H-9b), 3.58 (dd, J = 12.0, 6.5 Hz, 1H, H-7), 2.50 (m, 4H, CH2CH2CCH), 2.38 (s, 
1H, CH2CH2CCH), 2.29 (dd, J = 12.8, 4.8 Hz, 1H, H-3eq), 1.86 (dd, J = 12.8, 11.5 Hz, 1H, 
H-3ax) ppm.  
13C-NMR (100 MHz, D2O) δ: 175.4 (s, NHCOR), 173.7 (s, C-1), 95.5 (s, C-2), 83.4 (s, 
CH2CH2CCH), 70.3 (d, CH2CH2CCH), 70.3 (d, C-8), 70.2 (d, C-6), 68.2 (d, C-7), 66.7 (d, 
C-4), 63.1 (t, C-9), 52.0 (d, C-5), 38.9 (t, C-3), 34.7 (t, CH2CH2CCH), 14.5 (t, 
CH2CH2CCH) ppm. 
ESI: calcd for C14H20O9N [M-H]-: 346.1138; found: 346.1155. 
N-4-Azidobutanoyl-neuraminic acid 63 
 
N-Amino methoxyneuraminic acid methyl ester 107 (100 mg, 0.34 mmol) was dissolved in 
anhydrous DMF (2 mL) and cooled to 0 °C. NHS-ester 108b (153.8 mg, 0.68 mmol) and 
DIPEA (291 µL, 1.7 mmol) were added to the mixture, subsequently. The reaction mixture 
was warmed up to 40 °C, and stirred for 24 h. Deprotection steps were carried out according 
to the synthesis of N-4-pentynoyl-neuraminic acid 35. Lyophilization afforded N-4-
azidobutytyl-neuraminic acid 63 (75 mg, 0.20 mmol, 58%) as a colorless solid.  
1H-NMR (400 MHz, D2O) δ: 4.08-4.02 (m, 2H, H-4 & H-6), 3.95-3.90 (appt, J = 10.2 Hz, 
1H, H-5), 3.83 (dd, J = 11.9, 2.4 Hz, 1H, H-9a), 3.73 (dt, J = 6.5, 2.4 Hz, 1H, H-8), 3.60 (dd, 
J = 12.0, 6.5 Hz, 1H, H-7), 3.53 (dd, J = 11.9, 1.0 Hz, 1H, H-9b), 3.37 (t, J = 6.5 Hz, 2H, 
CH2CH2CH2N3), 2.39 (t, J = 7.5 Hz, 2H, CH2CH2CH2N3), 2.29 (dd, J = 12.8, 4.8 Hz, 1H, 
H-3eq), 1.83-1.90 (m, 3H, CH2CH2CH2N3 and H-3ax) ppm.  
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13C-NMR (100 MHz, D2O) δ: 176.5 (s, NHCOR), 173.5 (s, C-1), 95.2 (s, C-2), 70.4 (d, C-6), 
70.1 (d, C-8), 68.3 (d, C-7), 66.6 (d, C-4), 63.1 (t, C-9), 51.9 (d, C-5), 50.4 (t, 
CH2CH2CH2N3), 38.7 (t, C-3), 33.0 (t, CH2CH2CH2N3), 24.5 (t, CH2CH2CH2N3) ppm. 
ESI: calcd for C13H21O9N4 [M-H]-: 377.1309; found: 377.1293. 
N-Methacryl-neuraminic acid 110 
 
N-Amino methoxyneuraminic acid methyl ester 107 (100 mg, 0.34 mmol) was dissolved in 
anhydrous pyridine (2 mL) and cooled to 0 °C. After dropwise addition of methacrylic anhy-
dride (256 µL, 0.5 mmol) the mixture was slowly warmed up to room temperature and stirred 
over night. Deprotection steps were carried out according to the synthesis of N-4-pentynoyl-
neuraminic acid 35. After work up, N-methacryl-neuraminic acid 110 was obtained as a color-
less solid (70 mg, 0.21 mmol, 61%). 
1H-NMR (400 MHz, D2O) δ: 5.70 (s, 1H, COC(CH3)CH2cis), 5.47 (s, 1H, COC(CH3)CH2trans), 
4.08-4.02 (m, 2H, H-4 & H-6), 3.90 (t, J = 10.1 Hz, 1H, H-5), 3.82 (dd, J = 12.0, 2.7 Hz, 1H, 
H-9a), 3.73 (dt, J = 6.5, 2.4 Hz, 1H, H-8), 3.58 (dd, J = 12.0, 6.5 Hz, 1H, H-7), 3.54 (dd, J = 
12.0, 1.0 Hz, 1H, H-9b), 2.32 (dd, J = 13.0, 4.8 Hz, 1H, H-3eq), 1.94 (s, COC(CH3)CH2), 1.89 
(dd, J = 13.0, 11.5 Hz, 1H, H-3ax) ppm.  
13C-NMR (100 MHz, D2O) δ: 172.8 (s, NHCOR), 171.0 (s, C-1), 139.0 (s, COC(CH3)CH2), 
121.1 (t, COC(CH3)CH2), 95.3 (s, C-2), 70.3 (d, C-8), 70.2 (d, C-6), 68.3 (d, C-7), 66.4 (d, 
C-4), 63.2 (t, C-9), 52.2 (d, C-5), 38.7 (t, C-3), 17.7 (q, COC(CH3)CH2) ppm. 
ESI: calcd for C13H20O9N [M-H]-: 334.1138; found: 334.1149. 
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N-4-Pentenoyl-neuraminic acid 111 
 
N-Amino methoxyneuraminic acid methyl ester 107 (100 mg, 0.34 mmol) was dissolved in 
anhydrous DMF (2 mL) and cooled to 0 °C. NHS-ester 108d (101 mg, 0.51 mmol) and 
DIPEA (291 µL, 1.7 mmol) were added to the mixture, subsequently. The reaction mixture 
was stirred for 24 h at 40 °C. Deprotection steps were archieved according to the synthesis of 
N-4-pentynoyl-neuraminic acid 35. After work up product 111 was collected as a colorless 
solid (80 mg, 0.24 mmol, 67%). 
1H-NMR (400 MHz, D2O) δ: 5.85 (m, 1H, CH2CH2CHCH2), 5.06 (dd, J = 17.2, 1.7 Hz, 1H, 
CH2CH2CHCH2cis), 5.06 (dd, J = 17.2, 1.2 Hz, 1H, CH2CH2CHCH2trans), 4.08-4.02 (m, 2H, 
H-4 & H-6), 3.87-3.93 (t, J = 10.2 Hz, 1H, H-5), 3.83 (dd, J = 12.0, 2.7 Hz, 1H, H-9a), 3.73 
(dt, J = 6.5, 2.4 Hz, 1H, H-8), 3.59 (dd, J = 12.0, 1.0 Hz, 1H, H-9b), 3.55 (dd, J = 12.0, 
6.5 Hz, 1H, H-7), 2.39 (m, 4H, CH2CH2CHCH2), 2.29 (dd, J = 12.9, 4.8 Hz, 1H, H-3eq), 1.88 
(dd, J = 12.9, 11.5 Hz, 1H, H-3ax) ppm.  
13C-NMR (100 MHz, D2O) δ: 176.9 (s, NHCOR), 171.0 (s, C-1), 137.0 (d, CH2CH2CHCH2), 
115.8 (t, CH2CH2CHCH2), 95.2 (s, C-2), 70.4 (d, C-8), 70.2 (d, C-6), 68.3 (d, C-7), 66.5 (d, 
C-4), 63.2 (t, C-9), 51.9 (d, C-5), 38.7 (t, C-3), 35.2 (t, CH2CH2CHCH2), 27.4 (t, 
CH2CH2CHCH2) ppm. 
ESI: calcd for C14H22O9N [M-H]-: 348.1295; found: 348.1283. 
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6 Spectra 
Trifluoro-butynoic acid ethyl ester (16) 
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Oxanorbornadienyl ethyl ester 17 
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Oxanorbornadienyl carboxylic acid 18  
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N-4-Pentynoyl-neuraminic acid 35 
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γ-Amino polySia (sodium salt) 36   
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γ-Amino polySia (TBA salt) 37   
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N-(4-Azidobutyryl)-polySia 41  
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N-(4-Pentynoyl)-polySia 44  
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Ethoxycarbonylmethyl-triphenyl-phosphonium bromide (46) 
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Trifluoro-3-oxo-2-(triphenyl-phosphanylidene)-butyric acid ethyl ester (47) 
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Oxanorbornadienyl propanoic acid 52a 
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N-Oxanorbornadienyl-polySia 53a  
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N-Oxanorbornadienyl-polySia 53b 
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N-Oxanorbornadienyl-polySia 53c (Before reacetylation) 
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4-Azidobutanamide (54) 
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Pent-4-ynamide (55) 
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4-(4-(3-Amino-3-oxopropyl)-1H-1,2,3-triazol-1-yl)butanamide (56) 
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Alkyno-analogue 57 
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4-Azido-N-benzylbutanamide (60) 
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N-Benzylbutanamido-polySia 61 
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N-4-Azidobutanoyl-neuraminic acid 63 
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N-Methacryl-polySia 68 
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N-Methacryl-polySia 74 
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PolySia lactone 75 
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PolySia hydrazide 76 
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N-(1,2-diol) polySia 81 
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N-Aldehydo-polySia 82 
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Benzhydrazone-polySia 83 
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Benzylamino-polySia 89 
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C-1 Azido-neuraminic acid 97 
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C-1 Alkyno-neuraminic acid 98 
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Neuraminic acid methyl ester 99  
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C-1 Benzylhydrazido-neuraminic acid 101 
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Methoxyneuraminic acid methyl ester 105 
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N-Amino methoxyneuraminic acid 106  
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N-Amino methoxyneuraminic acid methyl ester 107 
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4-Pentynoyl NHS-ester 108a 
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4-Azidobutanoyl NHS-ester 108b 
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4-Pentenoyl NHS-ester 108c 
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Oxanorbornadienyl NHS-ester 108e  
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Oxanorbornadienyl NHS-ester 108f  
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Oxanorbornadienyl NHS-ester 108g 
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N-Methacryl-neuraminic acid 110 
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N-4-Pentenoyl-neuraminic acid 111 
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